,words,labels,sentence_id,full sentence
335,Increasing,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
336,milk,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
337,yield,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
338,is,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
339,still,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
340,the,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
341,most,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
342,profitable,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
343,breeding,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
344,objective,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
345,for,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
346,several,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
347,breeds,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
348,.,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
349,Almost,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
350,all,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
351,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
352,is,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
353,used,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
354,for,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
355,cheese,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
356,production,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
357,and,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
358,",",O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
359,consequently,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
360,",",O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
361,milk,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
362,content,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
363,traits,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
364,are,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
365,very,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
366,important,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
367,.,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
368,Moreover,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
369,",",O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
370,other,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
371,traits,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
372,are,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
373,gaining,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
374,interest,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
375,for,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
376,selection,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
377,:,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
378,machine,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
379,milking,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
380,ability,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
381,and,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
382,udder,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
383,morphology,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
384,",",O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
385,resistance,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
386,to,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
387,diseases,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
388,(,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
389,mastitis,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
390,",",O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
391,internal,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
392,parasites,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
393,",",O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
394,scrapie,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
395,),O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
396,",",O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
397,and,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
398,traits,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
399,related,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
400,to,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
401,the,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
402,nutritional,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
403,value,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
404,of,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
405,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
406,(,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
407,fatty,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
408,acid,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
409,composition,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
410,),O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
411,.,O,11.0,"Moreover , other traits are gaining interest for selection : machine milking ability and udder morphology , resistance to diseases ( mastitis , internal parasites , scrapie ) , and traits related to the nutritional value of milk ( fatty acid composition ) ."
716,The,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
717,ratio,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
718,of,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
719,fasting,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
720,urinary,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
721,hydroxyproline,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
722,to,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
723,creatinine,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
724,did,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
725,not,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
726,decrease,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
727,",",O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
728,indicating,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
729,no,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
730,significant,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
731,reduction,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
732,of,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
733,bone,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
734,resorption,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
735,in,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
736,our,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
737,subjects,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
738,.,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
997,Overweight,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
998,and,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
999,obesity,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1000,constitute,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1001,a,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1002,global,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1003,pandemic,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1004,with,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1005,devastating,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1006,consequences,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1007,that,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1008,affect,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1009,>,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1010,2,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1011,billion,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1012,people,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1013,.,O,31.0,Overweight and obesity constitute a global pandemic with devastating consequences that affect > 2 billion people .
1177,Education,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1178,to,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1179,promote,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1180,positive,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1181,choices,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1182,and,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1183,physical,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1184,activity,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1185,and,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1186,resolute,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1187,public,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1188,health,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1189,interventions,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1190,on,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1191,food,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1192,delivery,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1193,are,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1194,requested,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1195,to,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1196,reduce,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1197,the,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1198,burden,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1199,of,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1200,obesity,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1201,-,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1202,related,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1203,cancer,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1204,and,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1205,lighten,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1206,the,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1207,unsustainable,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1208,growing,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1209,expenses,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1210,to,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1211,health,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1212,systems,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1213,.,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1275,Several,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1276,spices,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1277,are,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1278,potential,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1279,sources,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1280,for,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1281,prevention,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1282,and,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1283,treatment,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1284,of,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1285,cancers,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1286,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1287,such,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1288,as,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1289,Curcuma,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1290,longa,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1291,(,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1292,tumeric,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1293,),O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1294,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1295,Nigella,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1296,sativa,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1297,(,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1298,black,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1299,cumin,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1300,),O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1301,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1302,Zingiber,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1303,officinale,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1304,(,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1305,ginger,B-http://purl.bioontology.org/ontology/SNOMEDCT/227400003,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1306,),O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1307,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1308,Allium,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1309,sativum,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1310,(,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1311,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1312,),O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1313,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1314,Crocus,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1315,sativus,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1316,(,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1317,saffron,B-http://purl.bioontology.org/ontology/SNOMEDCT/735010000,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1318,),O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1319,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1320,Piper,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1321,nigrum,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1322,(,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1323,black,B-http://purl.bioontology.org/ontology/SNOMEDCT/412060000;http://purl.bioontology.org/ontology/SNOMEDCT/227563001,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1324,pepper,I-http://purl.bioontology.org/ontology/SNOMEDCT/412060000;http://purl.bioontology.org/ontology/SNOMEDCT/227563001,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1325,),O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1326,and,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1327,Capsicum,B-http://purl.bioontology.org/ontology/SNOMEDCT/421556008,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1328,annum,I-http://purl.bioontology.org/ontology/SNOMEDCT/421556008,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1329,(,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1330,chili,B-http://purl.bioontology.org/ontology/SNOMEDCT/710040007;http://purl.bioontology.org/ontology/SNOMEDCT/227563001,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1331,pepper,I-http://purl.bioontology.org/ontology/SNOMEDCT/710040007;http://purl.bioontology.org/ontology/SNOMEDCT/227563001,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1332,),O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1333,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1334,which,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1335,contained,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1336,several,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1337,important,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1338,bioactive,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1339,compounds,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1340,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1341,such,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1342,as,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1343,curcumin,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1344,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1345,thymoquinone,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1346,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1347,piperine,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1348,and,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1349,capsaicin,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1350,.,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1405,It,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1406,has,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1407,been,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1408,suggested,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1409,that,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1410,the,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1411,isoflavone,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1412,",",O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1413,genistein,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1414,",",O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1415,",",O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1416,may,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1417,have,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1418,some,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1419,role,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1420,as,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1421,a,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1422,chemopreventive,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1423,agent,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1424,against,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1425,cancer,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1426,in,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1427,humans,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1428,.,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1620,Soy,B-http://purl.bioontology.org/ontology/SNOMEDCT/227537006;http://purl.bioontology.org/ontology/SNOMEDCT/227519005,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1621,sauce,I-http://purl.bioontology.org/ontology/SNOMEDCT/227537006;http://purl.bioontology.org/ontology/SNOMEDCT/227519005,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1622,was,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1623,also,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1624,found,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1625,to,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1626,contain,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1627,both,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1628,isoflavones,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1629,",",O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1630,but,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1631,at,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1632,levels,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1633,lower,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1634,than,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1635,in,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1636,miso,B-http://purl.bioontology.org/ontology/SNOMEDCT/227354002,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1637,and,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1638,natto,B-http://purl.bioontology.org/ontology/SNOMEDCT/443621000124102,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1639,.,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1795,During,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1796,"2,193,751",O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1797,person,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1798,years,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1799,of,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1800,follow,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1801,-,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1802,up,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1803,from,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1804,1995/1996,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1805,-,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1806,2000,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1807,",",O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1808,787,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1809,participants,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1810,were,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1811,diagnosed,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1812,with,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1813,head,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1814,and,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1815,neck,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1816,cancer,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1817,.,O,56.0,"During 2,193,751 person years of follow - up from 1995/1996 - 2000 , 787 participants were diagnosed with head and neck cancer ."
1996,Results,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
1997,from,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
1998,this,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
1999,large,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2000,prospective,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2001,observational,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2002,study,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2003,are,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2004,consistent,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2005,with,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2006,previous,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2007,case,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2008,-,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2009,control,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2010,studies,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2011,and,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2012,support,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2013,the,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2014,hypothesis,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2015,that,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2016,total,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2017,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2018,and,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2019,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2020,intake,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2021,is,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2022,associated,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2023,with,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2024,reduced,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2025,risk,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2026,of,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2027,head,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2028,and,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2029,neck,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2030,cancer,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2031,.,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2079,One,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2080,wonders,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2081,which,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2082,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2083,and,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2084,other,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2085,cocoa,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2086,derivatives,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2087,can,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2088,be,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2089,considered,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2090,as,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2091,biofunctional,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2092,food,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2093,products,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2094,.,O,64.0,One wonders which chocolate and other cocoa derivatives can be considered as biofunctional food products .
2231,Ginger,B-http://purl.bioontology.org/ontology/SNOMEDCT/227400003,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2232,",",O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2233,one,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2234,of,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2235,the,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2236,most,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2237,widely,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2238,consumed,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2239,spices,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2240,",",O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2241,has,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2242,shown,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2243,beneficial,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2244,effects,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2245,against,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2246,obesity,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2247,and,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2248,related,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2249,metabolic,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2250,disorders,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2251,.,O,71.0,"Ginger , one of the most widely consumed spices , has shown beneficial effects against obesity and related metabolic disorders ."
2270,Mice,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2271,were,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2272,maintained,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2273,on,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2274,either,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2275,a,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2276,normal,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2277,control,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2278,diet,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2279,or,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2280,a,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2281,high,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2282,-,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2283,fat,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2284,diet,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2285,(,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2286,HFD,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2287,),O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2288,with,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2289,or,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2290,without,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2291,500,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2292,mg,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2293,/,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2294,kg,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2295,(,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2296,w,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2297,/,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2298,w,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2299,),O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2300,ginger,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2301,supplementation,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
2302,.,O,73.0,Mice were maintained on either a normal control diet or a high - fat diet ( HFD ) with or without 500 mg / kg ( w / w ) ginger supplementation .
3189,Insulin,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3190,AUC,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3191,was,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3192,higher,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3193,for,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3194,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3195,and,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3196,LFM,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3197,versus,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3198,OJ,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3199,and,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3200,water,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3201,;,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3202,(,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3203,2,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3204,),O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3205,Glucose,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3206,AUCs,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3207,were,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3208,not,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3209,different,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3210,among,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3211,water,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3212,and,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3213,milks,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3214,while,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3215,insulin,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3216,AUC,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3217,was,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3218,higher,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3219,for,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3220,milks,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3221,versus,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3222,water,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3223,.,O,99.0,Insulin AUC was higher for coffee and LFM versus OJ and water ; ( 2 ) Glucose AUCs were not different among water and milks while insulin AUC was higher for milks versus water .
3294,Trained,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3295,dietitians,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3296,interviewed,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3297,136,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3298,patients,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3299,diagnosed,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3300,with,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3301,GC,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3302,",",O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3303,and,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3304,the,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3305,same,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3306,number,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3307,of,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3308,controls,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3309,were,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3310,selected,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3311,by,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3312,matching,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3313,sex,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3314,",",O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3315,age,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3316,and,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3317,hospital,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3318,.,O,102.0,"Trained dietitians interviewed 136 patients diagnosed with GC , and the same number of controls were selected by matching sex , age and hospital ."
3880,Golden,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3881,-,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3882,Syrian,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3883,hamsters,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3884,were,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3885,fed,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3886,a,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3887,nonpurified,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3888,(,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3889,6.25,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3890,g/100,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3891,g,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3892,fat,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3893,),O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3894,diet,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3895,containing,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3896,an,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3897,additional,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3898,10,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3899,g/100,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3900,g,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3901,experimental,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3902,fat,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3903,and,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3904,0.1,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3905,g/100,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3906,g,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3907,cholesterol,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3908,for,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3909,6,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3910,wk,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3911,.,O,123.0,Golden - Syrian hamsters were fed a nonpurified ( 6.25 g/100 g fat ) diet containing an additional 10 g/100 g experimental fat and 0.1 g/100 g cholesterol for 6 wk .
3912,Canola,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3913,and,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3914,soybean,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3915,oils,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3916,significantly,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3917,lowered,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3918,serum,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3919,HDL,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3920,cholesterol,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3921,concentrations,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3922,relative,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3923,to,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3924,butter,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3925,.,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
4233,Isolation,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4234,and,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4235,identification,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4236,of,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4237,delta,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4238,-,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4239,viniferin,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4240,was,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4241,achieved,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4242,by,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4243,NMR,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4244,after,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4245,extraction,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4246,and,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4247,fractionation,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4248,of,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4249,red,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4250,wine,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4251,phenolics,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4252,.,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4380,It,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4381,would,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4382,be,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4383,important,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4384,in,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4385,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4386,future,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4387,to,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4388,investigate,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4389,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4390,origins,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4391,of,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4392,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4393,differences,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4394,in,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4395,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4396,stilbene,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4397,levels,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4398,in,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4399,relation,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4400,to,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4401,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4402,vine,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4403,varieties,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4404,",",O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4405,and,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4406,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4407,bioavailability,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4408,of,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4409,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4410,newly,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4411,extracted,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4412,stilbene,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4413,delta,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4414,-,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4415,viniferin,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4416,in,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4417,plasma,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4418,after,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4419,consumption,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4420,of,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4421,different,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4422,types,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4423,of,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4424,wines,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4425,.,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4426,Street,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4427,food,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4428,is,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4429,popular,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4430,in,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4431,Eastern,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4432,Europe,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4433,",",O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4434,but,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4435,its,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4436,diversity,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4437,and,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4438,nutritional,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4439,value,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4440,are,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4441,unknown,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4442,.,O,139.0,"Street food is popular in Eastern Europe , but its diversity and nutritional value are unknown ."
4539,Samples,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4540,of,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4541,the,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4542,most,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4543,commonly,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4544,available,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4545,foods,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4546,of,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4547,unknown,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4548,composition,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4549,were,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4550,collected,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4551,(,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4552,twenty,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4553,-,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4554,eight,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4555,home,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4556,-,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4557,made,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4558,and,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4559,twenty,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4560,-,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4561,four,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4562,industrial,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4563,),O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4564,.,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4565,Macronutrients,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4566,",",O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4567,Na,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4568,and,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4569,K,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4570,were,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4571,quantified,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4572,through,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4573,chemical,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4574,analysis,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4575,.,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4741,Concluding,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4742,",",O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4743,industrial,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4744,snacks,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4745,and,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4746,home,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4747,-,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4748,made,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4749,pastries,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4750,high,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4751,in,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4752,Na,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4753,and,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4754,unhealthy,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4755,fat,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4756,were,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4757,frequent,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4758,in,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4759,Chişinău,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4760,.,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
5090,Thus,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5091,",",O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5092,we,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5093,aimed,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5094,to,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5095,investigate,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5096,the,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5097,effect,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5098,of,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5099,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5100,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5101,in,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5102,a,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5103,preclinical,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5104,model,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5105,of,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5106,colon,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5107,cancer,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5108,by,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5109,targeting,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5110,genetic,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5111,and,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5112,epigenetic,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5113,mechanisms,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5114,.,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5236,Olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5237,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5238,markedly,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5239,decreased,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5240,the,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5241,expression,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5242,of,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5243,inflammatory,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5244,and,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5245,angiogenic,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5246,markers,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5247,and,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5248,restored,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5249,the,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5250,expression,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5251,of,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5252,pro,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5253,-,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5254,apoptotic,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5255,markers,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5256,in,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5257,DMH,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5258,-,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5259,treated,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5260,rats,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5261,.,O,168.0,Olive oil markedly decreased the expression of inflammatory and angiogenic markers and restored the expression of pro - apoptotic markers in DMH - treated rats .
5407,Several,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5408,milk,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5409,peptides,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5410,have,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5411,been,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5412,shown,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5413,to,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5414,have,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5415,antihypertensive,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5416,effects,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5417,in,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5418,animal,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5419,and,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5420,in,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5421,clinical,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5422,studies,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5423,.,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5599,Total,O,182.0,Total fluid intake was not associated with bladder cancer .
5600,fluid,O,182.0,Total fluid intake was not associated with bladder cancer .
5601,intake,O,182.0,Total fluid intake was not associated with bladder cancer .
5602,was,O,182.0,Total fluid intake was not associated with bladder cancer .
5603,not,O,182.0,Total fluid intake was not associated with bladder cancer .
5604,associated,O,182.0,Total fluid intake was not associated with bladder cancer .
5605,with,O,182.0,Total fluid intake was not associated with bladder cancer .
5606,bladder,O,182.0,Total fluid intake was not associated with bladder cancer .
5607,cancer,O,182.0,Total fluid intake was not associated with bladder cancer .
5608,.,O,182.0,Total fluid intake was not associated with bladder cancer .
5764,Similarly,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5765,",",O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5766,the,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5767,protection,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5768,from,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5769,water,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5770,intake,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5771,was,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5772,confined,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5773,to,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5774,women,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5775,who,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5776,did,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5777,not,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5778,experience,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5779,nocturia,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5780,and,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5781,to,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5782,men,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5783,who,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5784,did,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5785,.,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5973,Rats,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5974,were,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5975,fed,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5976,a,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5977,high,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5978,-,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5979,fat,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5980,-,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5981,sucrose,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5982,(,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5983,HFS,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5984,),O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5985,diet,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5986,with,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5987,or,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5988,without,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5989,supplementation,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5990,of,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5991,different,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5992,polyphenolic,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5993,plant,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5994,extracts,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5995,(,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5996,almond,B-http://purl.bioontology.org/ontology/SNOMEDCT/256350002,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5997,",",O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5998,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5999,",",O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6000,cinnamon,B-http://purl.bioontology.org/ontology/SNOMEDCT/227388008,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6001,",",O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6002,orange,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6003,blossom,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6004,",",O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6005,hamamelis,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6006,",",O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6007,lime,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6008,blossom,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6009,",",O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6010,grape,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6011,vine,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6012,",",O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6013,and,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6014,birch,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6015,),O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6016,for,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6017,56,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6018,-,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6019,64,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6020,days,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6021,.,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6110,Lycopene,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6111,is,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6112,chemically,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6113,acyclic,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6114,carotene,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6115,with,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6116,11,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6117,conjugated,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6118,double,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6119,bonds,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6120,",",O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6121,normally,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6122,in,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6123,transconfiguration,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6124,while,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6125,isomerization,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6126,occur,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6127,in,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6128,blood,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6129,plasma,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6130,for,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6131,its,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6132,better,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6133,absorption,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6134,.,O,199.0,"Lycopene is chemically acyclic carotene with 11 conjugated double bonds , normally in transconfiguration while isomerization occur in blood plasma for its better absorption ."
6135,It,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6136,has,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6137,ability,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6138,for,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6139,adenosine,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6140,deaminase,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6141,inhibition,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6142,that,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6143,plays,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6144,important,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6145,role,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6146,in,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6147,the,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6148,regression,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6149,of,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6150,tumor,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6151,.,O,200.0,It has ability for adenosine deaminase inhibition that plays important role in the regression of tumor .
6206,Both,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6207,in,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6208,vitro,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6209,and,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6210,in,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6211,vivo,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6212,studies,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6213,have,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6214,elucidated,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6215,the,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6216,potential,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6217,of,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6218,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6219,against,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6220,variety,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6221,of,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6222,metabolic,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6223,syndromes,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6224,.,O,203.0,Both in vitro and in vivo studies have elucidated the potential of tomato against variety of metabolic syndromes .
6479,Preliminary,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6480,data,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6481,suggest,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6482,that,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6483,polyphenols,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6484,in,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6485,some,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6486,100,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6487,%,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6488,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6489,juices,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6490,may,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6491,inhibit,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6492,absorption,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6493,of,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6494,naturally,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6495,occurring,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6496,sugars,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6497,.,O,211.0,Preliminary data suggest that polyphenols in some 100 % fruit juices may inhibit absorption of naturally occurring sugars .
6758,The,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6759,greatest,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6760,amount,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6761,of,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6762,dietary,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6763,calcium,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6764,is,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6765,obtained,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6766,from,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6767,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6768,and,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6769,dairy,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6770,foods,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6771,",",O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6772,which,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6773,also,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6774,provide,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6775,the,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6776,human,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6777,diet,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6778,with,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6779,vitamin,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6780,D,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6781,(,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6782,particularly,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6783,for,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6784,products,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6785,fortified,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6786,with,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6787,vitamin,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6788,D,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6789,),O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6790,",",O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6791,potassium,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6792,",",O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6793,and,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6794,other,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6795,macro-,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6796,and,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6797,micronutrients,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
6798,.,O,220.0,"The greatest amount of dietary calcium is obtained from milk and dairy foods , which also provide the human diet with vitamin D ( particularly for products fortified with vitamin D ) , potassium , and other macro- and micronutrients ."
7106,Sugar,O,234.0,Sugar and/or cream were added to the coffee samples to test whether MG levels were altered .
7107,and/or,O,234.0,Sugar and/or cream were added to the coffee samples to test whether MG levels were altered .
7108,cream,B-http://purl.bioontology.org/ontology/SNOMEDCT/255621006,234.0,Sugar and/or cream were added to the coffee samples to test whether MG levels were altered .
7109,were,O,234.0,Sugar and/or cream were added to the coffee samples to test whether MG levels were altered .
7110,added,O,234.0,Sugar and/or cream were added to the coffee samples to test whether MG levels were altered .
7111,to,O,234.0,Sugar and/or cream were added to the coffee samples to test whether MG levels were altered .
7112,the,O,234.0,Sugar and/or cream were added to the coffee samples to test whether MG levels were altered .
7113,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,234.0,Sugar and/or cream were added to the coffee samples to test whether MG levels were altered .
7114,samples,O,234.0,Sugar and/or cream were added to the coffee samples to test whether MG levels were altered .
7115,to,O,234.0,Sugar and/or cream were added to the coffee samples to test whether MG levels were altered .
7116,test,O,234.0,Sugar and/or cream were added to the coffee samples to test whether MG levels were altered .
7117,whether,O,234.0,Sugar and/or cream were added to the coffee samples to test whether MG levels were altered .
7118,MG,O,234.0,Sugar and/or cream were added to the coffee samples to test whether MG levels were altered .
7119,levels,O,234.0,Sugar and/or cream were added to the coffee samples to test whether MG levels were altered .
7120,were,O,234.0,Sugar and/or cream were added to the coffee samples to test whether MG levels were altered .
7121,altered,O,234.0,Sugar and/or cream were added to the coffee samples to test whether MG levels were altered .
7122,.,O,234.0,Sugar and/or cream were added to the coffee samples to test whether MG levels were altered .
7269,Due,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7270,to,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7271,the,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7272,overconsumption,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7273,of,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7274,exogenous,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7275,MG,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7276,",",O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7277,drinking,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7278,an,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7279,excess,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7280,of,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7281,any,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7282,type,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7283,of,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7284,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7285,poses,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7286,health,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7287,risks,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7288,.,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7468,However,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7469,",",O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7470,fruit,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7471,-,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7472,specific,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7473,IgE,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7474,antibodies,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7475,were,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7476,detected,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7477,only,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7478,in,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7479,serum,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7480,samples,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7481,from,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7482,32.1,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7483,%,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7484,of,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7485,the,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7486,patients,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7487,who,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7488,perceived,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7489,symptoms,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7490,due,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7491,to,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7492,these,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7493,fruits,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7494,.,O,248.0,"However , fruit - specific IgE antibodies were detected only in serum samples from 32.1 % of the patients who perceived symptoms due to these fruits ."
7624,In,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7625,particular,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7626,there,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7627,was,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7628,no,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7629,protective,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7630,effect,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7631,of,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7632,dietary,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7633,fibre,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7634,and,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7635,",",O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7636,for,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7637,cruciferous,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7638,vegetables,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7639,",",O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7640,only,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7641,a,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7642,minor,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7643,protective,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7644,effect,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7645,in,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7646,females,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7647,.,O,253.0,"In particular there was no protective effect of dietary fibre and , for cruciferous vegetables , only a minor protective effect in females ."
7695,For,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7696,males,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7697,",",O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7698,consumption,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7699,of,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7700,eggs,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7701,",",O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7702,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7703,and,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7704,veal,B-http://purl.bioontology.org/ontology/SNOMEDCT/226952003,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7705,significantly,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7706,increased,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7707,risk,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7708,but,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7709,not,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7710,consumption,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7711,of,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7712,pork,B-http://purl.bioontology.org/ontology/SNOMEDCT/226934003,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7713,",",O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7714,while,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7715,for,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7716,females,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7717,",",O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7718,there,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7719,was,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7720,a,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7721,non,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7722,-,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7723,significant,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7724,increase,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7725,in,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7726,risk,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7727,with,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7728,consumption,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7729,of,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7730,eggs,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7731,",",O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7732,no,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7733,increased,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7734,risk,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7735,with,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7736,consumption,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7737,of,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7738,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7739,or,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7740,veal,B-http://purl.bioontology.org/ontology/SNOMEDCT/226952003,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7741,and,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7742,a,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7743,significantly,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7744,increased,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7745,risk,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7746,with,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7747,consumption,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7748,of,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7749,pork,B-http://purl.bioontology.org/ontology/SNOMEDCT/226934003,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7750,.,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7751,There,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7752,was,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7753,no,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7754,protective,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7755,effect,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7756,of,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7757,dietary,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7758,fibre,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7759,or,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7760,of,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7761,cruciferous,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7762,vegetables,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7763,for,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7764,rectal,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7765,cancer,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7766,",",O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7767,but,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7768,in,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7769,females,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7770,",",O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7771,there,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7772,was,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7773,a,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7774,significantly,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7775,increased,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7776,risk,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7777,for,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7778,consumption,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7779,of,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7780,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7781,",",O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7782,though,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7783,this,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7784,was,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7785,somewhat,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7786,reduced,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7787,when,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7788,controlled,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7789,for,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7790,consumption,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7791,of,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7792,saturated,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7793,fat,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
7794,.,O,257.0,"There was no protective effect of dietary fibre or of cruciferous vegetables for rectal cancer , but in females , there was a significantly increased risk for consumption of beer , though this was somewhat reduced when controlled for consumption of saturated fat ."
8093,Food,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8094,fortification,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8095,is,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8096,designed,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8097,to,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8098,improve,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8099,the,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8100,nutritional,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8101,profile,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8102,of,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8103,diets,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8104,.,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8307,Under,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8308,the,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8309,realistic,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8310,scenario,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8311,",",O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8312,no,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8313,country,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8314,exceeded,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8315,100,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8316,%,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8317,of,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8318,the,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8319,UL,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8320,for,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8321,any,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8322,nutrient,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8323,.,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8465,A,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8466,validated,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8467,and,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8468,reproducible,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8469,food,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8470,frequency,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8471,questionnaire,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8472,",",O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8473,including,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8474,78,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8475,foods,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8476,and,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8477,beverages,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8478,",",O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8479,plus,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8480,a,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8481,separate,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8482,section,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8483,on,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8484,alcohol,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8485,drinking,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8486,",",O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8487,was,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8488,used,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8489,to,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8490,assess,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8491,patients,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8492,',O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8493,dietary,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8494,habits,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8495,2,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8496,years,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8497,before,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8498,diagnosis,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8499,or,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8500,hospital,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8501,admission,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8502,.,O,280.0,"A validated and reproducible food frequency questionnaire , including 78 foods and beverages , plus a separate section on alcohol drinking , was used to assess patients ' dietary habits 2 years before diagnosis or hospital admission ."
8574,Poultry,B-http://purl.bioontology.org/ontology/SNOMEDCT/28230009,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8575,(,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8576,OR,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8577,=,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8578,0.74,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8579,),O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8580,",",O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8581,processed,B-http://purl.bioontology.org/ontology/SNOMEDCT/227031001;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8582,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/227031001;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8583,(,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8584,OR,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8585,=,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8586,0.64,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8587,),O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8588,and,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8589,vegetables,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8590,(,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8591,OR,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8592,=,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8593,0.65,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8594,),O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8595,were,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8596,inversely,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8597,associated,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8598,with,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8599,RCC,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8600,risk,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8601,.,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
9016,Notably,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9017,",",O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9018,lactoferrin,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9019,produced,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9020,sustained,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9021,weight,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9022,and,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9023,fat,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9024,loss,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9025,",",O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9026,and,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9027,attenuated,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9028,the,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9029,reduction,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9030,in,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9031,energy,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9032,expenditure,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9033,associated,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9034,with,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9035,calorie,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9036,restriction,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9037,.,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9118,Dietary,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9119,lactalbumin,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9120,and,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9121,lactoferrin,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9122,improved,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9123,energy,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9124,balance,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9125,and,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9126,metabolism,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9127,",",O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9128,and,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9129,decreased,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9130,adiposity,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9131,",",O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9132,with,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9133,the,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9134,effects,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9135,of,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9136,lactoferrin,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9137,being,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9138,partly,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9139,independent,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9140,of,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9141,caloric,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9142,intake,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9143,.,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9489,Floral,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9490,transition,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9491,",",O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9492,from,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9493,vegetative,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9494,to,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9495,reproductive,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9496,stage,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9497,",",O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9498,in,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9499,a,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9500,plant,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9501,",",O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9502,is,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9503,regulated,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9504,by,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9505,environmental,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9506,(,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9507,light,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9508,",",O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9509,temperature,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9510,),O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9511,and,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9512,endogenous,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9513,factors,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
9514,.,O,314.0,"Floral transition , from vegetative to reproductive stage , in a plant , is regulated by environmental ( light , temperature ) and endogenous factors ."
10370,The,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10371,MOEs,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10372,for,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10373,the,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10374,younger,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10375,age,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10376,groups,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10377,indicate,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10378,a,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10379,health,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10380,concern,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10381,for,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10382,the,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10383,food,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10384,consumption,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10385,surveys,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10386,with,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10387,the,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10388,highest,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10389,mean,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10390,exposure,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10391,",",O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10392,as,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10393,well,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10394,as,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10395,for,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10396,the,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10397,P95,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10398,exposure,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10399,in,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10400,all,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10401,surveys,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10402,.,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10576,Further,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10577,",",O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10578,associations,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10579,between,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10580,nutritional,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10581,contents,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10582,(,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10583,vitamins,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10584,",",O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10585,minerals,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10586,and,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10587,low,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10588,fat,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10589,),O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10590,and,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10591,pharmacological,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10592,properties,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10593,of,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10594,plant,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10595,-,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10596,based,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10597,protein,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10598,may,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10599,have,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10600,extra,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10601,beneficial,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10602,effects,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10603,.,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10958,In,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10959,conclusion,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10960,",",O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10961,glucose,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10962,tolerance,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10963,status,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10964,did,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10965,not,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10966,",",O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10967,in,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10968,general,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10969,",",O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10970,affect,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10971,the,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10972,predictive,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10973,effect,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10974,of,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10975,the,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10976,dietary,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10977,patterns,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10978,.,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
11149,We,O,374.0,"We followed 15,765 adults without obesity at baseline ."
11150,followed,O,374.0,"We followed 15,765 adults without obesity at baseline ."
11151,"15,765",O,374.0,"We followed 15,765 adults without obesity at baseline ."
11152,adults,O,374.0,"We followed 15,765 adults without obesity at baseline ."
11153,without,O,374.0,"We followed 15,765 adults without obesity at baseline ."
11154,obesity,O,374.0,"We followed 15,765 adults without obesity at baseline ."
11155,at,O,374.0,"We followed 15,765 adults without obesity at baseline ."
11156,baseline,O,374.0,"We followed 15,765 adults without obesity at baseline ."
11157,.,O,374.0,"We followed 15,765 adults without obesity at baseline ."
11215,During,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11216,the,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11217,follow,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11218,-,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11219,up,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11220,",",O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11221,873,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11222,incident,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11223,cases,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11224,of,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11225,obesity,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11226,were,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11227,identified,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11228,.,O,377.0,"During the follow - up , 873 incident cases of obesity were identified ."
11394,Components,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11395,of,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11396,the,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11397,Mediterranean,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11398,diet,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11399,associated,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11400,with,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11401,better,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11402,cardiovascular,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11403,health,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11404,include,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11405,low,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11406,consumption,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11407,of,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11408,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11409,and,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11410,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/227003005;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11411,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/227003005;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11412,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11413,moderate,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11414,consumption,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11415,of,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11416,ethanol,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11417,(,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11418,mostly,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11419,from,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11420,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11421,),O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11422,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11423,and,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11424,high,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11425,consumption,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11426,of,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11427,vegetables,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11428,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11429,fruits,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11430,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11431,nuts,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11432,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11433,legumes,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11434,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11435,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11436,",",O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11437,and,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11438,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11439,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11440,.,O,381.0,"Components of the Mediterranean diet associated with better cardiovascular health include low consumption of meat and meat products , moderate consumption of ethanol ( mostly from wine ) , and high consumption of vegetables , fruits , nuts , legumes , fish , and olive oil ."
11960,The,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11961,objective,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11962,of,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11963,this,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11964,study,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11965,was,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11966,to,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11967,determine,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11968,the,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11969,effect,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11970,of,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11971,substitution,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11972,of,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11973,20,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11974,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11975,split,B-http://purl.bioontology.org/ontology/SNOMEDCT/260184002,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11976,yellow,I-http://purl.bioontology.org/ontology/SNOMEDCT/260184002,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11977,pea,I-http://purl.bioontology.org/ontology/SNOMEDCT/260184002,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11978,(,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11979,SYP,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11980,),O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11981,flour,B-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11982,treated,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11983,by,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11984,Revtech,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11985,thermal,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11986,processing,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11987,at,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11988,140,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11989, ,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11990,°,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11991,C,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11992,with,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11993,10,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11994,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11995,steam,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11996,(,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11997,RT10,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11998,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11999,),O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12000,and,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12001,without,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12002,steam,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12003,(,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12004,RT0,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12005,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12006,),O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12007,for,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12008,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12009,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12010,in,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12011,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12012,on,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12013,the,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12014,sensory,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12015,attributes,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12016,",",O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12017,acceptability,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12018,",",O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12019,nutrient,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12020,composition,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12021,",",O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12022,firmness,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12023,",",O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12024,color,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12025,",",O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12026,and,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12027,pH.,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12028,RT10,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12029,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12030,was,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12031,more,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12032,acceptable,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12033,overall,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12034,than,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12035,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/260184002;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12036,with,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/260184002;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12037,untreated,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/260184002;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12038,pea,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/260184002;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12039,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/260184002;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12040,(,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12041,USYP,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12042,),O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12043,or,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12044,RT0,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12045,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12046,as,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12047,assessed,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12048,by,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12049,110,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12050,consumers,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12051,.,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12731,The,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12732,possible,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12733,population,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12734,-,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12735,preventable,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12736,fraction,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12737,for,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12738,modifying,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12739,diet,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12740,in,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12741,relation,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12742,to,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12743,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12744,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12745,vegetable,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12746,consumption,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12747,was,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12748,calculated,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12749,as,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12750,well,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12751,as,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12752,an,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12753,overall,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12754,statement,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12755,about,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12756,the,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12757,degree,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12758,of,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12759,evidence,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12760,for,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12761,the,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12762,cancer,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12763,-,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12764,preventive,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12765,effect,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12766,of,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12767,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12768,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12769,vegetable,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12770,consumption,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12771,for,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12772,each,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12773,cancer,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12774,site,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12775,.,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12776,There,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12777,is,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12778,limited,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12779,evidence,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12780,for,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12781,a,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12782,cancer,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12783,-,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12784,preventive,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12785,effect,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12786,of,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12787,the,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12788,consumption,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12789,of,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12790,fruits,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12791,and,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12792,vegetables,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12793,for,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12794,cancer,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12795,of,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12796,the,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12797,mouth,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12798,and,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12799,pharynx,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12800,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12801,esophagus,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12802,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12803,stomach,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12804,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12805,colon,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12806,-,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12807,rectum,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12808,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12809,larynx,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12810,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12811,lung,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12812,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12813,ovary,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12814,(,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12815,vegetables,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12816,only,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12817,),O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12818,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12819,bladder,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12820,(,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12821,fruit,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12822,only,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12823,),O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12824,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12825,and,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12826,kidney,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12827,.,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
13040,Despite,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13041,a,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13042,different,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13043,methodology,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13044,",",O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13045,reports,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13046,from,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13047,several,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13048,Asian,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13049,centres,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13050,suggest,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13051,a,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13052,similar,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13053,frequency,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13054,of,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13055,hypersensitivity,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13056,to,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13057,these,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13058,foods,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13059,in,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13060,young,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13061,children,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13062,although,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13063,hypersensitivity,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13064,to,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13065,shellfish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735029006,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13066,and,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13067,seafood,B-http://purl.bioontology.org/ontology/SNOMEDCT/44027008,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13068,was,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13069,more,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13070,common,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13071,than,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13072,for,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13073,nuts,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13074,",",O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13075,peanut,B-http://purl.bioontology.org/ontology/SNOMEDCT/762952008,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13076,and,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13077,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13078,",",O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13079,if,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13080,seafoods,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13081,are,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13082,part,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13083,of,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13084,the,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13085,staple,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13086,infant,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13087,diet,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13088,.,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13131,The,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13132,aim,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13133,of,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13134,the,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13135,present,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13136,study,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13137,was,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13138,to,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13139,compare,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13140,the,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13141,acute,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13142,effect,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13143,of,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13144,meals,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13145,rich,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13146,in,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13147,casein,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13148,and,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13149,carbohydrate,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13150,and,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13151,a,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13152,combination,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13153,of,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13154,both,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13155,nutrients,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13156,on,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13157,postprandial,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13158,plasma,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13159,concentrations,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13160,of,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13161,IL-6,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13162,",",O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13163,a,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13164,marker,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13165,of,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13166,inflammation,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13167,",",O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13168,in,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13169,obese,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13170,women,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13171,.,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13763,Their,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13764,common,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13765,structural,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13766,features,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13767,",",O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13768,such,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13769,as,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13770,eight,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13771,conserved,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13772,cysteines,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13773,forming,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13774,disulfide,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13775,bridges,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13776,",",O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13777,basic,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13778,isoelectric,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13779,point,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13780,and,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13781,high,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13782,similarity,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13783,in,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13784,amino,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13785,acid,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13786,sequence,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13787,",",O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13788,are,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13789,the,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13790,basis,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13791,of,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13792,allergic,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13793,clinical,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13794,cross,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13795,-,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13796,reactivity,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13797,.,O,458.0,"Their common structural features , such as eight conserved cysteines forming disulfide bridges , basic isoelectric point and high similarity in amino acid sequence , are the basis of allergic clinical cross - reactivity ."
13875,They,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13876,have,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13877,been,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13878,identified,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13879,in,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13880,the,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13881,most,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13882,diffused,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13883,edible,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13884,seeds,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13885,and,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13886,nuts,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13887,",",O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13888,such,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13889,as,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13890,mustard,B-http://purl.bioontology.org/ontology/SNOMEDCT/51905005,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13891,",",O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13892,sesame,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13893,",",O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13894,Brazil,B-http://purl.bioontology.org/ontology/SNOMEDCT/256351003;http://purl.bioontology.org/ontology/SNOMEDCT/13577000,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13895,nut,I-http://purl.bioontology.org/ontology/SNOMEDCT/256351003;http://purl.bioontology.org/ontology/SNOMEDCT/13577000,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13896,",",O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13897,walnut,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13898,and,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13899,peanut,B-http://purl.bioontology.org/ontology/SNOMEDCT/762952008,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13900,.,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
14556,Questions,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14557,on,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14558,alcoholic,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14559,beverages,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14560,were,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14561,integrated,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14562,in,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14563,a,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14564,detailed,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14565,diet,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14566,history,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14567,interview,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14568,questionnaire,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14569,.,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
15342,Saturated,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15343,and,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15344,trans,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15345,fatty,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15346,acids,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15347,have,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15348,been,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15349,associated,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15350,with,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15351,the,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15352,risk,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15353,to,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15354,develop,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15355,cardiovascular,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15356,diseases,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15357,.,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
16078,This,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16079,pattern,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16080,had,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16081,the,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16082,lowest,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16083,contribution,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16084,of,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16085,most,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16086,food,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16087,groups,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16088,",",O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16089,with,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16090,the,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16091,exception,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16092,of,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16093,beans,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16094,(,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16095,~4.0,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16096,%,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16097,),O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16098,.,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16423,Liver,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16424,biopsies,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16425,were,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16426,collected,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16427,at,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16428,2,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16429,d,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16430,postpartum,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16431,",",O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16432,and,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16433,protein,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16434,content,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16435,was,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16436,analyzed,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16437,by,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16438,label,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16439,-,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16440,free,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16441,quantitative,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16442,shotgun,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16443,proteomics,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16444,(,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16445,nanoscale,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16446,liquid,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16447,chromatography,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16448,coupled,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16449,to,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16450,tandem,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16451,mass,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16452,spectrometry,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16453,),O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16454,.,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16565,Postprandial,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16566,plasma,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16567,glucose,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16568,and,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16569,triglyceride,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16570,concentrations,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16571,are,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16572,predictive,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16573,of,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16574,relative,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16575,cardiovascular,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16576,disease,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16577,(,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16578,CVD,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16579,),O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16580,risk,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16581,",",O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16582,and,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16583,the,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16584,pathogenesis,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16585,of,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16586,both,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16587,insulin,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16588,resistance,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16589,and,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16590,atherosclerosis,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16591,has,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16592,been,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16593,attributed,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16594,to,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16595,acute,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16596,states,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16597,of,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16598,hyperglycemia,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16599,and,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16600,hypertriglyceridemia,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
16601,.,O,550.0,"Postprandial plasma glucose and triglyceride concentrations are predictive of relative cardiovascular disease ( CVD ) risk , and the pathogenesis of both insulin resistance and atherosclerosis has been attributed to acute states of hyperglycemia and hypertriglyceridemia ."
17238,The,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17239,specificity,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17240,and,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17241,sensitivity,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17242,were,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17243,considered,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17244,to,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17245,be,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17246,sufficient,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17247,for,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17248,the,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17249,detection,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17250,of,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17251,trace,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17252,amounts,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17253,of,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17254,peach,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17255,or,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17256,apple,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17257,contamination,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17258,in,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17259,processed,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17260,foods,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17261,.,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17262,The,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17263,effect,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17264,of,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17265,coffee,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17266,total,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17267,lipids,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17268,(,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17269,CTL,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17270,),O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17271,",",O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17272,coffee,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17273,non,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17274,-,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17275,saponifiable,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17276,matter,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17277,(,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17278,NSM,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17279,),O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17280,and,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17281,coffee,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17282,diterpene,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17283,alcohols,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17284,(,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17285,DTA,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17286,),O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17287,extracted,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17288,from,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17289,Coffea,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17290,arabica,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17291,beans,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17292,on,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17293,serum,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17294,cholesterol,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17295,in,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17296,adult,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17297,male,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17298,Syrian,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17299,hamsters,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17300,was,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17301,examined,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17302,.,O,577.0,"The effect of coffee total lipids ( CTL ) , coffee non - saponifiable matter ( NSM ) and coffee diterpene alcohols ( DTA ) extracted from Coffea arabica beans on serum cholesterol in adult male Syrian hamsters was examined ."
17526,In,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17527,contrast,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17528,",",O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17529,in,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17530,study,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17531,2,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17532,there,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17533,were,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17534,no,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17535,significant,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17536,differences,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17537,in,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17538,serum,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17539,lipid,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17540,levels,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17541,between,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17542,control,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17543,and,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17544,coffee,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17545,lipid,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17546,-,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17547,treated,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17548,groups,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17549,across,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17550,time,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17551,.,O,584.0,"In contrast , in study 2 there were no significant differences in serum lipid levels between control and coffee lipid - treated groups across time ."
17623,A,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17624,high,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17625,saturated,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17626,fat,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17627,/,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17628,high,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17629,cholesterol,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17630,diet,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17631,may,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17632,mask,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17633,the,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17634,hypercholesterolaemic,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17635,effect,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17636,of,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17637,coffee,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17638,lipids,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17639,.,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17872,A,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17873,growing,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17874,interest,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17875,has,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17876,emerged,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17877,in,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17878,the,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17879,beneficial,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17880,effects,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17881,of,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17882,plant,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17883,-,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17884,based,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17885,diets,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17886,for,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17887,the,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17888,prevention,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17889,of,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17890,cardiovascular,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17891,disease,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17892,",",O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17893,diabetes,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17894,and,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17895,obesity,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17896,.,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17986,Most,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
17987,of,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
17988,these,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
17989,effects,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
17990,are,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
17991,attributable,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
17992,to,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
17993,bioactive,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
17994,ingredients,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
17995,including,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
17996,polyphenols,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
17997,",",O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
17998,mono-,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
17999,and,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
18000,poly,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
18001,-,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
18002,unsaturated,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
18003,fatty,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
18004,acids,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
18005,.,O,599.0,"Most of these effects are attributable to bioactive ingredients including polyphenols , mono- and poly - unsaturated fatty acids ."
18017,The,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18018,principal,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18019,classes,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18020,of,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18021,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18022,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18023,polyphenols,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18024,include,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18025,flavonols,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18026,(,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18027,quercetin,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18028,and,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18029,myricetin,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18030,),O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18031,",",O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18032,flavanols,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18033,(,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18034,catechin,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18035,and,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18036,epicatechin,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18037,),O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18038,",",O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18039,anthocyanin,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18040,and,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18041,stilbenes,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18042,(,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18043,resveratrol,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18044,),O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18045,.,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18055,Among,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18056,them,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18057,",",O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18058,the,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18059,main,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18060,are,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18061,simple,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18062,phenols,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18063,(,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18064,tyrosol,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18065,and,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18066,hydroxytyrosol,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18067,),O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18068,",",O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18069,secoroids,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18070,and,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18071,lignans,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18072,.,O,603.0,"Among them , the main are simple phenols ( tyrosol and hydroxytyrosol ) , secoroids and lignans ."
18238,Epidemiological,O,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18239,studies,O,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18240,have,O,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18241,reported,O,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18242,associations,O,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18243,between,O,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18244,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18245,intake,O,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18246,and,O,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18247,obesity,O,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18248,",",O,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18249,type,O,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18250,2,O,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18251,diabetes,O,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18252,and,O,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18253,cardiovascular,O,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18254,disease,O,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18255,.,O,610.0,"Epidemiological studies have reported associations between potato intake and obesity , type 2 diabetes and cardiovascular disease ."
18298,Future,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18299,research,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18300,should,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18301,consider,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18302,cooking,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18303,methods,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18304,in,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18305,the,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18306,study,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18307,design,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18308,in,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18309,order,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18310,to,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18311,reduce,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18312,confounding,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18313,factors,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18314,and,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18315,further,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18316,explore,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18317,the,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18318,health,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18319,impact,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18320,of,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18321,this,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18322,food,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18323,.,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18519,Contrasting,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18520,",",O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18521,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18522,for,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18523,dinner,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18524,prevented,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18525,re,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18526,-,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18527,entrainment,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18528,in,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18529,the,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18530,jet,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18531,-,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18532,lag,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18533,condition,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18534,and,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18535,favored,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18536,circadian,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18537,desynchrony,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18538,in,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18539,the,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18540,shift,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18541,-,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18542,work,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18543,models,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18544,.,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18733,Accordingly,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18734,",",O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18735,the,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18736,influential,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18737,factors,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18738,are,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18739,discussed,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18740,in,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18741,terms,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18742,of,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18743,the,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18744,total,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18745,substitution,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18746,of,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18747,malt,B-http://purl.bioontology.org/ontology/SNOMEDCT/710180001,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18748,with,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18749,other,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18750,grains,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18751,in,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18752,the,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18753,production,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18754,of,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18755,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18756,.,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
19111,Our,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19112,results,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19113,suggest,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19114,that,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19115,supplementation,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19116,of,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19117,FA,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19118,may,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19119,have,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19120,health,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19121,benefits,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19122,by,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19123,minimizing,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19124,the,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19125,cardiovascular,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19126,complications,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19127,of,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19128,MS,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19129,and,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19130,alleviating,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19131,its,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19132,symptoms,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19133,.,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19261,Analysis,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19262,by,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19263,cooking,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19264,method,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19265,showed,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19266,that,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19267,risk,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19268,of,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19269,stomach,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19270,cancer,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19271,from,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19272,the,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19273,same,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19274,foods,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19275,varied,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19276,with,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19277,preparation,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19278,.,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19302,Pickled,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19303,vegetables,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19304,increased,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19305,the,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19306,risk,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19307,",",O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19308,whereas,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19309,fresh,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19310,vegetables,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19311,did,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19312,not,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19313,.,O,644.0,"Pickled vegetables increased the risk , whereas fresh vegetables did not ."
19615,Consumption,O,655.0,"Consumption of water , fruit juice and beer appeared not associated with bladder cancer ."
19616,of,O,655.0,"Consumption of water , fruit juice and beer appeared not associated with bladder cancer ."
19617,water,O,655.0,"Consumption of water , fruit juice and beer appeared not associated with bladder cancer ."
19618,",",O,655.0,"Consumption of water , fruit juice and beer appeared not associated with bladder cancer ."
19619,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/129560007;http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,655.0,"Consumption of water , fruit juice and beer appeared not associated with bladder cancer ."
19620,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/129560007;http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,655.0,"Consumption of water , fruit juice and beer appeared not associated with bladder cancer ."
19621,and,O,655.0,"Consumption of water , fruit juice and beer appeared not associated with bladder cancer ."
19622,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,655.0,"Consumption of water , fruit juice and beer appeared not associated with bladder cancer ."
19623,appeared,O,655.0,"Consumption of water , fruit juice and beer appeared not associated with bladder cancer ."
19624,not,O,655.0,"Consumption of water , fruit juice and beer appeared not associated with bladder cancer ."
19625,associated,O,655.0,"Consumption of water , fruit juice and beer appeared not associated with bladder cancer ."
19626,with,O,655.0,"Consumption of water , fruit juice and beer appeared not associated with bladder cancer ."
19627,bladder,O,655.0,"Consumption of water , fruit juice and beer appeared not associated with bladder cancer ."
19628,cancer,O,655.0,"Consumption of water , fruit juice and beer appeared not associated with bladder cancer ."
19629,.,O,655.0,"Consumption of water , fruit juice and beer appeared not associated with bladder cancer ."
19887,These,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19888,functional,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19889,foods,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19890,may,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19891,provide,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19892,new,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19893,therapeutic,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19894,applications,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19895,for,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19896,hypertension,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19897,prevention,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19898,and,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19899,treatment,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19900,",",O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19901,and,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19902,contribute,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19903,to,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19904,a,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19905,healthy,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19906,cardiovascular,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19907,population,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19908,.,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19909,The,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19910,present,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19911,review,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19912,summarizes,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19913,the,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19914,antihypertensive,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19915,food,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19916,sources,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19917,and,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19918,their,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19919,bioactive,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19920,constituents,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19921,",",O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19922,as,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19923,well,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19924,as,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19925,physiological,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19926,mechanisms,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19927,of,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19928,dietary,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19929,products,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19930,",",O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19931,especially,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19932,focusing,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19933,on,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19934,ACE,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19935,inhibitory,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19936,activity,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
19937,.,O,664.0,"The present review summarizes the antihypertensive food sources and their bioactive constituents , as well as physiological mechanisms of dietary products , especially focusing on ACE inhibitory activity ."
20749,To,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20750,further,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20751,elucidate,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20752,the,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20753,role,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20754,of,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20755,dietary,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20756,habits,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20757,",",O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20758,"1,225",O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20759,subjects,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20760,with,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20761,cancer,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20762,of,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20763,the,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20764,colon,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20765,",",O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20766,728,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20767,with,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20768,cancer,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20769,of,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20770,the,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20771,rectum,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20772,and,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20773,"4,154",O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20774,controls,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20775,",",O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20776,hospitalized,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20777,with,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20778,acute,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20779,non,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20780,-,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20781,neoplastic,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20782,diseases,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20783,",",O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20784,were,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20785,interviewed,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20786,between,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20787,1992,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20788,and,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20789,1996,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20790,in,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20791,6,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20792,different,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20793,Italian,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20794,areas,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20795,.,O,689.0,"To further elucidate the role of dietary habits , 1,225 subjects with cancer of the colon , 728 with cancer of the rectum and 4,154 controls , hospitalized with acute non - neoplastic diseases , were interviewed between 1992 and 1996 in 6 different Italian areas ."
20887,Intakes,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20888,of,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20889,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20890,(,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20891,OR,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20892,=,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20893,0.7,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20894,),O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20895,",",O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20896,raw,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20897,and,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20898,cooked,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20899,vegetables,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20900,(,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20901,OR,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20902,=,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20903,0.6,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20904,for,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20905,both,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20906,),O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20907,and,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20908,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20909,other,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20910,than,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20911,citrus,B-http://purl.bioontology.org/ontology/SNOMEDCT/102259006;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20912,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/102259006;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20913,(,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20914,OR,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20915,=,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20916,0.7,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20917,),O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20918,showed,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20919,a,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20920,negative,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20921,association,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20922,with,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20923,risk,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20924,.,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
21081,A,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21082,fixed,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21083,effects,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21084,regression,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21085,was,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21086,used,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21087,to,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21088,examine,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21089,factors,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21090,that,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21091,affected,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21092,milk,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21093,yield,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21094,while,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21095,controlling,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21096,for,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21097,herd,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21098,-,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21099,level,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21100,management,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21101,.,O,699.0,A fixed effects regression was used to examine factors that affected milk yield while controlling for herd - level management .
21174,Results,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21175,from,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21176,the,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21177,regression,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21178,were,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21179,used,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21180,to,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21181,estimate,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21182,a,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21183,monetary,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21184,value,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21185,of,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21186,milk,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21187,loss,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21188,related,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21189,to,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21190,SCC,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21191,as,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21192,a,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21193,function,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21194,of,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21195,cow,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21196,and,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21197,operation,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21198,related,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21199,explanatory,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21200,variables,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21201,for,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21202,a,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21203,representative,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21204,dairy,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21205,cow,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21206,.,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21439,Both,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21440,oral,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21441,and,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21442,external,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21443,oil,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21444,dosing,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21445,studies,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21446,identified,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21447,oil,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21448,-,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21449,related,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21450,toxicity,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21451,endpoints,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21452,associated,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21453,with,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21454,oxidative,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21455,stress,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21456,such,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21457,as,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21458,hemolytic,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21459,anemia,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21460,",",O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21461,liver,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21462,and,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21463,kidney,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21464,damage,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21465,",",O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21466,and,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21467,immuno,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21468,-,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21469,modulation,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21470,or,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21471,compromise,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21472,.,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21486,Infrared,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21487,thermal,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21488,images,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21489,indicated,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21490,significantly,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21491,greater,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21492,surface,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21493,temperatures,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21494,and,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21495,heat,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21496,loss,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21497,in,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21498,treated,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21499,birds,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21500,following,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21501,external,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21502,oil,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21503,applications,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21504,;,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21505,however,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21506,",",O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21507,measurements,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21508,collected,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21509,by,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21510,coelomically,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21511,implanted,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21512,temperature,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21513,transmitters,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21514,showed,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21515,that,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21516,internal,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21517,body,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21518,temperatures,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21519,were,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21520,stable,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21521,over,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21522,the,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21523,course,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21524,of,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21525,the,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21526,study,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21527,period,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21528,.,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21529,Birds,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21530,exposed,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21531,to,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21532,oil,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21533,externally,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21534,consumed,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21535,more,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21536,fish,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21537,than,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21538,control,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21539,birds,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21540,",",O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21541,indicating,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21542,metabolic,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21543,compensation,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21544,for,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21545,thermal,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21546,stress,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21547,.,O,715.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
21730,Twenty,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21731,case,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21732,reports,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21733,and,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21734,seven,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21735,case,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21736,series,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21737,",",O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21738,as,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21739,well,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21740,as,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21741,",",O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21742,spontaneous,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21743,reports,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21744,including,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21745,160,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21746,adverse,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21747,events,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21748,were,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21749,also,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21750,included,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
21751,.,O,723.0,"Twenty case reports and seven case series , as well as , spontaneous reports including 160 adverse events were also included ."
22665,The,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22666,possible,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22667,role,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22668,in,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22669,enhancing,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22670,the,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22671,activities,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22672,of,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22673,PPARalpha,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22674,",",O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22675,PPARdelta,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22676,",",O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22677,and,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22678,RXRalpha,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22679,",",O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22680,and,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22681,the,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22682,health,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22683,benefits,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22684,of,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22685,cow,B-http://purl.bioontology.org/ontology/SNOMEDCT/3718001;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22686,'s,I-http://purl.bioontology.org/ontology/SNOMEDCT/3718001;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22687,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/3718001;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22688,were,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22689,discussed,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22690,.,O,759.0,"The possible role in enhancing the activities of PPARalpha , PPARdelta , and RXRalpha , and the health benefits of cow 's milk were discussed ."
22802,This,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22803,resulted,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22804,in,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22805,frying,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22806,temperatures,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22807,of,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22808,160,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22809,and,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22810,180,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22811,°,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22812,C,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22813,",",O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22814,and,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22815,98,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22816,and,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22817,118,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22818,°,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22819,C,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22820,",",O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22821,for,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22822,atmospheric,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22823,and,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22824,vacuum,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22825,frying,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22826,",",O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22827,respectively,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22828,.,O,763.0,"This resulted in frying temperatures of 160 and 180 ° C , and 98 and 118 ° C , for atmospheric and vacuum frying , respectively ."
22861,Total,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22862,carotenoids,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22863,and,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22864,ascorbic,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22865,acid,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22866,(,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22867,AA,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22868,),O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22869,were,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22870,greatly,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22871,preserved,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22872,during,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22873,vacuum,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22874,frying,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22875,.,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
23474,Yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23475,intake,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23476,has,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23477,received,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23478,special,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23479,attention,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23480,because,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23481,its,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23482,association,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23483,with,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23484,health,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23485,benefits,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23486,is,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23487,more,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23488,consistent,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23489,than,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23490,that,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23491,of,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23492,other,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23493,types,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23494,of,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23495,dairy,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23496,products,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23497,.,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23498,In,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23499,the,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23500,present,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23501,article,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23502,",",O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23503,we,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23504,review,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23505,those,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23506,observational,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23507,studies,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23508,that,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23509,evaluated,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23510,the,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23511,association,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23512,between,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23513,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23514,consumption,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23515,and,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23516,type,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23517,2,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23518,diabetes,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23519,.,O,787.0,"In the present article , we review those observational studies that evaluated the association between yogurt consumption and type 2 diabetes ."
23738,Conversely,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23739,",",O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23740,what,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23741,is,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23742,available,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23743,on,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23744,the,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23745,shelf,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23746,will,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23747,have,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23748,an,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23749,impact,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23750,on,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23751,the,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23752,choices,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23753,consumers,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23754,make,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23755,",",O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23756,thereby,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23757,affecting,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23758,their,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23759,health,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
23760,.,O,797.0,"Conversely , what is available on the shelf will have an impact on the choices consumers make , thereby affecting their health ."
24067,Here,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24068,",",O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24069,disruption,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24070,was,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24071,not,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24072,a,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24073,chemical,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24074,disruption,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24075,",",O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24076,rather,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24077,a,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24078,physical,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24079,disruption,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24080,of,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24081,protein,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24082,curds,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24083,.,O,807.0,"Here , disruption was not a chemical disruption , rather a physical disruption of protein curds ."
24238,Changes,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24239,to,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24240,biochemical,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24241,parameters,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24242,",",O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24243,such,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24244,as,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24245,protein,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24246,secondary,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24247,structure,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24248,and,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24249,exposure,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24250,of,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24251,protein,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24252,hydrophobic,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24253,regions,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24254,",",O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24255,allowed,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24256,for,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24257,tofu,B-http://purl.bioontology.org/ontology/SNOMEDCT/227365007,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24258,to,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24259,be,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24260,made,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24261,from,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24262,yellow,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24263,field,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24264,peas,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24265,.,O,816.0,"Changes to biochemical parameters , such as protein secondary structure and exposure of protein hydrophobic regions , allowed for tofu to be made from yellow field peas ."
24556,Novel,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24557,data,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24558,suggesting,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24559,differences,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24560,in,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24561,diversity,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24562,of,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24563,the,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24564,microbiota,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24565,between,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24566,healthy,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24567,and,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24568,osteoporotic,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24569,women,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24570,are,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24571,provided,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24572,.,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
25461,Asthma,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25462,induced,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25463,by,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25464,cereal,B-http://purl.bioontology.org/ontology/SNOMEDCT/23182003;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,857.0,Asthma induced by cereal flour is a long recognized entity .
25465,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/23182003;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,857.0,Asthma induced by cereal flour is a long recognized entity .
25466,is,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25467,a,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25468,long,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25469,recognized,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25470,entity,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25471,.,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25592,We,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25593,call,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25594,attention,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25595,to,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25596,the,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25597,importance,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25598,of,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25599,cereal,B-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25600,flours,I-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25601,in,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25602,animal,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25603,formula,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25604,feeds,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25605,as,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25606,a,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25607,cause,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25608,of,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25609,occupational,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25610,asthma,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25611,in,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25612,farm,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25613,and,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25614,animal,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25615,feeders,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25616,.,O,863.0,We call attention to the importance of cereal flours in animal formula feeds as a cause of occupational asthma in farm and animal feeders .
25874,Oleuropein,O,875.0,"Oleuropein is the ester of elenolic acid and 3,4 - dihydroxyphenyl ethanol ( HT ) ."
25875,is,O,875.0,"Oleuropein is the ester of elenolic acid and 3,4 - dihydroxyphenyl ethanol ( HT ) ."
25876,the,O,875.0,"Oleuropein is the ester of elenolic acid and 3,4 - dihydroxyphenyl ethanol ( HT ) ."
25877,ester,O,875.0,"Oleuropein is the ester of elenolic acid and 3,4 - dihydroxyphenyl ethanol ( HT ) ."
25878,of,O,875.0,"Oleuropein is the ester of elenolic acid and 3,4 - dihydroxyphenyl ethanol ( HT ) ."
25879,elenolic,O,875.0,"Oleuropein is the ester of elenolic acid and 3,4 - dihydroxyphenyl ethanol ( HT ) ."
25880,acid,O,875.0,"Oleuropein is the ester of elenolic acid and 3,4 - dihydroxyphenyl ethanol ( HT ) ."
25881,and,O,875.0,"Oleuropein is the ester of elenolic acid and 3,4 - dihydroxyphenyl ethanol ( HT ) ."
25882,"3,4",O,875.0,"Oleuropein is the ester of elenolic acid and 3,4 - dihydroxyphenyl ethanol ( HT ) ."
25883,-,O,875.0,"Oleuropein is the ester of elenolic acid and 3,4 - dihydroxyphenyl ethanol ( HT ) ."
25884,dihydroxyphenyl,O,875.0,"Oleuropein is the ester of elenolic acid and 3,4 - dihydroxyphenyl ethanol ( HT ) ."
25885,ethanol,O,875.0,"Oleuropein is the ester of elenolic acid and 3,4 - dihydroxyphenyl ethanol ( HT ) ."
25886,(,O,875.0,"Oleuropein is the ester of elenolic acid and 3,4 - dihydroxyphenyl ethanol ( HT ) ."
25887,HT,O,875.0,"Oleuropein is the ester of elenolic acid and 3,4 - dihydroxyphenyl ethanol ( HT ) ."
25888,),O,875.0,"Oleuropein is the ester of elenolic acid and 3,4 - dihydroxyphenyl ethanol ( HT ) ."
25889,.,O,875.0,"Oleuropein is the ester of elenolic acid and 3,4 - dihydroxyphenyl ethanol ( HT ) ."
26956,Milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26957,from,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26958,flaxseed,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26959,-,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26960,supplemented,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26961,cows,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26962,together,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26963,with,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26964,the,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26965,high,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26966,conjugated,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26967,linoleic,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26968,acid,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26969,content,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26970,was,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26971,characterized,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26972,by,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26973,low,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26974,atherogenic,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26975,and,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26976,thrombogenic,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26977,indices,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26978,",",O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26979,suggesting,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26980,that,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26981,its,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26982,use,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26983,has,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26984,less,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26985,detrimental,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26986,effects,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26987,concerning,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26988,the,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26989,atherosclerosis,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26990,and,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26991,coronary,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26992,thrombosis,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26993,risk,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26994,associated,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26995,with,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26996,the,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26997,consumption,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26998,of,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
26999,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
27000,and,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
27001,dairy,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
27002,products,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
27003,.,O,914.0,"Milk from flaxseed - supplemented cows together with the high conjugated linoleic acid content was characterized by low atherogenic and thrombogenic indices , suggesting that its use has less detrimental effects concerning the atherosclerosis and coronary thrombosis risk associated with the consumption of milk and dairy products ."
27067,Male,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27068,Wistar,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27069,rats,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27070,fed,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27071,lifelong,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27072,on,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27073,diets,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27074,differing,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27075,in,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27076,the,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27077,fat,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27078,source,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27079,were,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27080,killed,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27081,at,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27082,6,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27083,and,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27084,at,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27085,24,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27086,months,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27087,of,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27088,age,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27089,.,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
28079,To,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28080,estimate,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28081,the,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28082,effects,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28083,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28084,consuming,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28085,hot,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28086,beverages,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28087,",",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28088,including,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28089,mate,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28090,(,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28091,an,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28092,infusion,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28093,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28094,the,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28095,herb,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28096,Ilex,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28097,paraguayensis,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28098,),O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28099,",",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28100,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28101,",",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28102,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28103,and,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28104,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/226470006;http://purl.bioontology.org/ontology/SNOMEDCT/29263009;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28105,with,I-http://purl.bioontology.org/ontology/SNOMEDCT/226470006;http://purl.bioontology.org/ontology/SNOMEDCT/29263009;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28106,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/226470006;http://purl.bioontology.org/ontology/SNOMEDCT/29263009;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28107,",",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28108,and,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28109,other,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28110,food,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28111,items,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28112,on,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28113,esophageal,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28114,cancer,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28115,risk,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28116,",",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28117,we,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28118,analyzed,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28119,data,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28120,from,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28121,830,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28122,cases,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28123,and,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28124,"1,779",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28125,controls,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28126,participating,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28127,in,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28128,a,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28129,series,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28130,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28131,5,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28132,hospital,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28133,-,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28134,based,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28135,case,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28136,-,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28137,control,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28138,studies,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28139,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28140,squamous,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28141,-,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28142,cell,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28143,carcinoma,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28144,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28145,the,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28146,esophagus,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28147,conducted,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28148,in,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28149,high,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28150,-,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28151,risk,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28152,areas,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28153,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28154,South,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28155,America,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28156,.,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28378,This,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28379,pooled,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28380,analysis,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28381,adds,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28382,evidence,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28383,for,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28384,a,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28385,carcinogenic,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28386,effect,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28387,of,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28388,chronic,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28389,thermal,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28390,injury,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28391,in,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28392,the,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28393,esophagus,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28394,induced,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28395,by,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28396,the,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28397,consumption,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28398,of,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28399,very,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28400,hot,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28401,drinks,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28402,",",O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28403,including,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28404,mate,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28405,.,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
29174,The,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29175,evidence,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29176,for,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29177,diabetes,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29178,-,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29179,related,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29180,health,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29181,outcomes,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29182,is,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29183,less,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29184,convincing,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29185,",",O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29186,while,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29187,the,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29188,included,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29189,meta,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29190,-,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29191,analyses,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29192,generally,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29193,suggested,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29194,an,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29195,inverse,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29196,association,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29197,between,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29198,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29199,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29200,and,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29201,BMI,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29202,-,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29203,related,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29204,and,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29205,blood,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29206,pressure,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29207,outcomes,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29208,.,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29335,In,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29336,addition,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29337,to,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29338,their,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29339,culinary,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29340,uses,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29341,",",O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29342,a,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29343,number,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29344,of,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29345,functional,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29346,properties,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29347,of,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29348,aromatic,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29349,herbs,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29350,and,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29351,spices,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29352,are,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29353,also,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29354,well,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29355,described,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29356,in,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29357,the,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29358,scientific,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29359,literature,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29360,.,O,994.0,"In addition to their culinary uses , a number of functional properties of aromatic herbs and spices are also well described in the scientific literature ."
29851,Although,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29852,the,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29853,H,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29854,diet,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29855,provoked,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29856,dislipemia,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29857,related,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29858,to,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29859,steatosis,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29860,",",O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29861,no,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29862,changes,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29863,in,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29864,isoprostanes,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29865,or,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29866,liver,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29867,malondialdehyde,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29868,(,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29869,MDA,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29870,),O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29871,were,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29872,observed,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29873,.,O,1011.0,"Although the H diet provoked dislipemia related to steatosis , no changes in isoprostanes or liver malondialdehyde ( MDA ) were observed ."
29976,Immunoblot,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29977,results,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29978,revealed,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29979,two,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29980,major,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29981,allergens,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29982,of,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29983,28,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29984,and,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29985,60,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29986,kDa,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29987,in,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29988,pepper,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29989,and,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29990,a,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29991,23,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29992,-,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29993,kDa,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29994,allergen,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29995,together,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29996,with,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29997,allergens,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29998,of,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
29999,higher,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
30000,molecular,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
30001,weight,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
30002,in,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
30003,paprika,B-http://purl.bioontology.org/ontology/SNOMEDCT/227408005,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
30004,.,O,1015.0,Immunoblot results revealed two major allergens of 28 and 60 kDa in pepper and a 23 - kDa allergen together with allergens of higher molecular weight in paprika .
30190,There,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30191,is,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30192,substantial,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30193,current,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30194,interest,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30195,in,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30196,linkages,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30197,between,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30198,livestock,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30199,-,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30200,keeping,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30201,and,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30202,human,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30203,nutrition,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30204,in,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30205,resource,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30206,-,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30207,poor,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30208,settings,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30209,.,O,1022.0,There is substantial current interest in linkages between livestock - keeping and human nutrition in resource - poor settings .
30688,The,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30689,present,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30690,study,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30691,investigated,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30692,the,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30693,effects,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30694,of,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30695,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30696,consumption,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30697,on,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30698,gene,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30699,expression,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30700,in,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30701,the,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30702,colon,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30703,mucosa,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30704,of,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30705,female,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30706,C57Bl/6,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30707,mice,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30708,using,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30709,cDNA,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30710,microarray,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30711,technology,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30712,.,O,1040.0,The present study investigated the effects of vegetable consumption on gene expression in the colon mucosa of female C57Bl/6 mice using cDNA microarray technology .
30844,The,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30845,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30846,mixture,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30847,used,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30848,in,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30849,diets,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30850,2,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30851,to,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30852,4,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30853,consisted,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30854,of,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30855,the,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30856,4,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30857,individual,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30858,vegetables,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30859,used,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30860,in,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30861,diets,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30862,5,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30863,to,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30864,8,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30865,:,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30866,cauliflower,B-http://purl.bioontology.org/ontology/SNOMEDCT/735336002,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30867,(,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30868,30,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30869,%,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30870,wet,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30871,wt,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30872,),O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30873,",",O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30874,carrots,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30875,(,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30876,30,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30877,%,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30878,wet,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30879,wt,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30880,),O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30881,",",O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30882,peas,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30883,(,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30884,30,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30885,%,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30886,wet,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30887,wt,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30888,),O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30889,",",O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30890,and,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30891,onions,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30892,(,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30893,10,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30894,%,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30895,wet,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30896,wt,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30897,),O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30898,.,O,1042.0,"The vegetable mixture used in diets 2 to 4 consisted of the 4 individual vegetables used in diets 5 to 8 : cauliflower ( 30 % wet wt ) , carrots ( 30 % wet wt ) , peas ( 30 % wet wt ) , and onions ( 10 % wet wt ) ."
30996,For,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
30997,7,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
30998,of,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
30999,the,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31000,genes,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31001,",",O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31002,the,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31003,modulation,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31004,by,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31005,the,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31006,mixture,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31007,was,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31008,due,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31009,to,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31010,the,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31011,effect,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31012,of,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31013,a,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31014,particular,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31015,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31016,.,O,1048.0,"For 7 of the genes , the modulation by the mixture was due to the effect of a particular vegetable ."
31226,More,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31227,human,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31228,studies,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31229,are,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31230,needed,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31231,to,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31232,provide,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31233,clear,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31234,evidence,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31235,of,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31236,their,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31237,health,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31238,protective,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31239,effects,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31240,and,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31241,to,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31242,better,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31243,evaluate,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31244,the,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31245,risks,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31246,possibly,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31247,resulting,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31248,from,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31249,too,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31250,high,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31251,a,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31252,polyphenol,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31253,consumption,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31254,.,O,1056.0,More human studies are needed to provide clear evidence of their health protective effects and to better evaluate the risks possibly resulting from too high a polyphenol consumption .
31462,Animal,O,1064.0,Animal and in vitro studies provide evidence of an anticarcinogenic potential of active ingredients in teas .
31463,and,O,1064.0,Animal and in vitro studies provide evidence of an anticarcinogenic potential of active ingredients in teas .
31464,in,O,1064.0,Animal and in vitro studies provide evidence of an anticarcinogenic potential of active ingredients in teas .
31465,vitro,O,1064.0,Animal and in vitro studies provide evidence of an anticarcinogenic potential of active ingredients in teas .
31466,studies,O,1064.0,Animal and in vitro studies provide evidence of an anticarcinogenic potential of active ingredients in teas .
31467,provide,O,1064.0,Animal and in vitro studies provide evidence of an anticarcinogenic potential of active ingredients in teas .
31468,evidence,O,1064.0,Animal and in vitro studies provide evidence of an anticarcinogenic potential of active ingredients in teas .
31469,of,O,1064.0,Animal and in vitro studies provide evidence of an anticarcinogenic potential of active ingredients in teas .
31470,an,O,1064.0,Animal and in vitro studies provide evidence of an anticarcinogenic potential of active ingredients in teas .
31471,anticarcinogenic,O,1064.0,Animal and in vitro studies provide evidence of an anticarcinogenic potential of active ingredients in teas .
31472,potential,O,1064.0,Animal and in vitro studies provide evidence of an anticarcinogenic potential of active ingredients in teas .
31473,of,O,1064.0,Animal and in vitro studies provide evidence of an anticarcinogenic potential of active ingredients in teas .
31474,active,O,1064.0,Animal and in vitro studies provide evidence of an anticarcinogenic potential of active ingredients in teas .
31475,ingredients,O,1064.0,Animal and in vitro studies provide evidence of an anticarcinogenic potential of active ingredients in teas .
31476,in,O,1064.0,Animal and in vitro studies provide evidence of an anticarcinogenic potential of active ingredients in teas .
31477,teas,O,1064.0,Animal and in vitro studies provide evidence of an anticarcinogenic potential of active ingredients in teas .
31478,.,O,1064.0,Animal and in vitro studies provide evidence of an anticarcinogenic potential of active ingredients in teas .
31601,The,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31602,studies,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31603,on,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31604,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31605,and,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31606,lung,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31607,cancer,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31608,also,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31609,suggest,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31610,an,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31611,increased,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31612,risk,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31613,with,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31614,increased,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31615,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31616,consumption,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31617,.,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31690,This,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31691,report,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31692,examines,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31693,associations,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31694,of,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31695,various,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31696,food,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31697,groups,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31698,with,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31699,colon,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31700,cancer,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31701,in,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31702,African,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31703,-,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31704,Americans,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31705,and,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31706,Caucasians,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31707,from,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31708,a,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31709,case,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31710,-,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31711,control,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31712,study,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31713,.,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
32000,Prevention,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32001,of,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32002,diabetes,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32003,through,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32004,the,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32005,diet,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32006,has,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32007,recently,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32008,received,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32009,an,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32010,increasing,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32011,interest,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32012,",",O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32013,and,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32014,polyphenolic,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32015,compounds,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32016,",",O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32017,such,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32018,as,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32019,flavanols,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32020,",",O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32021,have,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32022,become,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32023,important,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32024,potential,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32025,chemopreventive,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32026,natural,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32027,agents,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32028,due,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32029,to,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32030,their,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32031,proved,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32032,benefits,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32033,on,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32034,health,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32035,",",O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32036,with,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32037,low,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32038,toxicity,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32039,and,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32040,cost,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32041,.,O,1085.0,"Prevention of diabetes through the diet has recently received an increasing interest , and polyphenolic compounds , such as flavanols , have become important potential chemopreventive natural agents due to their proved benefits on health , with low toxicity and cost ."
32042,Tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32043,",",O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32044,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32045,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32046,and,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32047,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32048,are,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32049,good,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32050,sources,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32051,of,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32052,flavanols,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32053,and,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32054,these,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32055,highly,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32056,consumed,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32057,foods,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32058,might,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32059,contribute,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32060,to,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32061,prevent,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32062,diabetes,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32063,.,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32545,The,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32546,authors,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32547,conducted,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32548,a,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32549,case,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32550,-,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32551,control,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32552,study,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32553,in,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32554,Hawaii,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32555,and,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32556,Los,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32557,Angeles,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32558,",",O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32559,California,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32560,",",O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32561,to,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32562,examine,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32563,several,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32564,dietary,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32565,hypotheses,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32566,regarding,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32567,the,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32568,etiology,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32569,of,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32570,ovarian,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32571,cancer,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32572,in,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32573,a,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32574,population,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32575,with,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32576,a,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32577,broad,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32578,range,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32579,of,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32580,dietary,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32581,intakes,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32582,.,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32583,A,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32584,total,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32585,of,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32586,558,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32587,patients,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32588,with,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32589,ovarian,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32590,cancer,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32591,diagnosed,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32592,in,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32593,1993,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32594,-,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32595,1999,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32596,and,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32597,607,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32598,controls,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32599,were,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32600,interviewed,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32601,regarding,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32602,their,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32603,diet,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32604,.,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32640,Similar,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32641,inverse,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32642,gradients,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32643,in,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32644,the,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32645,odds,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32646,ratios,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32647,were,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32648,obtained,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32649,for,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32650,intakes,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32651,of,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32652,lactose,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32653,and,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32654,calcium,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32655,",",O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32656,although,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32657,these,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32658,nutrients,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32659,were,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32660,highly,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32661,correlated,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32662,(,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32663,r,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32664,=,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32665,0.77,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32666,),O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32667,.,O,1111.0,"Similar inverse gradients in the odds ratios were obtained for intakes of lactose and calcium , although these nutrients were highly correlated ( r = 0.77 ) ."
32668,The,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32669,odds,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32670,ratio,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32671,for,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32672,ovarian,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32673,cancer,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32674,was,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32675,0.46,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32676,(,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32677,95,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32678,%,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32679,confidence,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32680,interval,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32681,:,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32682,0.27,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32683,",",O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32684,0.76,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32685,),O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32686,among,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32687,women,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32688,in,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32689,the,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32690,highest,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32691,quartile,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32692,of,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32693,dietary,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32694,calcium,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32695,intake,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32696,versus,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32697,the,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32698,lowest,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32699,(,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32700,p,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32701,for,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32702,trend,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32703,=,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32704,0.0006,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32705,),O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
32706,.,O,1112.0,"The odds ratio for ovarian cancer was 0.46 ( 95 % confidence interval : 0.27 , 0.76 ) among women in the highest quartile of dietary calcium intake versus the lowest ( p for trend = 0.0006 ) ."
33031,Plasma,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33032,carotenoid,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33033,concentrations,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33034,on,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33035,a,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33036,random,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33037,28,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33038,%,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33039,sample,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33040,validated,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33041,self,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33042,-,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33043,reported,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33044,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33045,and,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33046,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33047,intake,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33048,",",O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33049,with,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33050,a,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33051,between,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33052,-,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33053,group,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33054,difference,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33055,of,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33056,66,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33057,%,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33058,at,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33059,1,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33060,y,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33061,and,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33062,over,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33063,40,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33064,%,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33065,at,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33066,4,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33067,y.,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33068,This,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33069,large,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33070,change,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33071,will,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33072,allow,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33073,testing,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33074,of,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33075,hypotheses,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33076,on,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33077,the,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33078,role,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33079,of,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33080,dietary,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33081,change,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33082,in,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33083,preventing,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33084,additional,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33085,breast,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33086,cancer,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33087,events,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33088,.,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33662,The,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33663,activity,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33664,of,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33665,the,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33666,alpha,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33667,-,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33668,glycerophosphate,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33669,shuttle,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33670,was,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33671,greater,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33672,in,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33673,rats,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33674,fed,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33675,the,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33676,coconut,B-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33677,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33678,diet,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33679,than,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33680,in,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33681,rats,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33682,fed,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33683,the,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33684,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33685,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33686,diet,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33687,.,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33821,The,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33822,amount,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33823,and,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33824,source,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33825,of,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33826,fat,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33827,was,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33828,varied,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33829,in,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33830,diets,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33831,fed,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33832,to,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33833,anemic,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33834,rats,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33835,for,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33836,assaying,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33837,the,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33838,bioavailability,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33839,of,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33840,iron,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33841,from,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33842,turkey,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33843,meat,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33844,.,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
34384,Incidence,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34385,of,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34386,animal,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34387,health,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34388,events,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34389,such,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34390,as,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34391,mastitis,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34392,",",O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34393,that,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34394,routinely,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34395,lead,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34396,to,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34397,milk,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34398,withdrawal,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34399,were,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34400,quantified,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34401,alongside,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34402,strategies,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34403,carried,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34404,out,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34405,by,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34406,farmers,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34407,to,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34408,reduce,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34409,milk,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34410,loss,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34411,.,O,1173.0,"Incidence of animal health events such as mastitis , that routinely lead to milk withdrawal were quantified alongside strategies carried out by farmers to reduce milk loss ."
34642,Therefore,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34643,",",O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34644,continuous,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34645,modifications,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34646,are,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34647,ongoing,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34648,either,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34649,to,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34650,develop,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34651,new,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34652,cultivars,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34653,for,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34654,different,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34655,purposes,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34656,",",O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34657,or,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34658,novel,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34659,processing,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34660,methods,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34661,to,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34662,improve,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34663,its,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34664,organoleptic,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34665,characters,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34666,.,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
35114,Mixtures,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35115,of,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35116,raw,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35117,and,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35118,roasted,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35119,English,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35120,walnuts,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35121,of,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35122,several,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35123,varieties,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35124,were,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35125,defatted,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35126,",",O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35127,powdered,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35128,",",O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35129,and,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35130,used,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35131,as,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35132,separate,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35133,antigens,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35134,in,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35135,sheep,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35136,and,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35137,New,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35138,Zealand,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35139,white,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35140,rabbits,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35141,.,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35750,However,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35751,",",O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35752,there,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35753,is,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35754,evidence,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35755,that,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35756,up,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35757,to,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35758,80,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35759,%,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35760,of,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35761,dietary,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35762,perchlorate,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35763,is,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35764,metabolized,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35765,in,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35766,clinically,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35767,healthy,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35768,cows,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35769,",",O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35770,thereby,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35771,restricting,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35772,the,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35773,available,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35774,transfer,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35775,of,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35776,ingested,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35777,perchlorate,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35778,into,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35779,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35780,.,O,1224.0,"However , there is evidence that up to 80 % of dietary perchlorate is metabolized in clinically healthy cows , thereby restricting the available transfer of ingested perchlorate into milk ."
35813,The,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35814,present,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35815,study,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35816,examined,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35817,the,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35818,effect,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35819,of,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35820,experimentally,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35821,induced,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35822,mastitis,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35823,on,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35824,milk,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35825,perchlorate,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35826,levels,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35827,in,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35828,cows,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35829,receiving,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35830,normal,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35831,and,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35832,perchlorate,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35833,-,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35834,supplemented,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35835,diets,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
35836,.,O,1226.0,The present study examined the effect of experimentally induced mastitis on milk perchlorate levels in cows receiving normal and perchlorate - supplemented diets .
36619,The,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36620,evidence,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36621,is,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36622,summarised,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36623,in,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36624,the,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36625,2018,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36626,World,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36627,Cancer,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36628,Research,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36629,Fund,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36630,/,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36631,American,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36632,Institute,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36633,for,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36634,Cancer,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36635,Research,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36636,report,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36637,Diet,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36638,",",O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36639,Nutrition,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36640,",",O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36641,Physical,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36642,Activity,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36643,and,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36644,Cancer,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36645,:,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36646,a,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36647,Global,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36648,Perspective,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36649,.,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
37186,These,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37187,Reference,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37188,Doses,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37189,would,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37190,guide,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37191,advisory,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37192,labeling,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37193,decisions,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37194,for,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37195,use,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37196,on,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37197,food,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37198,labels,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37199,.,O,1272.0,These Reference Doses would guide advisory labeling decisions for use on food labels .
37215,Statistical,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37216,dose,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37217,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37218,distribution,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37219,models,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37220,(,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37221,log,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37222,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37223,normal,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37224,",",O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37225,log,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37226,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37227,logistic,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37228,",",O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37229,Weibull,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37230,),O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37231,were,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37232,applied,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37233,to,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37234,the,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37235,individual,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37236,NOAELs,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37237,and,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37238,LOAELs,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37239,for,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37240,each,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37241,allergenic,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37242,food,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37243,.,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37410,The,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37411,relationship,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37412,of,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37413,selected,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37414,bone,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37415,-,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37416,related,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37417,nutrients,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37418,to,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37419,these,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37420,calcium,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37421,fluxes,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37422,exhibits,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37423,both,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37424,constructive,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37425,and,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37426,destructive,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37427,interactions,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37428,that,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37429,affect,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37430,the,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37431,overall,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37432,state,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37433,of,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37434,calcium,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37435,balance,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37436,.,O,1280.0,The relationship of selected bone - related nutrients to these calcium fluxes exhibits both constructive and destructive interactions that affect the overall state of calcium balance .
37610,Potassium,O,1287.0,Potassium itself is uniformly well absorbed regardless of the dietary source .
37611,itself,O,1287.0,Potassium itself is uniformly well absorbed regardless of the dietary source .
37612,is,O,1287.0,Potassium itself is uniformly well absorbed regardless of the dietary source .
37613,uniformly,O,1287.0,Potassium itself is uniformly well absorbed regardless of the dietary source .
37614,well,O,1287.0,Potassium itself is uniformly well absorbed regardless of the dietary source .
37615,absorbed,O,1287.0,Potassium itself is uniformly well absorbed regardless of the dietary source .
37616,regardless,O,1287.0,Potassium itself is uniformly well absorbed regardless of the dietary source .
37617,of,O,1287.0,Potassium itself is uniformly well absorbed regardless of the dietary source .
37618,the,O,1287.0,Potassium itself is uniformly well absorbed regardless of the dietary source .
37619,dietary,O,1287.0,Potassium itself is uniformly well absorbed regardless of the dietary source .
37620,source,O,1287.0,Potassium itself is uniformly well absorbed regardless of the dietary source .
37621,.,O,1287.0,Potassium itself is uniformly well absorbed regardless of the dietary source .
37622,Mean,O,1288.0,Mean 24 - h urinary potassium averaged 92 % of dietary intake .
37623,24,O,1288.0,Mean 24 - h urinary potassium averaged 92 % of dietary intake .
37624,-,O,1288.0,Mean 24 - h urinary potassium averaged 92 % of dietary intake .
37625,h,O,1288.0,Mean 24 - h urinary potassium averaged 92 % of dietary intake .
37626,urinary,O,1288.0,Mean 24 - h urinary potassium averaged 92 % of dietary intake .
37627,potassium,O,1288.0,Mean 24 - h urinary potassium averaged 92 % of dietary intake .
37628,averaged,O,1288.0,Mean 24 - h urinary potassium averaged 92 % of dietary intake .
37629,92,O,1288.0,Mean 24 - h urinary potassium averaged 92 % of dietary intake .
37630,%,O,1288.0,Mean 24 - h urinary potassium averaged 92 % of dietary intake .
37631,of,O,1288.0,Mean 24 - h urinary potassium averaged 92 % of dietary intake .
37632,dietary,O,1288.0,Mean 24 - h urinary potassium averaged 92 % of dietary intake .
37633,intake,O,1288.0,Mean 24 - h urinary potassium averaged 92 % of dietary intake .
37634,.,O,1288.0,Mean 24 - h urinary potassium averaged 92 % of dietary intake .
38725,Our,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38726,study,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38727,included,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38728,22,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38729,case,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38730,-,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38731,control,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38732,and,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38733,cohort,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38734,studies,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38735,with,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38736,a,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38737,total,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38738,of,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38739,2548,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38740,never,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38741,-,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38742,smoking,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38743,lung,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38744,cancer,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38745,patients,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38746,and,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38747,9362,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38748,never,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38749,-,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38750,smoking,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38751,controls,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38752,from,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38753,North,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38754,America,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38755,",",O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38756,Europe,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38757,and,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38758,Asia,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38759,within,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38760,the,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38761,International,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38762,Lung,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38763,Cancer,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38764,Consortium,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38765,(,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38766,ILCCO,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38767,),O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38768,and,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38769,SYNERGY,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38770,Consortium,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38771,.,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38810,Associations,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38811,by,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38812,type,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38813,of,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38814,alcohol,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38815,consumed,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38816,(,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38817,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38818,",",O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38819,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38820,and,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38821,liquor,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38822,),O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38823,were,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38824,also,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38825,investigated,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38826,.,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
39264,Following,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39265,introduction,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39266,of,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39267,minimum,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39268,unit,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39269,pricing,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39270,in,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39271,Scotland,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39272,",",O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39273,alcohol,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39274,sales,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39275,fell,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39276,by,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39277,3,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39278,%,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39279,",",O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39280,with,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39281,the,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39282,greatest,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39283,effect,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39284,on,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39285,heavy,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39286,drinkers,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39287,of,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39288,low,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39289,-,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39290,cost,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39291,alcohol,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39292,products,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39293,.,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39495,Understanding,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39496,of,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39497,the,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39498,harm,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39499,to,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39500,health,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39501,from,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39502,lifestyle,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39503,causes,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39504,among,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39505,the,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39506,general,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39507,population,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39508,is,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39509,low,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39510,",",O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39511,with,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39512,a,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39513,poor,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39514,knowledge,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39515,of,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39516,alcohol,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39517,consumption,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39518,and,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39519,dietary,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39520,guidelines,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39521,.,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39695,The,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39696,serum,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39697,lipid,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39698,profiles,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39699,of,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39700,these,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39701,animals,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39702,showed,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39703,a,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39704,dose,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39705,dependent,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39706,decrease,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39707,in,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39708,total,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39709,cholesterol,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39710,",",O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39711,low,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39712,density,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39713,lipoproteins,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39714,and,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39715,very,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39716,low,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39717,density,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39718,lipoproteins,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39719,cholesterol,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39720,",",O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39721,and,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39722,triglyceride,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39723,levels,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39724,when,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39725,ghee,B-http://purl.bioontology.org/ontology/SNOMEDCT/226901000,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39726,was,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39727,present,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39728,at,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39729,levels,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39730,greater,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39731,than,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39732,2.5,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39733,%,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39734,in,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39735,the,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39736,diet,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39737,.,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
40697,The,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40698,effects,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40699,of,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40700,the,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40701,type,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40702,of,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40703,dietary,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40704,fat,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40705,(,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40706,180,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40707,g,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40708,/,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40709,kg,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40710,diet,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40711,),O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40712,and,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40713,of,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40714,calcium,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40715,phosphate,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40716,(,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40717,CaHPO4,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40718,),O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40719,supplementation,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40720,(,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40721,25,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40722,vs.,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40723,225,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40724,mmol,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40725,/,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40726,kg,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40727,diet,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40728,),O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40729,on,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40730,luminal,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40731,solubility,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40732,of,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40733,fatty,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40734,acids,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40735,and,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40736,bile,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40737,acids,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40738,",",O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40739,cytotoxicity,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40740,of,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40741,fecal,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40742,water,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40743,and,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40744,intestinal,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40745,epitheliolysis,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40746,were,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40747,studied,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40748,in,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40749,rats,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40750,.,O,1396.0,"The effects of the type of dietary fat ( 180 g / kg diet ) and of calcium phosphate ( CaHPO4 ) supplementation ( 25 vs. 225 mmol / kg diet ) on luminal solubility of fatty acids and bile acids , cytotoxicity of fecal water and intestinal epitheliolysis were studied in rats ."
40882,This,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40883,reduction,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40884,in,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40885,concentration,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40886,of,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40887,fecal,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40888,water,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40889,surfactants,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40890,resulted,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40891,in,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40892,a,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40893,lower,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40894,cytotoxicity,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40895,of,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40896,fecal,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40897,water,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40898,.,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40943,Intestinal,O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40944,epitheliolysis,O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40945,and,O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40946,cytotoxicity,O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40947,of,O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40948,fecal,O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40949,water,O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40950,were,O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40951,correlated,O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40952,(,O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40953,r,O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40954,=,O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40955,0.92,O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40956,",",O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40957,P,O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40958,<,O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40959,0.001,O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40960,),O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
40961,.,O,1404.0,"Intestinal epitheliolysis and cytotoxicity of fecal water were correlated ( r = 0.92 , P < 0.001 ) ."
41038,The,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41039,study,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41040,population,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41041,consisted,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41042,of,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41043,7589,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41044,men,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41045,and,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41046,8585,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41047,women,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41048,40,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41049,-,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41050,67,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41051,y,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41052,of,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41053,age,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41054,and,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41055,with,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41056,no,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41057,history,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41058,of,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41059,hypertension,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41060,",",O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41061,diabetes,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41062,",",O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41063,ischemic,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41064,heart,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41065,disease,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41066,",",O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41067,or,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41068,cerebrovascular,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41069,disease,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41070,.,O,1407.0,"The study population consisted of 7589 men and 8585 women 40 - 67 y of age and with no history of hypertension , diabetes , ischemic heart disease , or cerebrovascular disease ."
41228,The,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41229,combination,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41230,of,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41231,cigarette,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41232,smoking,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41233,and,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41234,high,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41235,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41236,intake,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41237,was,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41238,associated,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41239,with,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41240,particularly,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41241,high,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41242,tHcy,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41243,concentrations,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41244,.,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41353,Fifteen,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41354,healthy,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41355,subjects,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41356,ate,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41357,2,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41358,bread,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41359,control,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41360,meals,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41361,and,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41362,3,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41363,test,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41364,meals,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41365,:,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41366,almonds,B-http://purl.bioontology.org/ontology/SNOMEDCT/256350002,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41367,and,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41368,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41369,;,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41370,parboiled,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41371,rice,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41372,;,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41373,and,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41374,instant,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41375,mashed,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41376,potatoes,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41377,",",O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41378,balanced,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41379,in,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41380,carbohydrate,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41381,",",O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41382,fat,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41383,",",O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41384,and,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41385,protein,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41386,",",O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41387,using,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41388,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41389,and,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41390,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41391,.,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41583,Therefore,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41584,",",O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41585,lowering,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41586,postprandial,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41587,glucose,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41588,excursions,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41589,may,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41590,decrease,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41591,the,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41592,risk,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41593,of,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41594,oxidative,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41595,damage,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41596,to,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41597,proteins,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41598,.,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41726,Cox,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41727,proportional,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41728,hazards,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41729,regression,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41730,was,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41731,used,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41732,to,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41733,calculate,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41734,hazard,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41735,ratios,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41736,for,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41737,incident,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41738,diabetes,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41739,according,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41740,to,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41741,categories,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41742,of,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41743,total,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41744,flavonoids,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41745,and,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41746,anthocyanidins,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41747,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41748,flavones,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41749,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41750,flavanones,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41751,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41752,flavonols,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41753,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41754,flavan-3,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41755,-,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41756,ol,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41757,monomers,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41758,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41759,isoflavones,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41760,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41761,and,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41762,proanthocyanidins,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41763,.,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
42522,We,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42523,selected,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42524,354,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42525,cases,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42526,of,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42527,pathologically,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42528,confirmed,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42529,gastric,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42530,adenocarcinoma,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42531,from,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42532,15,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42533,hospitals,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42534,",",O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42535,representative,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42536,of,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42537,nearly,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42538,all,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42539,those,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42540,in,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42541,the,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42542,study,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42543,areas,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
42544,.,O,1456.0,"We selected 354 cases of pathologically confirmed gastric adenocarcinoma from 15 hospitals , representative of nearly all those in the study areas ."
43174,The,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43175,BI,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43176,could,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43177,be,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43178,a,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43179,new,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43180,alternative,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43181,biomarker,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43182,for,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43183,future,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43184,epidemiological,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43185,studies,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43186,in,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43187,dietary,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43188,cancer,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43189,prevention,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43190,and,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43191,health,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43192,promotion,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43193,.,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43322,There,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43323,are,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43324,also,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43325,inconsistencies,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43326,in,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43327,reporting,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43328,of,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43329,data,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43330,with,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43331,limited,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43332,information,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43333,on,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43334,the,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43335,effect,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43336,of,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43337,cocoa,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43338,and,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43339,chocolate,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43340,supplementation,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43341,on,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43342,weight,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43343,and,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43344,glycemic,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43345,control,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43346,despite,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43347,the,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43348,potential,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43349,benefits,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43350,reported,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43351,with,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43352,respect,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43353,to,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43354,the,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43355,cardiovascular,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43356,risk,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43357,factors,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43358,of,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43359,endothelial,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43360,function,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43361,and,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43362,lipids,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43363,.,O,1488.0,There are also inconsistencies in reporting of data with limited information on the effect of cocoa and chocolate supplementation on weight and glycemic control despite the potential benefits reported with respect to the cardiovascular risk factors of endothelial function and lipids .
43488,We,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43489,included,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43490,5050,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43491,participants,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43492,with,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43493,baseline,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43494,data,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43495,on,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43496,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43497,intake,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43498,and,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43499,markers,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43500,of,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43501,3,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43502,CVD,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43503,domains,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43504,:,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43505,inflammation,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43506,(,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43507,hsCRP,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43508,[,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43509,high,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43510,-,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43511,sensitivity,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43512,C,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43513,-,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43514,reactive,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43515,protein,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43516,],O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43517,",",O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43518,interleukin-6,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43519,",",O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43520,and,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43521,fibrinogen,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43522,),O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43523,",",O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43524,vascular,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43525,function,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43526,(,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43527,aortic,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43528,distensibility,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43529,",",O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43530,carotid,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43531,distensibility,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43532,",",O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43533,and,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43534,brachial,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43535,flow,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43536,-,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43537,mediated,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43538,dilation,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43539,),O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43540,",",O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43541,and,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43542,subclinical,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43543,atherosclerosis,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43544,at,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43545,3,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43546,vascular,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43547,sites,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43548,(,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43549,carotid,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43550,intima,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43551,-,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43552,media,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43553,thickness,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43554,",",O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43555,coronary,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43556,artery,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43557,calcification,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43558,",",O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43559,and,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43560,ankle,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43561,-,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43562,brachial,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43563,index,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43564,),O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43565,.,O,1494.0,"We included 5050 participants with baseline data on rice intake and markers of 3 CVD domains : inflammation ( hsCRP [ high - sensitivity C - reactive protein ] , interleukin-6 , and fibrinogen ) , vascular function ( aortic distensibility , carotid distensibility , and brachial flow - mediated dilation ) , and subclinical atherosclerosis at 3 vascular sites ( carotid intima - media thickness , coronary artery calcification , and ankle - brachial index ) ."
43705,Conclusions,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43706,Rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43707,intake,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43708,was,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43709,not,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43710,associated,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43711,with,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43712,subclinical,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43713,CVD,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43714,markers,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43715,in,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43716,a,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43717,multiethnic,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43718,US,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43719,population,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43720,.,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43817,Many,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43818,of,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43819,these,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43820,antioxidants,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43821,cooperate,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43822,in,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43823,oxidative,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43824,stress,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43825,reduction,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43826,in,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43827,plants,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43828,",",O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43829,and,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43830,we,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43831,hypothesize,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43832,that,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43833,many,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43834,different,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43835,antioxidants,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43836,may,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43837,also,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43838,be,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43839,needed,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43840,for,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43841,the,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43842,proper,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43843,protection,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43844,of,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43845,animal,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43846,cells,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43847,.,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
44216,We,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44217,conclude,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44218,that,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44219,several,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44220,nutrition,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44221,-,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44222,related,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44223,processes,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44224,jointly,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44225,contribute,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44226,to,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44227,prostate,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44228,carcinogenesis,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44229,.,O,1523.0,We conclude that several nutrition - related processes jointly contribute to prostate carcinogenesis .
44230,60,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44231,migraine,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44232,patients,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44233,completed,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44234,elimination,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44235,diets,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44236,after,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44237,a,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44238,5,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44239,-,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44240,day,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44241,period,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44242,of,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44243,withdrawal,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44244,from,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44245,their,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44246,normal,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44247,diet,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44248,.,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44346,When,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44347,an,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44348,average,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44349,of,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44350,ten,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44351,common,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44352,foods,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44353,were,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44354,avoided,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44355,there,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44356,was,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44357,a,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44358,dramatic,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44359,fall,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44360,in,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44361,the,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44362,number,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44363,of,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44364,headaches,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44365,per,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44366,month,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44367,",",O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44368,85,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44369,%,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44370,of,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44371,patients,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44372,becoming,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44373,headache,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44374,-,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44375,free,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
44376,.,O,1527.0,"When an average of ten common foods were avoided there was a dramatic fall in the number of headaches per month , 85 % of patients becoming headache - free ."
45398,We,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45399,computed,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45400,the,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45401,odds,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45402,ratios,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45403,(,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45404,ORs,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45405,),O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45406,of,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45407,melanoma,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45408,and,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45409,the,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45410,corresponding,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45411,95,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45412,%,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45413,confidence,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45414,intervals,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45415,(,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45416,CIs,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45417,),O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45418,according,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45419,to,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45420,tertiles,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45421,of,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45422,daily,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45423,intake,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45424,of,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45425,each,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45426,food,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45427,item,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45428,",",O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45429,using,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45430,multiple,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45431,logistic,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45432,regression,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45433,models,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45434,adjusted,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45435,for,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45436,major,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45437,confounding,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45438,factors,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45439,.,O,1571.0,"We computed the odds ratios ( ORs ) of melanoma and the corresponding 95 % confidence intervals ( CIs ) according to tertiles of daily intake of each food item , using multiple logistic regression models adjusted for major confounding factors ."
45772,Spinach,B-http://purl.bioontology.org/ontology/SNOMEDCT/256329006,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45773,contained,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45774,the,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45775,largest,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45776,amount,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45777,of,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45778,SQDG,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45779,",",O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45780,followed,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45781,by,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45782,parsley,B-http://purl.bioontology.org/ontology/SNOMEDCT/735048005,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45783,",",O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45784,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45785,onion,I-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45786,",",O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45787,chive,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45788,",",O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45789,sweet,B-http://purl.bioontology.org/ontology/SNOMEDCT/227563001,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45790,pepper,I-http://purl.bioontology.org/ontology/SNOMEDCT/227563001,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45791,",",O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45792,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45793,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45794,",",O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45795,carrot,B-http://purl.bioontology.org/ontology/SNOMEDCT/256319004,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45796,and,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45797,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45798,.,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
46117,Functional,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46118,foods,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46119,that,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46120,contain,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46121,significant,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46122,amounts,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46123,of,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46124,bioactive,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46125,components,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46126,may,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46127,provide,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46128,desirable,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46129,health,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46130,benefits,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46131,beyond,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46132,basic,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46133,nutrition,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46134,and,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46135,play,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46136,important,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46137,roles,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46138,in,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46139,the,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46140,prevention,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46141,of,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46142,chronic,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46143,diseases,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46144,.,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46504,The,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46505,unusually,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46506,wide,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46507,range,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46508,of,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46509,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46510,consumption,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46511,in,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46512,Adventists,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46513,will,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46514,be,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46515,particularly,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46516,informative,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46517,with,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46518,regard,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46519,to,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46520,these,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46521,relations,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46522,.,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
47001,The,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47002,flavonoids,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47003,are,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47004,polyphenols,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47005,which,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47006,in,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47007,vitro,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47008,exhibit,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47009,antioxidant,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47010,properties,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47011,.,O,1626.0,The flavonoids are polyphenols which in vitro exhibit antioxidant properties .
47065,On,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47066,1,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47067,day,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47068,subjects,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47069,consumed,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47070,no,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47071,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47072,and,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47073,on,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47074,the,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47075,other,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47076,2,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47077,days,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47078,subjects,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47079,drank,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47080,either,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47081,black,B-http://purl.bioontology.org/ontology/SNOMEDCT/226476000;http://purl.bioontology.org/ontology/SNOMEDCT/226474002;http://purl.bioontology.org/ontology/SNOMEDCT/16313001;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47082,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/226476000;http://purl.bioontology.org/ontology/SNOMEDCT/226474002;http://purl.bioontology.org/ontology/SNOMEDCT/16313001;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47083,with,I-http://purl.bioontology.org/ontology/SNOMEDCT/226476000;http://purl.bioontology.org/ontology/SNOMEDCT/226474002;http://purl.bioontology.org/ontology/SNOMEDCT/16313001;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47084,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/226476000;http://purl.bioontology.org/ontology/SNOMEDCT/226474002;http://purl.bioontology.org/ontology/SNOMEDCT/16313001;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47085,",",O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47086,or,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47087,black,B-http://purl.bioontology.org/ontology/SNOMEDCT/226476000;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47088,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/226476000;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47089,alone,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47090,at,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47091,hourly,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47092,intervals,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47093,between,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47094,9.00,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47095,a.m.,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47096,and,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47097,14.00,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47098,p.m.,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47099,Blood,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47100,was,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47101,sampled,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47102,at,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47103,9.00,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47104,a.m.,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47105,and,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47106,at,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47107,12.00,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47108,p.m.,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47109,and,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47110,15.00,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47111,p.m.,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47112,The,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47113,antioxidant,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47114,potential,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47115,of,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47116,plasma,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47117,was,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47118,determined,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47119,using,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47120,the,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47121,ferric,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47122,reducing,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47123,antioxidant,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47124,power,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47125,(,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47126,FRAP,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47127,),O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47128,assay,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47129,.,O,1630.0,"On 1 day subjects consumed no tea and on the other 2 days subjects drank either black tea with milk , or black tea alone at hourly intervals between 9.00 a.m. and 14.00 p.m. Blood was sampled at 9.00 a.m. and at 12.00 p.m. and 15.00 p.m. The antioxidant potential of plasma was determined using the ferric reducing antioxidant power ( FRAP ) assay ."
47130,Subjects,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47131,consuming,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47132,no,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47133,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47134,exhibited,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47135,no,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47136,significant,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47137,change,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47138,in,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47139,FRAP,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47140,across,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47141,the,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47142,6,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47143,hours,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47144,of,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47145,the,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47146,study,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47147,day,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47148,.,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47708,The,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47709,',O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47710,high,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47711,-,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47712,fat,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47713,/,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47714,low,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47715,-,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47716,fibre,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47717,',O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47718,dietary,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47719,pattern,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47720,was,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47721,associated,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47722,with,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47723,an,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47724,increased,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47725,risk,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47726,of,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47727,all,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47728,-,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47729,cause,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47730,mortality,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47731,only,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47732,",",O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47733,after,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47734,adjustment,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47735,for,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47736,confounders,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47737,(,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47738,highest,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47739,v.,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47740,lowest,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47741,quartile,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47742,;,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47743,hazard,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47744,ratio,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47745,1·44,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47746,;,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47747,95,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47748,%,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47749,CI,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47750,1·13,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47751,",",O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47752,1·84,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47753,),O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47754,.,O,1649.0,"The ' high - fat / low - fibre ' dietary pattern was associated with an increased risk of all - cause mortality only , after adjustment for confounders ( highest v. lowest quartile ; hazard ratio 1·44 ; 95 % CI 1·13 , 1·84 ) ."
47924,The,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47925,glucose,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47926,area,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47927,responses,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47928,following,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47929,ingestion,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47930,of,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47931,cottage,B-http://purl.bioontology.org/ontology/SNOMEDCT/226814003;http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47932,cheese,I-http://purl.bioontology.org/ontology/SNOMEDCT/226814003;http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47933,or,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47934,egg,B-http://purl.bioontology.org/ontology/SNOMEDCT/256443002,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47935,white,I-http://purl.bioontology.org/ontology/SNOMEDCT/256443002,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47936,were,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47937,very,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47938,small,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47939,compared,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47940,with,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47941,those,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47942,of,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47943,the,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47944,glucose,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47945,meal,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47946,",",O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47947,and,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47948,were,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47949,not,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47950,significantly,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47951,different,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47952,from,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47953,one,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47954,another,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
47955,.,O,1656.0,"The glucose area responses following ingestion of cottage cheese or egg white were very small compared with those of the glucose meal , and were not significantly different from one another ."
48012,When,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48013,either,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48014,protein,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48015,was,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48016,ingested,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48017,with,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48018,glucose,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48019,",",O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48020,the,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48021,insulin,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48022,area,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48023,response,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48024,was,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48025,greater,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48026,than,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48027,the,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48028,sum,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48029,of,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48030,the,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48031,individual,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48032,responses,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48033,",",O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48034,indicating,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48035,a,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48036,synergistic,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48037,effect,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48038,(,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48039,glucose,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48040,alone,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48041,",",O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48042,732,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48043,pmol,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48044,/,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48045,L.h,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48046,;,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48047,glucose,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48048,with,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48049,cottage,B-http://purl.bioontology.org/ontology/SNOMEDCT/226814003;http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48050,cheese,I-http://purl.bioontology.org/ontology/SNOMEDCT/226814003;http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48051,",",O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48052,"1,637",O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48053,pmol,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48054,/,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48055,L.h,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48056,;,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48057,glucose,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48058,with,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48059,egg,B-http://purl.bioontology.org/ontology/SNOMEDCT/256443002,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48060,white,I-http://purl.bioontology.org/ontology/SNOMEDCT/256443002,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48061,",",O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48062,"1,213",O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48063,pmol,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48064,/,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48065,L.h,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48066,),O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48067,.,O,1659.0,"When either protein was ingested with glucose , the insulin area response was greater than the sum of the individual responses , indicating a synergistic effect ( glucose alone , 732 pmol / L.h ; glucose with cottage cheese , 1,637 pmol / L.h ; glucose with egg white , 1,213 pmol / L.h ) ."
48082,The,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48083,AAN,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48084,area,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48085,response,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48086,was,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48087,approximately,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48088,twofold,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48089,greater,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48090,following,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48091,ingestion,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48092,of,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48093,cottage,B-http://purl.bioontology.org/ontology/SNOMEDCT/226814003;http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48094,cheese,I-http://purl.bioontology.org/ontology/SNOMEDCT/226814003;http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48095,compared,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48096,with,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48097,egg,B-http://purl.bioontology.org/ontology/SNOMEDCT/256443002,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48098,white,I-http://purl.bioontology.org/ontology/SNOMEDCT/256443002,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48099,.,O,1661.0,The AAN area response was approximately twofold greater following ingestion of cottage cheese compared with egg white .
48100,Following,O,1662.0,"Following ingestion of glucose , it was negative ."
48101,ingestion,O,1662.0,"Following ingestion of glucose , it was negative ."
48102,of,O,1662.0,"Following ingestion of glucose , it was negative ."
48103,glucose,O,1662.0,"Following ingestion of glucose , it was negative ."
48104,",",O,1662.0,"Following ingestion of glucose , it was negative ."
48105,it,O,1662.0,"Following ingestion of glucose , it was negative ."
48106,was,O,1662.0,"Following ingestion of glucose , it was negative ."
48107,negative,O,1662.0,"Following ingestion of glucose , it was negative ."
48108,.,O,1662.0,"Following ingestion of glucose , it was negative ."
48221,We,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48222,conducted,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48223,a,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48224,multicentre,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48225,case,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48226,-,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48227,control,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48228,study,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48229,in,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48230,3,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48231,regions,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48232,expected,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48233,to,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48234,have,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48235,different,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48236,diet,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48237,and,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48238,drinking,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48239,habits,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48240,(,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48241,Normandy,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48242,",",O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48243,Burgundy,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48244,and,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48245,Midi,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48246,Pyrénées,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48247,),O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48248,.,O,1667.0,"We conducted a multicentre case - control study in 3 regions expected to have different diet and drinking habits ( Normandy , Burgundy and Midi Pyrénées ) ."
48533,Eleven,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48534,trained,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48535,panelists,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48536,evaluated,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48537,the,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48538,snacks,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48539,and,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48540,found,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48541,eight,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48542,significantly,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48543,different,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48544,attributes,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48545,for,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48546,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/227589001;http://purl.bioontology.org/ontology/SNOMEDCT/735053000;http://purl.bioontology.org/ontology/SNOMEDCT/227282006,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48547,chips,I-http://purl.bioontology.org/ontology/SNOMEDCT/227589001;http://purl.bioontology.org/ontology/SNOMEDCT/735053000;http://purl.bioontology.org/ontology/SNOMEDCT/227282006,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48548,and,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48549,seven,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48550,significantly,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48551,different,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48552,attributes,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48553,for,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48554,puffed,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48555,rice,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48556,.,O,1677.0,Eleven trained panelists evaluated the snacks and found eight significantly different attributes for potato chips and seven significantly different attributes for puffed rice .
48679,PRACTICAL,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48680,APPLICATION,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48681,:,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48682,Our,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48683,findings,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48684,suggest,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48685,the,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48686,addition,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48687,of,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48688,flavor,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48689,enhancers,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48690,maintains,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48691,or,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48692,improves,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48693,the,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48694,palatability,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48695,of,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48696,reduced,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48697,sodium,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48698,products,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48699,with,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48700,eight,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48701,attributes,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48702,influencing,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48703,liking,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48704,of,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48705,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/227589001;http://purl.bioontology.org/ontology/SNOMEDCT/735053000;http://purl.bioontology.org/ontology/SNOMEDCT/227282006,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48706,chips,I-http://purl.bioontology.org/ontology/SNOMEDCT/227589001;http://purl.bioontology.org/ontology/SNOMEDCT/735053000;http://purl.bioontology.org/ontology/SNOMEDCT/227282006,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48707,and,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48708,seven,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48709,attributes,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48710,influencing,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48711,liking,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48712,of,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48713,puffed,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48714,rice,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48715,.,O,1683.0,PRACTICAL APPLICATION : Our findings suggest the addition of flavor enhancers maintains or improves the palatability of reduced sodium products with eight attributes influencing liking of potato chips and seven attributes influencing liking of puffed rice .
48786,This,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48787,has,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48788,led,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48789,to,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48790,the,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48791,creation,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48792,of,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48793,a,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48794,"""",O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48795,glycemic,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48796,index,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48797,",",O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48798,"""",O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48799,a,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48800,classification,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48801,of,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48802,dietary,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48803,carbohydrates,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48804,on,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48805,the,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48806,basis,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48807,of,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48808,the,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48809,relative,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48810,rise,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48811,in,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48812,plasma,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48813,glucose,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48814,after,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48815,the,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48816,administration,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48817,of,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48818,the,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48819,food,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48820,in,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48821,question,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48822,as,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48823,compared,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48824,to,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48825,a,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48826,standard,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48827,glucose,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48828,challenge,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48829,.,O,1686.0,"This has led to the creation of a "" glycemic index , "" a classification of dietary carbohydrates on the basis of the relative rise in plasma glucose after the administration of the food in question as compared to a standard glucose challenge ."
48959,The,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48960,plasma,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48961,insulin,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48962,responses,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48963,to,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48964,the,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48965,four,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48966,carbohydrate,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48967,foods,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48968,paralleled,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48969,the,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48970,glucose,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48971,responses,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
48972,.,O,1691.0,The plasma insulin responses to the four carbohydrate foods paralleled the glucose responses .
49273,A,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49274,longitudinal,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49275,study,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49276,was,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49277,conducted,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49278,to,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49279,assess,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49280,to,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49281,what,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49282,extent,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49283,intramammary,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49284,infection,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49285,(,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49286,IMI,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49287,),O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49288,with,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49289,non,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49290,-,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49291,aureus,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49292,staphylococci,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49293,(,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49294,NAS,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49295,),O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49296,within,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49297,the,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49298,first,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49299,4,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49300,d,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49301,after,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49302,calving,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49303,in,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49304,dairy,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49305,heifers,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49306,affects,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49307,quarter,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49308,milk,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49309,yield,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49310,(,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49311,qMY,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49312,),O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49313,and,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49314,quarter,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49315,milk,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49316,somatic,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49317,cell,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49318,count,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49319,(,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49320,qSCC,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49321,),O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49322,during,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49323,the,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49324,first,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49325,4,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49326,mo,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49327,of,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49328,lactation,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49329,.,O,1701.0,A longitudinal study was conducted to assess to what extent intramammary infection ( IMI ) with non - aureus staphylococci ( NAS ) within the first 4 d after calving in dairy heifers affects quarter milk yield ( qMY ) and quarter milk somatic cell count ( qSCC ) during the first 4 mo of lactation .
49488,The,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49489,milk,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49490,prolactin,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49491,level,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49492,in,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49493,early,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49494,lactation,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49495,did,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49496,not,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49497,differ,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49498,between,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49499,NAS,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49500,-,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49501,infected,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49502,and,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49503,noninfected,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49504,quarters,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49505,either,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49506,.,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49670,A,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49671,PEF,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49672,can,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49673,increase,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49674,the,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49675,permeability,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49676,and,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49677,breaking,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49678,of,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49679,the,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49680,cell,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49681,membranes,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49682,with,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49683,a,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49684,consequent,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49685,positive,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49686,result,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49687,on,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49688,oil,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49689,extractability,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49690,and,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49691,quality,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49692,",",O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49693,mainly,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49694,related,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49695,to,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49696,the,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49697,compounds,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49698,involved,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49699,in,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49700,the,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49701,health,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49702,and,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49703,sensory,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49704,properties,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49705,of,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49706,extra,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49707,virgin,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49708,olive,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49709,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49710,.,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49711,The,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49712,PEF,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49713,was,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49714,tested,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49715,on,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49716,three,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49717,Italian,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49718,olive,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49719,cultivars,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49720,(,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49721,Carolea,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49722,",",O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49723,Coratina,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49724,",",O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49725,and,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49726,Ottobratica,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49727,),O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
49728,.,O,1715.0,"The PEF was tested on three Italian olive cultivars ( Carolea , Coratina , and Ottobratica ) ."
50075,Peanut,B-http://purl.bioontology.org/ontology/SNOMEDCT/762952008,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50076,and,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50077,peanut,B-http://purl.bioontology.org/ontology/SNOMEDCT/762952008,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50078,component,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50079,diets,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50080,retarded,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50081,an,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50082,increase,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50083,in,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50084,TC,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50085,and,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50086,CE,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50087,.,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50419,Food,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50420,PS,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50421,",",O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50422,which,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50423,are,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50424,defined,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50425,as,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50426,the,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50427,weight,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50428,of,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50429,food,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50430,(,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50431,g,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50432,),O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50433,consumed,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50434,per,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50435,eating,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50436,occasion,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50437,",",O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50438,were,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50439,calculated,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50440,for,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50441,comparable,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50442,foods,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50443,and,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50444,beverages,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50445,in,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50446,two,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50447,nationally,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50448,representative,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50449,cross,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50450,-,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50451,sectional,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50452,Irish,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50453,food,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50454,consumption,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50455,surveys,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50456,and,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50457,were,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50458,published,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50459,in,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50460,NSIFCS,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50461,and,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50462,NANS,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50463,.,O,1739.0,"Food PS , which are defined as the weight of food ( g ) consumed per eating occasion , were calculated for comparable foods and beverages in two nationally representative cross - sectional Irish food consumption surveys and were published in NSIFCS and NANS ."
50839,Broccoli,B-http://purl.bioontology.org/ontology/SNOMEDCT/735123009,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50840,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50841,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50842,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50843,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50844,ratio=5.5,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50845,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50846,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50847,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50848,ratio=2.3,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50849,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50850,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50851,calcot,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50852,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50853,Allium,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50854,cepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50855,L.,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50856,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50857,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50858,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50859,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50860,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50861,ratio=4.7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50862,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50863,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50864,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50865,ratio=.5,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50866,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50867,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50868,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50869,onion,I-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50870,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50871,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50872,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50873,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50874,ratio=4.6,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50875,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50876,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50877,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50878,ratio=2,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50879,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50880,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50881,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/461801000124102;http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50882,cabbage,I-http://purl.bioontology.org/ontology/SNOMEDCT/461801000124102;http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50883,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50884,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50885,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50886,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50887,ratio=3.6,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50888,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50889,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50890,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50891,ratio=2.7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50892,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50893,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50894,purple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50895,cabbage,I-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50896,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50897,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50898,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50899,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50900,ratio=3.4,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50901,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50902,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50903,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50904,ratio=2,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50905,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50906,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50907,and,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50908,black,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50909,cabbage,I-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50910,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50911,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50912,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50913,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50914,ratio=3,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50915,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50916,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50917,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50918,ratio=3,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50919,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50920,were,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50921,active,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50922,NQO1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50923,inducers,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50924,in,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50925,both,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50926,murine,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50927,hepatoma,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50928,cell,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50929,lines,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50930,.,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50931,Extracts,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50932,from,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50933,broccoli,B-http://purl.bioontology.org/ontology/SNOMEDCT/735123009,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50934,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50935,ratio=3.5,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50936,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50937,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50938,calcot,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50939,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50940,ratio=4.8,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50941,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50942,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50943,cauliflower,B-http://purl.bioontology.org/ontology/SNOMEDCT/735336002,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50944,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50945,ratio=4.2,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50946,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50947,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50948,cabbage,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50949,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50950,ratio=2.2,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50951,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50952,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50953,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50954,onion,I-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50955,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50956,ratio=3.2,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50957,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50958,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50959,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/461801000124102;http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50960,cabbage,I-http://purl.bioontology.org/ontology/SNOMEDCT/461801000124102;http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50961,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50962,ratio=3.6,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50963,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50964,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50965,black,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50966,cabbage,I-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50967,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50968,ratio=4.5,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50969,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50970,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50971,and,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50972,purple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50973,cabbage,I-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50974,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50975,ratio=3.7,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50976,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50977,were,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50978,confirmed,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50979,to,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50980,contain,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50981,MIs,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50982,in,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50983,the,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50984,AREPE,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50985,cell,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50986,line,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50987,.,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
51085,Confirmatory,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51086,factor,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51087,analysis,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51088,with,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51089,the,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51090,16,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51091,items,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51092,that,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51093,had,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51094,factor,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51095,loadings,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51096,of,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51097,at,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51098,least,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51099,0.60,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51100,validated,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51101,the,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51102,four,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51103,dietary,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51104,patterns,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51105,.,O,1754.0,Confirmatory factor analysis with the 16 items that had factor loadings of at least 0.60 validated the four dietary patterns .
51348,Wheat,O,1762.0,Wheat ( Triticum spp .
51349,(,O,1762.0,Wheat ( Triticum spp .
51350,Triticum,O,1762.0,Wheat ( Triticum spp .
51351,spp,O,1762.0,Wheat ( Triticum spp .
51352,.,O,1762.0,Wheat ( Triticum spp .
52000,The,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52001,effect,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52002,of,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52003,flour,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52004,fortification,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52005,on,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52006,blood,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52007,folate,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52008,concentration,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52009,in,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52010,this,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52011,group,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52012,of,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52013,women,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52014,(,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52015,n,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52016,=,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52017,605,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52018,),O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52019,was,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52020,evaluated,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52021,in,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52022,a,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52023,follow,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52024,-,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52025,up,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52026,study,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52027,.,O,1783.0,The effect of flour fortification on blood folate concentration in this group of women ( n = 605 ) was evaluated in a follow - up study .
52975,The,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52976,identification,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52977,and,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52978,quantification,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52979,of,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52980,spice,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52981,-,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52982,specific,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52983,phytochemicals,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52984,provided,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52985,insight,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52986,into,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52987,the,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52988,potential,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52989,influence,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52990,of,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52991,these,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52992,chemicals,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52993,on,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52994,the,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52995,gut,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52996,microbial,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52997,communities,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52998,and,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52999,activities,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
53000,.,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
65930,Metabolomic,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65931,analysis,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65932,of,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65933,the,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65934,liver,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65935,and,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65936,plasma,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65937,shows,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65938,a,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65939,positive,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65940,correlation,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65941,between,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65942,obesity,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65943,and,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65944,hepatic,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65945,C18,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65946,oxylipin,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65947,metabolites,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65948,of,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65949,omega-6,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65950,(,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65951,ω6,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65952,),O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65953,and,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65954,omega-3,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65955,(,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65956,ω3,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65957,),O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65958,fatty,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65959,acids,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65960,(,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65961,linoleic,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65962,and,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65963,α,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65964,-,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65965,linolenic,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65966,acid,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65967,",",O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65968,respectively,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65969,),O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65970,in,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65971,the,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65972,cytochrome,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65973,P450,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65974,/,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65975,soluble,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65976,epoxide,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65977,hydrolase,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65978,pathway,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
65979,.,O,2300.0,"Metabolomic analysis of the liver and plasma shows a positive correlation between obesity and hepatic C18 oxylipin metabolites of omega-6 ( ω6 ) and omega-3 ( ω3 ) fatty acids ( linoleic and α - linolenic acid , respectively ) in the cytochrome P450 / soluble epoxide hydrolase pathway ."
66031,Increasing,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66032,evidence,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66033,suggest,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66034,that,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66035,low,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66036,-,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66037,dose,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66038,alcohol,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66039,consumption,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66040,(,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66041,LAC,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66042,),O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66043,reduces,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66044,the,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66045,incidence,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66046,and,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66047,improves,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66048,the,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66049,functional,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66050,outcome,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66051,of,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66052,ischemic,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66053,stroke,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66054,.,O,2303.0,Increasing evidence suggest that low - dose alcohol consumption ( LAC ) reduces the incidence and improves the functional outcome of ischemic stroke .
66280,Our,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66281,findings,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66282,suggest,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66283,that,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66284,LAC,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66285,may,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66286,protect,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66287,the,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66288,brain,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66289,against,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66290,its,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66291,I,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66292,/,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66293,R,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66294,injury,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66295,by,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66296,suppressing,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66297,post,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66298,-,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66299,ischemic,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66300,inflammation,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66301,.,O,2313.0,Our findings suggest that LAC may protect the brain against its I / R injury by suppressing post - ischemic inflammation .
66573,In,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66574,recent,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66575,decades,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66576,",",O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66577,researchers,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66578,have,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66579,found,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66580,novel,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66581,bioactive,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66582,phytocompounds,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66583,able,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66584,to,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66585,counteract,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66586,the,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66587,effects,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66588,of,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66589,physical,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66590,and,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66591,chemical,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66592,mutagens,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
66593,.,O,2325.0,"In recent decades , researchers have found novel bioactive phytocompounds able to counteract the effects of physical and chemical mutagens ."
67237,The,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67238,encouraging,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67239,results,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67240,of,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67241,the,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67242,present,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67243,study,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67244,justify,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67245,extending,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67246,it,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67247,to,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67248,an,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67249,in,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67250,vivo,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67251,investigation,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67252,to,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67253,conclusively,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67254,determine,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67255,the,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67256,effect,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67257,of,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67258,time,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67259,of,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67260,addition,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67261,of,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67262,fat,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67263,when,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67264,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67265,is,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67266,cooked,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67267,on,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67268,blood,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67269,glucose,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67270,homeostasis,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67271,.,O,2349.0,The encouraging results of the present study justify extending it to an in vivo investigation to conclusively determine the effect of time of addition of fat when rice is cooked on blood glucose homeostasis .
67299,Cases,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67300,were,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67301,residents,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67302,aged,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67303,21,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67304,to,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67305,79,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67306,years,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67307,who,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67308,were,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67309,newly,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67310,diagnosed,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67311,with,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67312,stomach,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67313,cancer,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67314,between,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67315,March,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67316,1,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67317,",",O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67318,1994,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67319,",",O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67320,and,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67321,April,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67322,30,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67323,",",O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67324,1997,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67325,.,O,2351.0,"Cases were residents aged 21 to 79 years who were newly diagnosed with stomach cancer between March 1 , 1994 , and April 30 , 1997 ."
67417,Among,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67418,men,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67419,",",O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67420,the,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67421,risk,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67422,of,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67423,stomach,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67424,cancer,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67425,was,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67426,significantly,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67427,elevated,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67428,among,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67429,current,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67430,smokers,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67431,(,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67432,OR,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67433,=,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67434,1.7,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67435,",",O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67436,95,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67437,%,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67438,CI,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67439,=,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67440,1.1,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67441,-,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67442,2.7,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67443,),O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67444,but,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67445,not,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67446,among,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67447,former,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67448,smokers,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67449,.,O,2355.0,"Among men , the risk of stomach cancer was significantly elevated among current smokers ( OR = 1.7 , 95 % CI = 1.1 - 2.7 ) but not among former smokers ."
67561,Our,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67562,findings,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67563,confirm,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67564,an,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67565,association,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67566,with,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67567,cigarette,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67568,smoking,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67569,",",O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67570,which,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67571,is,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67572,estimated,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67573,to,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67574,account,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67575,for,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67576,approximately,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67577,20,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67578,%,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67579,of,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67580,stomach,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67581,cancers,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67582,diagnosed,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67583,among,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67584,Warsaw,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67585,residents,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67586,during,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67587,the,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67588,study,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67589,period,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67590,.,O,2360.0,"Our findings confirm an association with cigarette smoking , which is estimated to account for approximately 20 % of stomach cancers diagnosed among Warsaw residents during the study period ."
67612,There,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67613,is,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67614,emerging,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67615,epidemiology,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67616,data,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67617,supporting,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67618,the,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67619,connection,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67620,between,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67621,increased,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67622,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67623,consumption,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67624,and,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67625,reduced,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67626,risk,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67627,for,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67628,both,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67629,cardiovascular,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67630,disease,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67631,and,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67632,prostate,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67633,cancer,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67634,.,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
68054,The,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68055,numerous,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68056,beneficial,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68057,effects,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68058,of,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68059,lactic,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68060,fermentation,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68061,of,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68062,pseudocereals,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68063,can,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68064,be,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68065,exploited,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68066,to,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68067,design,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68068,novel,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68069,and,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68070,healthier,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68071,foods,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68072,or,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68073,grain,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68074,ingredients,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68075,destined,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68076,to,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68077,general,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68078,population,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68079,and,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68080,especially,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68081,to,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68082,patients,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68083,with,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68084,coeliac,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68085,disease,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68086,.,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68553,A,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68554,100,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68555,mg,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68556,increase,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68557,of,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68558,dietary,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68559,cholesterol,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68560,per,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68561,4184,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68562,kJ,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68563,(,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68564,or,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68565,1000,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68566,kcal,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68567,),O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68568,was,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68569,associated,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68570,with,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68571,a,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68572,14,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68573,%,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68574,increase,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68575,in,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68576,the,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68577,risk,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68578,of,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68579,diabetes,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68580,(,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68581,HR,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68582,1·14,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68583,;,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68584,95,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68585,%,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68586,CI,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68587,1·02,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68588,",",O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68589,1·26,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68590,),O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68591,.,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68841,A,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68842,reduction,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68843,of,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68844,one,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68845,serving,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68846,of,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68847,SSBs,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68848,(,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68849,375,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68850,mL,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68851,),O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68852,had,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68853,the,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68854,greatest,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68855,potential,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68856,impact,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68857,in,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68858,terms,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68859,of,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68860,weight,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68861,reduction,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68862,",",O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68863,particularly,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68864,in,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68865,ages,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68866,19,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68867,-,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68868,24,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68869,years,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68870,(,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68871,mean,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68872,0.31,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68873,kg,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68874,",",O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68875,95,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68876,%,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68877,UI,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68878,:,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68879,0.23,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68880,kg,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68881,to,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68882,0.37,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68883,kg,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68884,),O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68885,and,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68886,overall,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68887,healthcare,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68888,cost,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68889,savings,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68890,of,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68891,AUD,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68892,793.4,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68893,million,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68894,(,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68895,95,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68896,%,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68897,UI,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68898,:,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68899,589.1,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68900,M,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68901,to,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68902,976.1,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68903,M,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68904,),O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68905,.,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
69182,Nutritional,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69183,quality,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69184,of,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69185,gluten,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69186,-,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69187,free,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69188,diets,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69189,and,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69190,health,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69191,of,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69192,celiac,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69193,patients,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69194,may,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69195,be,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69196,compromised,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69197,.,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69244,These,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69245,test,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69246,meals,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69247,were,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69248,randomly,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69249,assigned,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69250,using,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69251,a,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69252,three,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69253,factor,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69254,experiment,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69255,design,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69256,.,O,2414.0,These test meals were randomly assigned using a three factor experiment design .
69352,Mixing,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69353,the,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69354,meals,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69355,significantly,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69356,increased,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69357,the,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69358,insulinemic,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69359,indexes,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69360,(,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69361,p,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69362,less,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69363,than,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69364,0.05,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69365,),O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69366,and,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69367,introduced,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69368,a,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69369,positive,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69370,correlation,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69371,between,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69372,glycemic,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69373,and,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69374,insulinemic,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69375,indexes,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69376,(,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69377,n,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69378,=,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69379,6,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69380,",",O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69381,r,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69382,=,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69383,0.903,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69384,;,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69385,p,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69386,less,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69387,than,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69388,0.05,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69389,),O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69390,.,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69563,Among,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69564,the,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69565,Hausas,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69566,",",O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69567,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69568,is,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69569,usually,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69570,reserved,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69571,for,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69572,special,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69573,occasions,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69574,.,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
70769,These,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70770,findings,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70771,suggest,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70772,that,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70773,milk,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70774,-,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70775,drinking,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70776,is,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70777,not,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70778,a,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70779,source,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70780,of,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70781,ovarian,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70782,cancer,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70783,risk,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70784,independently,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70785,of,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70786,its,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70787,fat,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70788,content,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
70789,.,O,2466.0,These findings suggest that milk - drinking is not a source of ovarian cancer risk independently of its fat content .
71340,Therefore,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71341,",",O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71342,various,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71343,metabolites,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71344,produced,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71345,by,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71346,cocobiota,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71347,can,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71348,mimic,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71349,some,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71350,medicinal,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71351,effects,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71352,of,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71353,dark,B-http://purl.bioontology.org/ontology/SNOMEDCT/443931000124105;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71354,chocolate,I-http://purl.bioontology.org/ontology/SNOMEDCT/443931000124105;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71355,and,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71356,other,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71357,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71358,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71359,derived,I-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71360,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71361,previously,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71362,attributed,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71363,to,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71364,cocoa,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71365,flavonoids,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71366,and,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71367,methylxanthines,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71368,and,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71369,need,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71370,to,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71371,be,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71372,thoroughly,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71373,investigated,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71374,in,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71375,in,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71376,vitro,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71377,and,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71378,in,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71379,vivo,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71380,systems,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71381,.,O,2482.0,"Therefore , various metabolites produced by cocobiota can mimic some medicinal effects of dark chocolate and other cocoa - derived products previously attributed to cocoa flavonoids and methylxanthines and need to be thoroughly investigated in in vitro and in vivo systems ."
71382,Studies,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71383,on,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71384,the,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71385,association,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71386,between,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71387,dietary,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71388,patterns,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71389,and,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71390,bone,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71391,mineral,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71392,density,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71393,(,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71394,BMD,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71395,),O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71396,have,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71397,reported,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71398,inconsistent,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71399,findings,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71400,.,O,2483.0,Studies on the association between dietary patterns and bone mineral density ( BMD ) have reported inconsistent findings .
71490,Pattern,O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71491,1,O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71492,(,O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71493,',O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71494,prudent,O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71495,pattern,O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71496,',O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71497,),O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71498,was,O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71499,characterised,O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71500,by,O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71501,high,O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71502,intake,O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71503,of,O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71504,fruits,O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71505,",",O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71506,vegetables,O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71507,",",O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71508,sugar,O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71509,",",O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71510,nut,B-http://purl.bioontology.org/ontology/SNOMEDCT/13577000;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71511,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/13577000;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71512,based,I-http://purl.bioontology.org/ontology/SNOMEDCT/13577000;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71513,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/13577000;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71514,",",O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71515,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71516,",",O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71517,legumes,O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71518,and,O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71519,high,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71520,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71521,fibre,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71522,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
71523,.,O,2488.0,"Pattern 1 ( ' prudent pattern ' ) was characterised by high intake of fruits , vegetables , sugar , nut - based milk , fish , legumes and high - fibre bread ."
72238,We,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72239,investigated,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72240,associations,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72241,between,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72242,dietary,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72243,patterns,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72244,and,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72245,QoL,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72246,changes,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72247,in,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72248,colorectal,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72249,cancer,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72250,(,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72251,CRC,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72252,),O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72253,patients,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72254,.,O,2512.0,We investigated associations between dietary patterns and QoL changes in colorectal cancer ( CRC ) patients .
72673,The,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72674,wild,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72675,vegetable,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72676,could,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72677,be,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72678,promoted,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72679,as,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72680,a,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72681,protein,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72682,supplement,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72683,for,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72684,cereal,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72685,-,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72686,based,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72687,diets,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72688,in,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72689,poor,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72690,rural,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72691,communities,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72692,",",O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72693,while,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72694,its,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72695,high,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72696,potassium,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72697,content,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72698,could,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72699,be,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72700,utilized,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72701,for,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72702,the,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72703,management,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72704,of,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72705,hypertension,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72706,and,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72707,other,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72708,cardiovascular,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72709,conditions,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
72710,.,O,2526.0,"The wild vegetable could be promoted as a protein supplement for cereal - based diets in poor rural communities , while its high potassium content could be utilized for the management of hypertension and other cardiovascular conditions ."
73395,We,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73396,estimated,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73397,regression,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73398,coefficients,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73399,(,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73400,or,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73401,percentage,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73402,differences,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73403,),O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73404,and,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73405,their,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73406,95,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73407,%,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73408,CI,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73409,using,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73410,multiple,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73411,linear,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73412,regression,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73413,models,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73414,.,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73592,The,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73593,circulating,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73594,insulin,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73595,and,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73596,glucose,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73597,responses,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73598,in,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73599,type,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73600,II,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73601,diabetic,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73602,subjects,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73603,were,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73604,determined,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73605,for,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73606,5,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73607,h,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73608,after,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73609,ingestion,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73610,of,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73611,various,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73612,meals,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73613,",",O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73614,each,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73615,containing,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73616,50,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73617,g,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73618,carbohydrate,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73619,.,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73955,Three,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73956,dietary,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73957,patterns,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73958,were,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73959,identified,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73960,:,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73961,1,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73962,),O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73963,high,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73964,-,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73965,protein,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73966,/,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73967,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73968,(,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73969,characterized,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73970,by,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73971,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73972,",",O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73973,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73974,",",O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73975,chicken,B-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73976,",",O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73977,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73978,",",O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73979,and,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73980,some,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73981,whole,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73982,grains,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73983,),O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73984,;,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73985,2,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73986,),O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73987,high,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73988,-,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73989,fat,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73990,/,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73991,sugar,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73992,/,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73993,takeaway,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73994,(,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73995,takeaway,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73996,foods,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73997,",",O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73998,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/227589001;http://purl.bioontology.org/ontology/SNOMEDCT/735053000;http://purl.bioontology.org/ontology/SNOMEDCT/227282006,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
73999,chips,I-http://purl.bioontology.org/ontology/SNOMEDCT/227589001;http://purl.bioontology.org/ontology/SNOMEDCT/735053000;http://purl.bioontology.org/ontology/SNOMEDCT/227282006,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74000,",",O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74001,refined,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74002,grains,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74003,),O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74004,;,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74005,and,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74006,3,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74007,),O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74008,vegetarian,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74009,-,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74010,type,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74011,(,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74012,vegetables,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74013,",",O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74014,legumes,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74015,",",O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74016,whole,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74017,grains,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74018,),O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74019,.,O,2571.0,"Three dietary patterns were identified : 1 ) high - protein / fruit ( characterized by fish , meat , chicken , fruit , and some whole grains ) ; 2 ) high - fat / sugar / takeaway ( takeaway foods , potato chips , refined grains ) ; and 3 ) vegetarian - type ( vegetables , legumes , whole grains ) ."
74586,Apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74587,",",O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74588,kiwi,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74589,",",O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74590,and,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74591,chestnut,B-http://purl.bioontology.org/ontology/SNOMEDCT/260188004,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74592,were,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74593,the,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74594,most,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74595,common,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74596,SPT,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74597,-,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74598,positive,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74599,foods,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74600,.,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74933,Food,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74934,Standards,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74935,Australia,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74936,New,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74937,Zealand,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74938,'s,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74939,(,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74940,FSANZ,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74941,),O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74942,custom,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74943,-,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74944,built,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74945,dietary,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74946,modelling,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74947,program,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74948,(,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74949,DIAMOND,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74950,),O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74951,was,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74952,used,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74953,for,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74954,the,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74955,estimates,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74956,.,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
75652,Trends,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75653,in,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75654,food,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75655,consumption,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75656,show,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75657,increases,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75658,in,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75659,intakes,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75660,of,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75661,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75662,",",O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75663,dairy,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75664,products,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75665,",",O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75666,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75667,",",O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75668,and,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75669,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75670,",",O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75671,but,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75672,decreases,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75673,in,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75674,consumption,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75675,of,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75676,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75677,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75678,",",O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75679,sugar,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75680,",",O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75681,and,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75682,all,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75683,foods,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75684,rich,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75685,in,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75686,carbohydrates,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75687,.,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75763,Nevertheless,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75764,",",O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75765,we,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75766,suggest,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75767,dietary,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75768,guidelines,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75769,for,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75770,prevention,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75771,of,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75772,CHD,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75773,in,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75774,Spain,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
75775,.,O,2635.0,"Nevertheless , we suggest dietary guidelines for prevention of CHD in Spain ."
76289,Nonlinear,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76290,mixed,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76291,-,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76292,effects,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76293,modeling,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76294,(,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76295,NLME,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76296,),O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76297,has,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76298,been,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76299,advocated,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76300,as,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76301,a,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76302,suitable,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76303,pharmaco,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76304,-,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76305,statistical,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76306,method,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76307,for,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76308,the,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76309,study,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76310,of,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76311,drug,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76312,residues,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76313,in,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76314,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76315,.,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76624,By,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76625,December,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76626,31,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76627,",",O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76628,2001,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76629,",",O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76630,238,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76631,cases,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76632,had,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76633,occurred,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76634,in,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76635,which,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76636,HER-2,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76637,status,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76638,was,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76639,known,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76640,.,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76854,A,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76855,total,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76856,of,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76857,"1,501",O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76858,individuals,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76859,",",O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76860,in,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76861,197,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76862,households,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76863,",",O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76864,from,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76865,35,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76866,villages,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76867,in,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76868,different,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76869,regions,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76870,were,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76871,studied,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76872,.,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
77855,In,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77856,stratified,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77857,analyses,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77858,",",O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77859,among,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77860,men,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77861,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77862,consumption,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77863,was,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77864,inversely,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77865,related,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77866,to,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77867,ESCC,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77868,(,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77869,HR,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77870,for,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77871,comparison,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77872,of,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77873,extreme,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77874,tertiles,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77875,0.42,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77876,",",O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77877,95,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77878,%,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77879,CI,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77880,0.20,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77881,-,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77882,0.88,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77883,;,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77884,p,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77885,-,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77886,trend=0.022,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77887,),O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77888,",",O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77889,but,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77890,not,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77891,among,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77892,women,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77893,.,O,2702.0,"In stratified analyses , among men coffee consumption was inversely related to ESCC ( HR for comparison of extreme tertiles 0.42 , 95 % CI 0.20 - 0.88 ; p - trend=0.022 ) , but not among women ."
77944,However,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77945,",",O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77946,no,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77947,statistically,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77948,significant,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77949,findings,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77950,were,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77951,observed,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77952,using,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77953,the,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77954,continuous,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77955,variable,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77956,(,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77957,per,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77958,100,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77959,mL,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77960,/,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77961,d,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77962,),O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77963,.,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
78587,Consumption,O,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78588,of,O,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78589,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78590,",",O,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78591,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78592,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78593,",",O,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78594,oolong,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78595,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78596,",",O,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78597,black,B-http://purl.bioontology.org/ontology/SNOMEDCT/226476000;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78598,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/226476000;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78599,and,O,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78600,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78601,snacks,I-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78602,were,O,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78603,measured,O,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78604,with,O,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78605,a,O,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78606,semi,O,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78607,-,O,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78608,quantitative,O,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78609,FFQ,O,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78610,in,O,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78611,1992,O,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78612,.,O,2726.0,"Consumption of coffee , green tea , oolong tea , black tea and chocolate snacks were measured with a semi - quantitative FFQ in 1992 ."
78670,Among,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78671,men,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78672,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78673,consumed,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78674,one,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78675,cup,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78676,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78677,month,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78678,to,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78679,six,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78680,cups,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78681,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78682,week,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78683,and,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78684,among,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78685,those,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78686,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78687,consumed,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78688,one,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78689,cup,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78690,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78691,d,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78692,or,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78693,more,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78694,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78695,the,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78696,associated,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78697,hazard,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78698,ratios,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78699,were,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78700,0.69,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78701,(,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78702,95,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78703,%,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78704,CI,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78705,0.50,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78706,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78707,0.97,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78708,),O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78709,and,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78710,0.69,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78711,(,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78712,95,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78713,%,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78714,CI,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78715,0.49,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78716,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78717,0.98,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78718,),O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78719,compared,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78720,with,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78721,those,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78722,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78723,drank,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78724,little,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78725,to,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78726,no,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78727,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78728,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78729,with,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78730,a,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78731,P,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78732,value,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78733,for,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78734,trend,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78735,of,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78736,0.32,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78737,.,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
79987,Red,O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
79988,-,O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
79989,purple,O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
79990,foods,O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
79991,contain,O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
79992,anthocyanins,O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
79993,",",O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
79994,which,O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
79995,are,O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
79996,powerful,O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
79997,antioxidants,O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
79998,found,O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
79999,in,O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
80000,red,O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
80001,apples,O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
80002,",",O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
80003,grapes,B-http://purl.bioontology.org/ontology/SNOMEDCT/256317002,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
80004,",",O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
80005,berries,O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
80006,and,O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
80007,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
80008,.,O,2770.0,"Red - purple foods contain anthocyanins , which are powerful antioxidants found in red apples , grapes , berries and wine ."
80108,The,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80109,color,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80110,code,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80111,provides,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80112,simplification,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80113,",",O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80114,but,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80115,it,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80116,is,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80117,also,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80118,important,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80119,as,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80120,a,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80121,way,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80122,to,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80123,help,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80124,consumers,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80125,to,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80126,find,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80127,common,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80128,fruits,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80129,and,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80130,vegetables,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80131,easily,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80132,while,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80133,traveling,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80134,",",O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80135,eating,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80136,in,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80137,restaurants,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80138,or,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80139,working,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80140,.,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80159,Emerging,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80160,literature,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80161,suggests,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80162,that,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80163,diet,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80164,plays,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80165,an,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80166,important,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80167,modulatory,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80168,role,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80169,in,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80170,rheumatoid,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80171,arthritis,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80172,(,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80173,RA,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80174,),O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80175,because,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80176,diet,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80177,is,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80178,an,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80179,environmental,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80180,factor,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80181,that,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80182,affects,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80183,inflammation,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80184,",",O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80185,antigen,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80186,presentation,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80187,",",O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80188,antioxidant,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80189,defense,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80190,mechanisms,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80191,and,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80192,gut,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80193,microbiota,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80194,.,O,2778.0,"Emerging literature suggests that diet plays an important modulatory role in rheumatoid arthritis ( RA ) because diet is an environmental factor that affects inflammation , antigen presentation , antioxidant defense mechanisms and gut microbiota ."
80673,An,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80674,increased,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80675,risk,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80676,of,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80677,GBC,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80678,was,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80679,observed,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80680,with,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80681,deep,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80682,frying,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80683,of,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80684,fresh,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80685,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80686,in,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80687,mustard,B-http://purl.bioontology.org/ontology/SNOMEDCT/51905005,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80688,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/51905005,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80689,(,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80690,OR,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80691,=,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80692,1.57,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80693,",",O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80694,95,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80695,%,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80696,CI,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80697,=,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80698,0.99,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80699,-,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80700,2.47,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80701,",",O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80702,p,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80703,-,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80704,value,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80705,=,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80706,0.052,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80707,),O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80708,.,O,2792.0,"An increased risk of GBC was observed with deep frying of fresh fish in mustard oil ( OR = 1.57 , 95 % CI = 0.99 - 2.47 , p - value = 0.052 ) ."
80827,However,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80828,",",O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80829,comparisons,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80830,across,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80831,nuts,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80832,(,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80833,walnuts,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80834,",",O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80835,almonds,B-http://purl.bioontology.org/ontology/SNOMEDCT/256350002,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80836,and,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80837,pistachios,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80838,),O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80839,with,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80840,varying,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80841,physical,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80842,properties,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80843,do,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80844,not,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80845,support,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80846,this,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80847,view,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80848,.,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
81071,The,O,2809.0,The exact nature of the protective effect remains to be established .
81072,exact,O,2809.0,The exact nature of the protective effect remains to be established .
81073,nature,O,2809.0,The exact nature of the protective effect remains to be established .
81074,of,O,2809.0,The exact nature of the protective effect remains to be established .
81075,the,O,2809.0,The exact nature of the protective effect remains to be established .
81076,protective,O,2809.0,The exact nature of the protective effect remains to be established .
81077,effect,O,2809.0,The exact nature of the protective effect remains to be established .
81078,remains,O,2809.0,The exact nature of the protective effect remains to be established .
81079,to,O,2809.0,The exact nature of the protective effect remains to be established .
81080,be,O,2809.0,The exact nature of the protective effect remains to be established .
81081,established,O,2809.0,The exact nature of the protective effect remains to be established .
81082,.,O,2809.0,The exact nature of the protective effect remains to be established .
81083,However,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81084,",",O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81085,mechanisms,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81086,including,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81087,low,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81088,-,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81089,density,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81090,lipoproteins,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81091,oxidation,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81092,",",O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81093,inhibition,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81094,of,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81095,platelet,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81096,aggregation,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81097,",",O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81098,modification,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81099,of,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81100,eicosanoid,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81101,metabolism,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81102,",",O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81103,and,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81104,endothelium,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81105,-,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81106,dependent,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81107,relaxation,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81108,of,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81109,blood,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81110,vessels,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81111,are,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81112,recognized,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81113,as,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81114,contributory,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81115,.,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81116,In,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81117,this,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81118,study,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81119,",",O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81120,a,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81121,new,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81122,approach,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81123,has,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81124,been,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81125,examined,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81126,",",O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81127,based,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81128,on,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81129,previous,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81130,reports,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81131,that,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81132,platelet,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81133,-,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81134,activating,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81135,factor,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81136,(,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81137,PAF,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81138,),O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81139,is,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81140,involved,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81141,in,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81142,atherogenesis,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81143,.,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81279,Understanding,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81280,the,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81281,early,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81282,determinants,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81283,of,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81284,food,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81285,intake,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81286,",",O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81287,in,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81288,particular,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81289,the,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81290,role,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81291,of,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81292,food,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81293,sensory,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81294,quality,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81295,",",O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81296,is,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81297,a,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81298,necessary,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81299,step,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81300,to,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81301,improve,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81302,the,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81303,prevention,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81304,of,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81305,unhealthy,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81306,food,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81307,habits,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81308,.,O,2816.0,"Understanding the early determinants of food intake , in particular the role of food sensory quality , is a necessary step to improve the prevention of unhealthy food habits ."
81628,Specific,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81629,serum,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81630,IgE,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81631,was,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81632,measured,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81633,by,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81634,four,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81635,different,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81636,commercially,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81637,available,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81638,tests,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81639,and,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81640,by,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81641,an,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81642,inhouse,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81643,Maxisorp,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81644,RAST,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81645,using,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81646,freshly,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81647,prepared,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81648,food,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81649,extracts,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81650,.,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81840,Measuring,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81841,egg,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81842,-,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81843,yolk,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81844,-,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81845,specific,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81846,IgE,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81847,or,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81848,using,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81849,freshly,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81850,prepared,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81851,food,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81852,extracts,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81853,for,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81854,specific,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81855,IgE,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81856,measurements,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81857,added,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81858,no,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81859,further,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81860,diagnostic,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81861,information,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81862,.,O,2836.0,Measuring egg - yolk - specific IgE or using freshly prepared food extracts for specific IgE measurements added no further diagnostic information .
81863,The,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81864,rate,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81865,of,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81866,clinically,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81867,insignificant,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81868,positive,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81869,test,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81870,results,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81871,seems,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81872,to,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81873,be,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81874,influenced,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81875,by,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81876,the,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81877,prevalence,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81878,of,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81879,other,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81880,food,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81881,allergies,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81882,and/or,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81883,atopic,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81884,dermatitis,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81885,in,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81886,the,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81887,population,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81888,under,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81889,study,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81890,.,O,2837.0,The rate of clinically insignificant positive test results seems to be influenced by the prevalence of other food allergies and/or atopic dermatitis in the population under study .
81933,Well,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81934,-,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81935,planned,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81936,vegetarian,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81937,diets,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81938,are,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81939,appropriate,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81940,for,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81941,individuals,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81942,during,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81943,all,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81944,stages,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81945,of,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81946,the,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81947,life,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81948,cycle,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81949,",",O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81950,including,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81951,pregnancy,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81952,",",O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81953,lactation,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81954,",",O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81955,infancy,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81956,",",O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81957,childhood,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81958,",",O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81959,and,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81960,adolescence,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81961,",",O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81962,and,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81963,for,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81964,athletes,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
81965,.,O,2839.0,"Well - planned vegetarian diets are appropriate for individuals during all stages of the life cycle , including pregnancy , lactation , infancy , childhood , and adolescence , and for athletes ."
82316,Between,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82317,both,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82318,beverages,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82319,",",O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82320,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82321,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82322,showed,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82323,a,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82324,clear,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82325,trend,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82326,for,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82327,being,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82328,more,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82329,active,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82330,in,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82331,stimulating,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82332,gastric,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82333,acid,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82334,secretion,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82335,than,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82336,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82337,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82338,(,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82339,p,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82340,=,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82341,0.054,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82342,),O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82343,.,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82391,RT,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82392,-,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82393,qPCR,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82394,experiments,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82395,on,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82396,cells,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82397,exposed,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82398,to,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82399,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82400,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82401,also,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82402,revealed,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82403,a,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82404,more,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82405,pronounced,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82406,effect,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82407,than,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82408,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82409,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82410,on,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82411,the,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82412,fold,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82413,change,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82414,expression,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82415,of,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82416,genes,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82417,associated,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82418,with,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82419,gastric,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82420,acid,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82421,secretion,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82422,.,O,2855.0,RT - qPCR experiments on cells exposed to red wine also revealed a more pronounced effect than white wine on the fold change expression of genes associated with gastric acid secretion .
82516,The,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82517,objective,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82518,of,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82519,the,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82520,present,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82521,study,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82522,was,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82523,to,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82524,determine,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82525,the,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82526,potential,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82527,health,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82528,benefits,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82529,of,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82530,legumes,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82531,as,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82532,a,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82533,good,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82534,source,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82535,of,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82536,dietary,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82537,fibre,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
82538,.,O,2860.0,The objective of the present study was to determine the potential health benefits of legumes as a good source of dietary fibre .
83670,Nonsensory,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83671,factors,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83672,such,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83673,as,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83674,demographic,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83675,profile,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83676,",",O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83677,innovativeness,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83678,",",O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83679,social,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83680,representation,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83681,",",O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83682,sensation,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83683,-,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83684,seeking,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83685,",",O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83686,and,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83687,personality,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83688,traits,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83689,were,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83690,also,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83691,assessed,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83692,.,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83986,Corn,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83987,dextrin,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83988,had,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83989,no,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83990,effect,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83991,on,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83992,the,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83993,storage,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83994,and,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83995,loss,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83996,moduli,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83997,",",O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83998,but,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83999,affected,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84000,the,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84001,gel,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84002,-,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84003,sol,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84004,transition,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84005,temperature,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84006,.,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
85012,These,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85013,changes,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85014,have,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85015,occurred,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85016,along,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85017,with,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85018,dietary,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85019,shifts,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85020,in,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85021,the,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85022,population,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85023,",",O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85024,from,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85025,a,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85026,diet,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85027,predominantly,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85028,of,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85029,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85030,and,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85031,small,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85032,portions,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85033,of,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85034,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85035,",",O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85036,vegetables,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85037,",",O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85038,and,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85039,fish,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85040,to,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85041,one,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85042,with,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85043,larger,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85044,portions,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85045,of,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85046,all,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85047,foods,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85048,but,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85049,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85050,and,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85051,eggs,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85052,.,O,2946.0,"These changes have occurred along with dietary shifts in the population , from a diet predominantly of rice and small portions of meat , vegetables , and fish to one with larger portions of all foods but rice and eggs ."
85590,The,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85591,word,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85592,cacao,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85593,is,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85594,derived,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85595,from,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85596,Olmec,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85597,and,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85598,the,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85599,subsequent,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85600,Mayan,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85601,languages,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85602,(,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85603,kakaw,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85604,),O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85605,;,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85606,the,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85607,chocolate,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85608,-,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85609,related,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85610,term,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85611,cacahuatl,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85612,is,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85613,Nahuatl,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85614,(,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85615,Aztec,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85616,language,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85617,),O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85618,",",O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85619,derived,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85620,from,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85621,Olmec,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85622,/,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85623,Mayan,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85624,etymology,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85625,.,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85819,Chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85820,paste,I-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85821,was,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85822,a,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85823,medium,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85824,used,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85825,to,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85826,administer,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85827,drugs,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85828,and,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85829,to,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85830,counter,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85831,the,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85832,taste,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85833,of,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85834,bitter,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85835,pharmacological,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85836,additives,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85837,.,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
87362,Fatty,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87363,acid,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87364,concentrations,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87365,were,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87366,similar,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87367,to,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87368,those,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87369,found,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87370,for,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87371,the,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87372,other,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87373,meals,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87374,.,O,3023.0,Fatty acid concentrations were similar to those found for the other meals .
87716,Due,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87717,to,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87718,their,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87719,estrogen,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87720,-,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87721,like,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87722,structure,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87723,",",O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87724,soy,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87725,isoflavones,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87726,may,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87727,affect,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87728,IGF,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87729,-,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87730,I,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87731,levels,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87732,in,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87733,a,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87734,similar,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87735,way,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87736,as,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87737,exogenous,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87738,estrogens,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87739,.,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87740,In,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87741,a,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87742,cross,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87743,-,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87744,sectional,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87745,design,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87746,",",O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87747,we,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87748,compared,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87749,IGF,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87750,-,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87751,I,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87752,levels,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87753,between,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87754,women,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87755,with,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87756,high,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87757,and,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87758,low,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87759,soy,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87760,intake,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87761,.,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87908,Mean,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87909,IGF,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87910,-,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87911,I,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87912,levels,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87913,were,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87914,11,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87915,%,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87916,lower,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87917,among,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87918,women,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87919,in,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87920,the,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87921,highest,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87922,tofu,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87923,intake,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87924,category,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87925,compared,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87926,with,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87927,the,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87928,lowest,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87929,",",O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87930,but,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87931,the,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87932,difference,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87933,in,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87934,IGF,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87935,-,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87936,I,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87937,levels,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87938,between,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87939,the,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87940,highest,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87941,and,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87942,lowest,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87943,tofu,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87944,category,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87945,was,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87946,only,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87947,significant,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87948,among,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87949,women,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87950,in,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87951,Japan,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87952,.,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
88072,Flavanols,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88073,have,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88074,been,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88075,described,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88076,to,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88077,exert,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88078,favorable,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88079,effects,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88080,on,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88081,endothelium,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88082,-,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88083,derived,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88084,vasodilation,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88085,via,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88086,the,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88087,stimulation,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88088,of,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88089,nitric,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88090,oxide,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88091,-,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88092,synthase,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88093,",",O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88094,the,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88095,increased,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88096,availability,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88097,of,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88098,l,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88099,-,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88100,arginine,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88101,",",O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88102,and,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88103,the,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88104,decreased,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88105,degradation,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88106,of,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88107,NO,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88108,.,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88256,This,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88257,paper,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88258,summarizes,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88259,new,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88260,findings,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88261,concerning,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88262,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88263,effects,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88264,on,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88265,blood,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88266,pressure,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88267,and,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88268,cardiovascular,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88269,health,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88270,",",O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88271,focusing,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88272,on,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88273,putative,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88274,mechanisms,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88275,of,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88276,action,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88277,and,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88278,"""",O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88279,nutraceutical,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88280,"""",O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88281,viewpoints,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88282,.,O,3057.0,"This paper summarizes new findings concerning cocoa effects on blood pressure and cardiovascular health , focusing on putative mechanisms of action and "" nutraceutical "" viewpoints ."
88590,Cows,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88591,were,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88592,fed,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88593,to,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88594,100,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88595,%,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88596,National,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88597,Research,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88598,Council,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88599,requirements,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88600,for,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88601,metabolizable,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88602,protein,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88603,(,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88604,MP,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88605,),O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88606,and,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88607,energy,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88608,(,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88609,ME,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88610,),O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88611,for,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88612,9,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88613,d,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88614,",",O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88615,after,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88616,which,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88617,they,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88618,were,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88619,feed,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88620,-,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88621,restricted,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88622,for,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88623,5,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88624,d,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88625,to,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88626,85,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88627,%,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88628,of,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88629,their,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88630,individual,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88631,ad,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88632,libitum,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88633,intake,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88634,and,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88635,then,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88636,abomasally,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88637,infused,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88638,with,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88639,1,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88640,of,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88641,6,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88642,treatments,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
88643,.,O,3071.0,"Cows were fed to 100 % National Research Council requirements for metabolizable protein ( MP ) and energy ( ME ) for 9 d , after which they were feed - restricted for 5 d to 85 % of their individual ad libitum intake and then abomasally infused with 1 of 6 treatments ."
89118,No,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89119,differences,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89120,in,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89121,DM,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89122,intake,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89123,were,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89124,detected,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89125,",",O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89126,and,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89127,ME,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89128,intake,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89129,in,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89130,LRS,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89131,was,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89132,lower,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89133,than,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89134,in,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89135,CON,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89136,(,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89137,"1,095",O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89138,vs.,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89139,"1,180",O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89140,kJ,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89141,/,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89142,kg,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89143,of,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89144,metabolic,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89145,body,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89146,weight,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89147,),O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89148,.,O,3085.0,"No differences in DM intake were detected , and ME intake in LRS was lower than in CON ( 1,095 vs. 1,180 kJ / kg of metabolic body weight ) ."
89454,Total,O,3096.0,Total vegetable consumption was not particularly associated with risk .
89455,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,3096.0,Total vegetable consumption was not particularly associated with risk .
89456,consumption,O,3096.0,Total vegetable consumption was not particularly associated with risk .
89457,was,O,3096.0,Total vegetable consumption was not particularly associated with risk .
89458,not,O,3096.0,Total vegetable consumption was not particularly associated with risk .
89459,particularly,O,3096.0,Total vegetable consumption was not particularly associated with risk .
89460,associated,O,3096.0,Total vegetable consumption was not particularly associated with risk .
89461,with,O,3096.0,Total vegetable consumption was not particularly associated with risk .
89462,risk,O,3096.0,Total vegetable consumption was not particularly associated with risk .
89463,.,O,3096.0,Total vegetable consumption was not particularly associated with risk .
89618,The,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89619,traditional,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89620,Chinese,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89621,medicinal,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89622,plants,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89623,such,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89624,as,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89625,flowers,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89626,and,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89627,buds,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89628,of,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89629,Lonicera,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89630,japonica,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89631,Thunb,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89632,and,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89633,the,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89634,leaves,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89635,of,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89636,Eucommia,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89637,ulmodies,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89638,contained,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89639,CGAs,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89640,as,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89641,bioactive,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89642,compound,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89643,.,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89881,Regarding,O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
89882,bread,O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
89883,-,O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
89884,making,O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
89885,processes,O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
89886,",",O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
89887,the,O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
89888,impact,O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
89889,of,O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
89890,mixing,O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
89891,",",O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
89892,dough,O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
89893,treatment,O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
89894,and,O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
89895,baking,O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
89896,is,O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
89897,stated,O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
89898,.,O,3114.0,"Regarding bread - making processes , the impact of mixing , dough treatment and baking is stated ."
90066,Thus,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90067,",",O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90068,the,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90069,purpose,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90070,of,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90071,this,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90072,research,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90073,was,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90074,to,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90075,manipulate,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90076,the,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90077,bitterness,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90078,of,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90079,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009;http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90080,ice,I-http://purl.bioontology.org/ontology/SNOMEDCT/102262009;http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90081,cream,I-http://purl.bioontology.org/ontology/SNOMEDCT/102262009;http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90082,to,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90083,examine,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90084,how,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90085,this,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90086,influences,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90087,consumer,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90088,preferences,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90089,.,O,3122.0,"Thus , the purpose of this research was to manipulate the bitterness of chocolate ice cream to examine how this influences consumer preferences ."
90090,The,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90091,main,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90092,goal,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90093,of,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90094,this,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90095,study,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90096,was,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90097,to,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90098,estimate,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90099,group,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90100,rejection,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90101,thresholds,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90102,for,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90103,bitterness,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90104,in,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90105,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009;http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90106,ice,I-http://purl.bioontology.org/ontology/SNOMEDCT/102262009;http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90107,cream,I-http://purl.bioontology.org/ontology/SNOMEDCT/102262009;http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90108,",",O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90109,and,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90110,to,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90111,see,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90112,if,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90113,solid,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90114,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90115,preferences,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90116,(,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90117,dark,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90118,vs.,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90119,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90120,),O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90121,generalized,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90122,to,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90123,ice,B-http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90124,cream,I-http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90125,.,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90640,The,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90641,apparent,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90642,viscosity,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90643,tended,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90644,to,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90645,increase,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90646,with,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90647,the,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90648,addition,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90649,of,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90650,sugar,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90651,and,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90652,oil,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
90653,.,O,3140.0,The apparent viscosity tended to increase with the addition of sugar and oil .
91014,Factor,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91015,2,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91016,",",O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91017,characterized,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91018,by,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91019,salad,B-http://purl.bioontology.org/ontology/SNOMEDCT/227927005,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91020,and,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91021,cooked,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91022,vegetables,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91023,",",O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91024,was,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91025,inversely,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91026,associated,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91027,with,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91028,diabetes,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91029,.,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91138,As,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91139,a,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91140,result,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91141,",",O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91142,the,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91143,polyunsaturated,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91144,fatty,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91145,acid,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91146,content,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91147,was,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91148,27,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91149,to,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91150,28,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91151,per,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91152,cent,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91153,of,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91154,the,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91155,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91156,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91157,and,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91158,butterfat,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91159,;,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91160,saturated,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91161,fatty,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91162,acids,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91163,(,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91164,C12:0,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91165,to,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91166,tc16:0,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91167,),O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91168,were,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91169,18,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91170,to,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91171,19,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91172,per,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91173,cent,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91174,.,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91572,Low,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91573,energy,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91574,reporters,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91575,had,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91576,a,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91577,healthier,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91578,diet,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91579,than,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91580,the,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91581,rest,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91582,with,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91583,the,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91584,weighed,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91585,record,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91586,.,O,3176.0,Low energy reporters had a healthier diet than the rest with the weighed record .
91734,Energy,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91735,and,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91736,sugar,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91737,(,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91738,%,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91739,of,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91740,total,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91741,energy,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91742,),O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91743,intakes,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91744,were,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91745,not,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91746,significantly,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91747,different,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91748,across,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91749,all,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91750,fat,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91751,intakes,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91752,;,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91753,energy,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91754,density,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91755,decreased,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91756,with,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91757,decreasing,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91758,fat,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91759,quartile,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
91760,.,O,3179.0,Energy and sugar ( % of total energy ) intakes were not significantly different across all fat intakes ; energy density decreased with decreasing fat quartile .
93536,Urine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93537,volume,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93538,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93539,pH,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93540,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93541,oxalate,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93542,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93543,creatinine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93544,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93545,uric,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93546,acid,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93547,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93548,theobromine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93549,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93550,and,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93551,a,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93552,uric,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93553,acid,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93554,crystallization,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93555,test,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93556,were,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93557,determined,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93558,for,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93559,each,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93560,sample,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93561,.,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93596,The,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93597,results,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93598,indicated,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93599,that,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93600,increased,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93601,concentrations,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93602,of,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93603,urinary,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93604,theobromine,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93605,reduced,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93606,the,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93607,risk,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93608,of,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93609,uric,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93610,acid,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93611,crystallization,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93612,.,O,3247.0,The results indicated that increased concentrations of urinary theobromine reduced the risk of uric acid crystallization .
93751,Immunoblot,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93752,of,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93753,raw,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93754,carrot,B-http://purl.bioontology.org/ontology/SNOMEDCT/256319004,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93755,showed,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93756,a,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93757,single,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93758,IgE,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93759,-,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93760,binding,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93761,18,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93762,-,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93763,kDa,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93764,band,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93765,.,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
95019,Current,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95020,US,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95021,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95022,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95023,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95024,intake,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95025,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95026,which,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95027,averages,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95028,about,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95029,3.4,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95030,servings,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95031,per,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95032,day,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95033,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95034,is,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95035,discussed,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95036,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95037,as,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95038,are,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95039,possible,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95040,noncancer,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95041,-,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95042,related,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95043,effects,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95044,of,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95045,increased,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95046,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95047,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95048,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95049,consumption,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95050,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95051,including,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95052,benefits,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95053,against,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95054,cardiovascular,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95055,disease,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95056,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95057,diabetes,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95058,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95059,stroke,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95060,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95061,obesity,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95062,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95063,diverticulosis,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95064,",",O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95065,and,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95066,cataracts,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95067,.,O,3293.0,"Current US vegetable and fruit intake , which averages about 3.4 servings per day , is discussed , as are possible noncancer - related effects of increased vegetable and fruit consumption , including benefits against cardiovascular disease , diabetes , stroke , obesity , diverticulosis , and cataracts ."
95157,This,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95158,",",O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95159,in,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95160,turn,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95161,",",O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95162,can,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95163,increase,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95164,the,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95165,risk,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95166,of,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95167,major,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95168,chronic,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95169,diseases,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95170,such,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95171,as,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95172,osteoporosis,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95173,(,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95174,porous,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95175,bones,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95176,),O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95177,and,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95178,hypertension,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95179,.,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95399,Celery,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95400,-,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95401,birch,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95402,positive,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95403,patients,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95404,(,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95405,n,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95406,=,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95407,13,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95408,),O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95409,showed,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95410,negative,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95411,or,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95412,low,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95413,RASTs,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95414,to,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95415,heated,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95416,celery,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95417,extracts,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95418,and,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95419,to,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95420,stick,B-http://purl.bioontology.org/ontology/SNOMEDCT/256326004,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95421,celery,I-http://purl.bioontology.org/ontology/SNOMEDCT/256326004,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95422,.,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95569,The,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95570,aim,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95571,of,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95572,this,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95573,study,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95574,is,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95575,to,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95576,reanalyze,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95577,the,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95578,effect,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95579,of,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95580,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95581,and,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95582,vegetables,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95583,(,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95584,F&V,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95585,),O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95586,",",O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95587,based,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95588,on,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95589,a,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95590,longer,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95591,follow,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95592,-,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95593,up,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95594,and,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95595,twice,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95596,the,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95597,number,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95598,of,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95599,GC,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95600,cases,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
95601,.,O,3312.0,"The aim of this study is to reanalyze the effect of fruit and vegetables ( F&V ) , based on a longer follow - up and twice the number of GC cases ."
96135,Controlled,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96136,field,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96137,experiments,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96138,with,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96139,potatoes,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96140,",",O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96141,beans,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96142,and,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96143,lettuce,B-http://purl.bioontology.org/ontology/SNOMEDCT/735042006,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96144,(,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96145,Solanum,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96146,tuberosum,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96147,L.,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96148,",",O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96149,Phaseolus,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96150,vulgaris,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96151,L.,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96152,and,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96153,Lactuca,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96154,sativa,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96155,L.,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96156,),O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96157,were,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96158,carried,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96159,out,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96160,in,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96161,a,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96162,contaminated,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96163,soil,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96164,used,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96165,by,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96166,local,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96167,farmers,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96168,located,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96169,near,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96170,a,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96171,closed,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96172,Portuguese,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96173,uranium,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96174,mine,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96175,(,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96176,Cunha,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96177,Baixa,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96178,",",O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96179,Mangualde,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96180,),O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96181,.,O,3335.0,"Controlled field experiments with potatoes , beans and lettuce ( Solanum tuberosum L. , Phaseolus vulgaris L. and Lactuca sativa L. ) were carried out in a contaminated soil used by local farmers located near a closed Portuguese uranium mine ( Cunha Baixa , Mangualde ) ."
96444,Among,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96445,the,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96446,various,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96447,types,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96448,of,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96449,animal,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96450,-,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96451,based,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96452,protein,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96453,foods,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96454,",",O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96455,a,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96456,higher,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96457,intake,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96458,of,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96459,dairy,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96460,products,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96461,(,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96462,such,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96463,as,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96464,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96465,",",O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96466,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96467,",",O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96468,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96469,and,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96470,whey,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96471,protein,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96472,),O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96473,consistently,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96474,shows,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96475,a,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96476,beneficial,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96477,relationship,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96478,with,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96479,glucose,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96480,regulation,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96481,and/or,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96482,type,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96483,2,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96484,diabetes,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96485,risk,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96486,reduction,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96487,.,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96583,Furthermore,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96584,",",O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96585,fermentation,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96586,and,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96587,fortification,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96588,of,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96589,dairy,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96590,products,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96591,with,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96592,probiotics,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96593,and,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96594,vitamin,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96595,D,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96596,may,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96597,improve,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96598,a,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96599,dairy,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96600,product,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96601,'s,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96602,glucoregulatory,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96603,effects,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96604,.,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96605,Epidemiologic,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96606,studies,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96607,from,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96608,numerous,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96609,disparate,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96610,populations,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96611,reveal,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96612,that,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96613,individuals,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96614,with,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96615,the,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96616,habit,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96617,of,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96618,daily,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96619,moderate,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96620,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96621,consumption,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96622,enjoy,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96623,significant,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96624,reductions,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96625,in,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96626,all,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96627,-,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96628,cause,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96629,and,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96630,particularly,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96631,cardiovascular,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96632,mortality,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96633,when,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96634,compared,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96635,with,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96636,individuals,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96637,who,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96638,abstain,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96639,or,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96640,who,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96641,drink,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96642,alcohol,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96643,to,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96644,excess,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96645,.,O,3346.0,Epidemiologic studies from numerous disparate populations reveal that individuals with the habit of daily moderate wine consumption enjoy significant reductions in all - cause and particularly cardiovascular mortality when compared with individuals who abstain or who drink alcohol to excess .
96659,Moderate,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96660,ethanol,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96661,intake,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96662,from,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96663,any,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96664,type,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96665,of,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96666,beverage,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96667,improves,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96668,lipoprotein,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96669,metabolism,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96670,and,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96671,lowers,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96672,cardiovascular,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96673,mortality,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96674,risk,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96675,.,O,3348.0,Moderate ethanol intake from any type of beverage improves lipoprotein metabolism and lowers cardiovascular mortality risk .
96847,Probiotic,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96848,foods,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96849,",",O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96850,including,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96851,fermented,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96852,dairy,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96853,(,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96854,FD,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96855,),O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96856,products,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96857,such,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96858,as,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96859,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96860,and,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96861,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96862,",",O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96863,naturally,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96864,contain,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96865,live,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96866,microorganisms,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96867,",",O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96868,but,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96869,the,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96870,relationship,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96871,between,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96872,the,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96873,consumption,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96874,of,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96875,probiotic,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96876,foods,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96877,and,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96878,health,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96879,is,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96880,unclear,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
96881,.,O,3355.0,"Probiotic foods , including fermented dairy ( FD ) products such as yogurt and cheese , naturally contain live microorganisms , but the relationship between the consumption of probiotic foods and health is unclear ."
97385,This,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97386,cross,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97387,-,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97388,sectional,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97389,study,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97390,determined,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97391,the,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97392,frequency,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97393,of,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97394,consumption,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97395,of,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97396,traditional,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97397,meats,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97398,(,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97399,e.g.,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97400,caribou,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97401,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97402,polar,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97403,bear,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97404,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97405,seal,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97406,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97407,char,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97408,and,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97409,whale,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97410,),O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97411,and,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97412,non,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97413,-,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97414,traditional,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97415,store,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97416,-,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97417,bought,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97418,foods,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97419,including,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97420,non,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97421,-,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97422,traditional,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97423,meats,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97424,(,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97425,e.g.,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97426,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97427,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97428,pork,B-http://purl.bioontology.org/ontology/SNOMEDCT/226934003,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97429,and,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97430,chicken,B-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97431,),O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97432,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97433,grains,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97434,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97435,dairy,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97436,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97437,fruits,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97438,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97439,vegetables,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97440,and,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97441,non,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97442,-,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97443,nutrient,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97444,dense,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97445,foods,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97446,(,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97447,NNDFs,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97448,),O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97449,(,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97450,e.g.,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97451,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97452,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97453,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97454,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97455,chips,B-http://purl.bioontology.org/ontology/SNOMEDCT/227282006,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97456,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97457,candy,B-http://purl.bioontology.org/ontology/SNOMEDCT/227607007,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97458,and,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97459,pop,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97460,),O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97461,by,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97462,Inuvialuit,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97463,adults,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97464,(,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97465,175,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97466,women,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97467,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97468,mean,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97469,age,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97470,44,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97471,±,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97472,14,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97473,years,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97474,;,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97475,55,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97476,men,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97477,",",O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97478,mean,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97479,age,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97480,41,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97481,±,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97482,13,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97483,years,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97484,),O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97485,in,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97486,three,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97487,remote,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97488,communities,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97489,in,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97490,the,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97491,Northwest,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97492,Territories,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
97493,.,O,3376.0,"This cross - sectional study determined the frequency of consumption of traditional meats ( e.g. caribou , polar bear , seal , char and whale ) and non - traditional store - bought foods including non - traditional meats ( e.g. beef , pork and chicken ) , grains , dairy , fruits , vegetables and non - nutrient dense foods ( NNDFs ) ( e.g. butter , chocolate , chips , candy and pop ) by Inuvialuit adults ( 175 women , mean age 44 ± 14 years ; 55 men , mean age 41 ± 13 years ) in three remote communities in the Northwest Territories ."
98185,Women,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98186,of,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98187,both,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98188,ethnic,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98189,groups,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98190,were,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98191,found,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98192,to,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98193,avoid,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98194,saturated,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98195,fat,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98196,and,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98197,cholesterol,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98198,to,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98199,a,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98200,greater,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98201,degree,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98202,than,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98203,men,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98204,",",O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98205,scoring,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98206,higher,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98207,on,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98208,five,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98209,of,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98210,the,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98211,six,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98212,components,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98213,of,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98214,the,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98215,scale,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98216,.,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98612,Food,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98613,sources,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98614,of,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98615,nutrients,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98616,in,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98617,Mexican,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98618,children,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98619,are,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98620,not,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98621,well,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98622,known,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98623,.,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98659,Percent,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98660,contribution,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98661,of,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98662,each,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98663,food,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98664,group,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98665,to,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98666,nutrient,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98667,intake,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98668,was,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98669,estimated,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98670,for,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98671,four,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98672,age,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98673,groups,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98674,:,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98675,0,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98676,-,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98677,5.9,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98678,",",O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98679,6,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98680,-,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98681,11.9,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98682,",",O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98683,12,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98684,-,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98685,23.9,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98686,",",O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98687,and,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98688,24,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98689,-,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98690,47.9,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98691,months,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
98692,.,O,3422.0,"Percent contribution of each food group to nutrient intake was estimated for four age groups : 0 - 5.9 , 6 - 11.9 , 12 - 23.9 , and 24 - 47.9 months ."
99051,Postprandial,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99052,blood,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99053,samples,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99054,were,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99055,collected,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99056,to,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99057,assess,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99058,glucose,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99059,",",O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99060,insulin,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99061,",",O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99062,and,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99063,triglyceride,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99064,responses,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99065,to,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99066,feeding,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99067,",",O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99068,and,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99069,24,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99070,-,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99071,h,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99072,urine,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99073,was,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99074,collected,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99075,to,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99076,quantify,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99077,urinary,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99078,glucose,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99079,excretion,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99080,.,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99213,Two,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99214,groups,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99215,of,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99216,cows,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99217,received,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99218,either,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99219,a,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99220,total,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99221,mixed,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99222,ration,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99223,as,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99224,a,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99225,control,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99226,diet,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99227,or,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99228,the,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99229,same,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99230,total,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99231,mixed,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99232,ration,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99233,supplemented,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99234,with,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99235,1,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99236,%,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99237,of,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99238,GSGME,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99239,over,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99240,the,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99241,period,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99242,from,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99243,wk,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99244,3,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99245,prepartum,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99246,to,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99247,wk,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99248,9,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99249,postpartum,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99250,.,O,3439.0,Two groups of cows received either a total mixed ration as a control diet or the same total mixed ration supplemented with 1 % of GSGME over the period from wk 3 prepartum to wk 9 postpartum .
99268,However,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99269,",",O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99270,the,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99271,cows,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99272,fed,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99273,the,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99274,diet,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99275,supplemented,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99276,with,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99277,GSGME,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99278,had,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99279,an,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99280,increased,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99281,milk,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99282,yield,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99283,and,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99284,an,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99285,increased,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99286,daily,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99287,milk,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99288,protein,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99289,yield,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99290,.,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99291,Cows,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99292,supplemented,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99293,with,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99294,GSGME,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99295,moreover,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99296,had,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99297,a,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99298,significantly,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99299,reduced,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99300,mRNA,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99301,abundancy,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99302,of,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99303,fibroblast,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99304,growth,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99305,factor,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99306,(,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99307,FGF,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99308,),O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99309,21,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99310,",",O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99311,a,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99312,stress,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99313,hormone,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99314,induced,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99315,by,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99316,various,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99317,stress,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99318,conditions,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99319,",",O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99320,in,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99321,the,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99322,liver,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99323,in,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99324,wk,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99325,1,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99326,and,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99327,3,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99328,postpartum,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99329,.,O,3442.0,"Cows supplemented with GSGME moreover had a significantly reduced mRNA abundancy of fibroblast growth factor ( FGF ) 21 , a stress hormone induced by various stress conditions , in the liver in wk 1 and 3 postpartum ."
99476,At,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99477,2,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99478,wk,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99479,before,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99480,anticipated,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99481,calving,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99482,",",O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99483,Holstein,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99484,cows,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99485,were,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99486,fed,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99487,diets,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99488,that,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99489,provided,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99490,0,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99491,(,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99492,16,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99493,cows,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99494,),O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99495,or,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99496,30,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99497,(,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99498,15,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99499,cows,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99500,),O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99501,g,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99502,/,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99503,d,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99504,of,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99505,supplemental,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99506,vitamin,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99507,C,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99508,(,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99509,phosphorylated,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99510,ascorbic,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99511,acid,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99512,),O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99513,.,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99659,Supplemental,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99660,vitamin,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99661,C,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99662,had,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99663,no,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99664,effect,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99665,on,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99666,neutrophil,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99667,phagocytosis,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99668,or,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99669,bacterial,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99670,kill,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99671,.,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99672,Dietary,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99673,vitamin,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99674,C,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99675,reduced,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99676,the,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99677,milk,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99678,somatic,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99679,cell,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99680,count,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99681,but,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99682,did,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99683,not,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99684,affect,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99685,the,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99686,febrile,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99687,response,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99688,or,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99689,milk,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99690,production,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99691,following,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99692,LPS,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99693,infusion,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99694,.,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99786,Unfortunately,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99787,",",O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99788,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99789,can,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99790,contain,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99791,high,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99792,contents,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99793,of,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99794,total,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99795,(,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99796,t,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99797,-,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99798,As,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99799,),O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99800,and,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99801,inorganic,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99802,(,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99803,i,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99804,-,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99805,As,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99806,),O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99807,arsenic,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99808,.,O,3457.0,"Unfortunately , rice can contain high contents of total ( t - As ) and inorganic ( i - As ) arsenic ."
99939,Consumption,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99940,of,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99941,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99942,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99943,within,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99944,the,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99945,Mediterranean,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99946,diet,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99947,has,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99948,been,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99949,long,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99950,known,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99951,to,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99952,have,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99953,many,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99954,health,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99955,benefits,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99956,.,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99957,However,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99958,",",O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99959,only,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99960,over,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99961,the,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99962,last,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99963,decade,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99964,has,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99965,epidemiological,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99966,research,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99967,confirmed,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99968,its,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99969,protective,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99970,role,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99971,against,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99972,developing,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99973,several,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99974,chronic,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99975,diseases,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99976,.,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
100070,There,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100071,is,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100072,converging,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100073,evidence,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100074,on,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100075,the,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100076,benefits,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100077,of,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100078,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100079,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100080,for,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100081,preventing,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100082,several,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100083,CVD,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100084,risk,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100085,factors,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100086,",",O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100087,including,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100088,diabetes,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100089,",",O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100090,MetS,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100091,and,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100092,obesity,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100093,.,O,3466.0,"There is converging evidence on the benefits of olive oil for preventing several CVD risk factors , including diabetes , MetS and obesity ."
100164,Despite,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100165,the,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100166,accumulating,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100167,epidemiological,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100168,research,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100169,",",O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100170,there,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100171,is,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100172,still,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100173,a,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100174,lack,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100175,of,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100176,consistent,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100177,results,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100178,from,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100179,high,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100180,-,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100181,quality,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100182,studies,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100183,for,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100184,many,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100185,health,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100186,outcomes,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100187,(,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100188,i.e.,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100189,certain,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100190,cancers,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100191,and,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100192,metabolism,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100193,-,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100194,related,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100195,disorders,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100196,),O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100197,.,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100348,No,O,3476.0,No evidence for other rosemary constituents was found .
100349,evidence,O,3476.0,No evidence for other rosemary constituents was found .
100350,for,O,3476.0,No evidence for other rosemary constituents was found .
100351,other,O,3476.0,No evidence for other rosemary constituents was found .
100352,rosemary,B-http://purl.bioontology.org/ontology/SNOMEDCT/227410007,3476.0,No evidence for other rosemary constituents was found .
100353,constituents,O,3476.0,No evidence for other rosemary constituents was found .
100354,was,O,3476.0,No evidence for other rosemary constituents was found .
100355,found,O,3476.0,No evidence for other rosemary constituents was found .
100356,.,O,3476.0,No evidence for other rosemary constituents was found .
100497,Population,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100498,minimal,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100499,eliciting,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100500,dose,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100501,(,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100502,EDp,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100503,),O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100504,distributions,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100505,based,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100506,on,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100507,this,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100508,dataset,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100509,were,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100510,published,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100511,for,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100512,11,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100513,allergenic,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100514,foods,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100515,in,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100516,2014,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100517,.,O,3482.0,Population minimal eliciting dose ( EDp ) distributions based on this dataset were published for 11 allergenic foods in 2014 .
100778,Incident,O,3495.0,Incident stroke cases were identified in national registers .
100779,stroke,O,3495.0,Incident stroke cases were identified in national registers .
100780,cases,O,3495.0,Incident stroke cases were identified in national registers .
100781,were,O,3495.0,Incident stroke cases were identified in national registers .
100782,identified,O,3495.0,Incident stroke cases were identified in national registers .
100783,in,O,3495.0,Incident stroke cases were identified in national registers .
100784,national,O,3495.0,Incident stroke cases were identified in national registers .
100785,registers,O,3495.0,Incident stroke cases were identified in national registers .
100786,.,O,3495.0,Incident stroke cases were identified in national registers .
100910,We,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100911,did,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100912,not,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100913,observe,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100914,any,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100915,associations,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100916,for,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100917,haemorrhagic,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100918,stroke,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100919,.,O,3500.0,We did not observe any associations for haemorrhagic stroke .
101362,In,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101363,the,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101364,time,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101365,period,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101366,1996,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101367,-,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101368,2004,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101369,",",O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101370,697,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101371,cases,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101372,with,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101373,lymphoid,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101374,neoplasms,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101375,and,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101376,3606,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101377,controls,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101378,with,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101379,nonneoplastic,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101380,conditions,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101381,were,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101382,included,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101383,in,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101384,a,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101385,case,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101386,-,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101387,control,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101388,study,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101389,conducted,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101390,in,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101391,the,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101392,Cancer,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101393,Institute,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101394,of,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101395,Uruguay,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101396,.,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101514,On,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101515,the,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101516,other,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101517,hand,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101518,",",O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101519,plant,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101520,foods,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101521,",",O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101522,particularly,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101523,total,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101524,fruits,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101525,",",O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101526,and,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101527,alcoholic,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101528,beverages,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101529,(,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101530,mainly,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101531,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101532,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101533,),O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101534,were,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101535,protective,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101536,.,O,3520.0,"On the other hand , plant foods , particularly total fruits , and alcoholic beverages ( mainly red wine ) were protective ."
101819,After,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101820,each,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101821,chocolate,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101822,sample,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101823,",",O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101824,participants,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101825,completed,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101826,the,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101827,Psychoactive,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101828,Effects,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101829,Questionnaire,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101830,(,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101831,PEQ,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101832,),O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
101833,.,O,3533.0,"After each chocolate sample , participants completed the Psychoactive Effects Questionnaire ( PEQ ) ."
102415,For,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102416,this,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102417,purpose,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102418,",",O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102419,current,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102420,guidelines,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102421,recommend,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102422,increasing,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102423,fluid,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102424,intake,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102425,",",O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102426,maintaining,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102427,a,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102428,balanced,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102429,calcium,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102430,intake,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102431,",",O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102432,reducing,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102433,dietary,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102434,intake,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102435,of,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102436,sodium,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102437,and,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102438,animal,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102439,proteins,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102440,",",O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102441,and,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102442,increasing,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102443,intake,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102444,of,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102445,fruits,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102446,and,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102447,fibers,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
102448,.,O,3554.0,"For this purpose , current guidelines recommend increasing fluid intake , maintaining a balanced calcium intake , reducing dietary intake of sodium and animal proteins , and increasing intake of fruits and fibers ."
103589,Given,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103590,the,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103591,putative,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103592,relationship,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103593,between,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103594,inflammation,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103595,and,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103596,insulin,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103597,resistance,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103598,",",O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103599,the,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103600,consumption,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103601,of,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103602,flavonoids,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103603,or,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103604,flavonoid,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103605,-,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103606,rich,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103607,foods,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103608,has,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103609,been,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103610,suggested,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103611,to,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103612,reduce,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103613,the,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103614,risk,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103615,of,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103616,diabetes,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103617,by,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103618,targeting,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103619,inflammatory,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103620,signals,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103621,.,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103710,However,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103711,",",O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103712,the,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103713,scientific,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103714,and,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103715,technological,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103716,revolution,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103717,in,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103718,Western,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103719,countries,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103720,made,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103721,fermentation,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103722,turn,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103723,from,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103724,a,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103725,household,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103726,to,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103727,a,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103728,controlled,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103729,process,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103730,suitable,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103731,for,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103732,industrial,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103733,scale,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103734,production,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103735,systems,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103736,intended,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103737,for,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103738,the,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103739,mass,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103740,marketplace,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103741,.,O,3601.0,"However , the scientific and technological revolution in Western countries made fermentation turn from a household to a controlled process suitable for industrial scale production systems intended for the mass marketplace ."
103825,Fermentation,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103826,was,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103827,found,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103828,to,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103829,increase,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103830,antioxidant,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103831,activity,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103832,of,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103833,milks,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103834,",",O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103835,cereals,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103836,",",O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103837,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103838,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103839,vegetables,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103840,",",O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103841,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103842,and,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103843,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103844,.,O,3604.0,"Fermentation was found to increase antioxidant activity of milks , cereals , fruit and vegetables , meat and fish ."
103882,Other,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103883,effects,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103884,such,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103885,as,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103886,anti,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103887,-,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103888,diabetic,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103889,properties,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103890,",",O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103891,FODMAP,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103892,reduction,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103893,",",O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103894,and,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103895,changes,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103896,in,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103897,fatty,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103898,acid,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103899,profile,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103900,are,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103901,peculiar,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103902,of,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103903,specific,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103904,food,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103905,categories,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103906,.,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
104788,Despite,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104789,its,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104790,lower,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104791,protein,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104792,content,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104793,",",O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104794,SAv,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104795,seems,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104796,to,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104797,be,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104798,more,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104799,allergenic,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104800,than,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104801,HAv,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104802,",",O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104803,both,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104804,in,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104805,vivo,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104806,and,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104807,in,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104808,vitro,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
104809,.,O,3645.0,"Despite its lower protein content , SAv seems to be more allergenic than HAv , both in vivo and in vitro ."
105018,All,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105019,three,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105020,chocolates,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105021,provoked,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105022,a,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105023,sustained,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105024,rise,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105025,in,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105026,blood,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105027,glucose,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105028,",",O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105029,which,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105030,reached,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105031,a,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105032,maximum,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105033,at,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105034,90,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105035,min,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105036,after,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105037,ingestion,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105038,and,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105039,returned,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105040,to,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105041,baseline,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105042,values,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105043,by,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105044,5,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105045,h.,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105046,The,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105047,highest,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105048,blood,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105049,glucose,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105050,levels,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105051,occurred,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105052,after,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105053,conventional,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105054,chocolate,I-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105055,",",O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105056,and,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105057,differences,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105058,were,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105059,statistically,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105060,significant,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105061,at,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105062,60,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105063,and,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105064,90,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105065,min,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105066,(,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105067,P,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105068,less,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105069,than,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105070,0.05,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105071,),O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105072,.,O,3654.0,"All three chocolates provoked a sustained rise in blood glucose , which reached a maximum at 90 min after ingestion and returned to baseline values by 5 h. The highest blood glucose levels occurred after conventional chocolate , and differences were statistically significant at 60 and 90 min ( P less than 0.05 ) ."
105139,All,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105140,three,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105141,chocolates,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105142,led,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105143,to,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105144,a,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105145,similar,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105146,sustained,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105147,rise,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105148,in,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105149,serum,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105150,triglyceride,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105151,levels,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105152,.,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105373,Participants,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105374,in,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105375,the,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105376,higher,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105377,UK,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105378,/,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105379,BW,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105380,quartile,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105381,consumed,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105382,significantly,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105383,more,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105384,vegetables,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105385,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105386,fruits,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105387,",",O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105388,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105389,",",O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105390,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105391,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105392,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105393,dairy,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105394,products,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105395,",",O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105396,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105397,ate,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105398,less,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105399,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105400,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105401,noodles,B-http://purl.bioontology.org/ontology/SNOMEDCT/226735005,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105402,.,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105993,The,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
105994,dietary,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
105995,patterns,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
105996,reviewed,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
105997,include,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
105998,low,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
105999,carbohydrate,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106000,diet,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106001,",",O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106002,low,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106003,-,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106004,fat,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106005,diet,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106006,",",O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106007,Mediterranean,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106008,diet,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106009,",",O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106010,and,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106011,the,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106012,DASH,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106013,diet,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106014,.,O,3686.0,"The dietary patterns reviewed include low carbohydrate diet , low - fat diet , Mediterranean diet , and the DASH diet ."
106560,Their,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106561,association,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106562,with,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106563,colorectal,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106564,tumors,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106565,was,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106566,investigated,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106567,in,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106568,516,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106569,adenoma,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106570,cases,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106571,(,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106572,175,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106573,high,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106574,-,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106575,risk,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106576,adenomas,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106577,),O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106578,and,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106579,"4,804",O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106580,polyp,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106581,-,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106582,free,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106583,women,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106584,and,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106585,in,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106586,172,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106587,colorectal,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106588,cancer,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106589,cases,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106590,and,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106591,"67,312",O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106592,cancer,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106593,-,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106594,free,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106595,women,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106596,.,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106597,The,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106598,authors,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106599,identified,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106600,four,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106601,dietary,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106602,patterns,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106603,:,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106604,"""",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106605,healthy,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106606,"""",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106607,(,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106608,vegetables,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106609,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106610,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106611,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106612,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106613,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106614,sea,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106615,products,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106616,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106617,and,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106618,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106619,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106620,),O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106621,;,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106622,"""",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106623,Western,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106624,"""",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106625,(,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106626,potatoes,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106627,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106628,pizzas,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106629,and,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106630,pies,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106631,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106632,sandwiches,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106633,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106634,sweets,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106635,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106636,cakes,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106637,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106638,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106639,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106640,cereal,B-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106641,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106642,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106643,processed,B-http://purl.bioontology.org/ontology/SNOMEDCT/227031001;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106644,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/227031001;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106645,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106646,eggs,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106647,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106648,and,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106649,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106650,),O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106651,;,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106652,"""",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106653,drinker,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106654,"""",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106655,(,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106656,sandwiches,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106657,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106658,snacks,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106659,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106660,processed,B-http://purl.bioontology.org/ontology/SNOMEDCT/227031001;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106661,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/227031001;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106662,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106663,and,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106664,alcoholic,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106665,beverages,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106666,),O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106667,;,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106668,and,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106669,"""",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106670,meat,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106671,eaters,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106672,"""",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106673,(,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106674,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106675,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106676,poultry,B-http://purl.bioontology.org/ontology/SNOMEDCT/28230009,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106677,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106678,and,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106679,margarine,B-http://purl.bioontology.org/ontology/SNOMEDCT/226890008,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106680,),O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106681,.,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106790,Dietary,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106791,patterns,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106792,that,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106793,reflect,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106794,a,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106795,Western,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106796,way,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106797,of,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106798,life,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106799,are,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106800,associated,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106801,with,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106802,a,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106803,higher,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106804,risk,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106805,of,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106806,colorectal,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106807,tumors,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106808,.,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106809,Observational,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106810,studies,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106811,support,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106812,the,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106813,role,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106814,of,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106815,modifying,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106816,lifestyle,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106817,-,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106818,related,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106819,risk,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106820,factors,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106821,such,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106822,as,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106823,diet,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106824,",",O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106825,physical,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106826,activity,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106827,and,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106828,alcohol,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106829,use,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106830,in,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106831,stroke,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106832,prevention,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106833,.,O,3713.0,"Observational studies support the role of modifying lifestyle - related risk factors such as diet , physical activity and alcohol use in stroke prevention ."
106861,Moderately,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106862,elevated,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106863,homocysteine,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106864,levels,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106865,may,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106866,be,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106867,associated,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106868,with,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106869,stroke,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106870,and,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106871,are,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106872,associated,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106873,with,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106874,deficiency,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106875,of,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106876,dietary,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106877,intake,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106878,of,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106879,folate,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106880,",",O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106881,vitamin,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106882,B6,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106883,and,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106884,vitamin,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106885,B12,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106886,.,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106916,Regular,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106917,physical,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106918,activity,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106919,may,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106920,also,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106921,protect,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106922,against,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106923,stroke,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106924,through,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106925,its,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106926,role,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106927,in,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106928,controlling,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106929,various,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106930,risk,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106931,factors,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106932,such,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106933,as,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106934,hypertension,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106935,",",O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106936,diabetes,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106937,mellitus,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106938,and,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106939,obesity,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106940,.,O,3717.0,"Regular physical activity may also protect against stroke through its role in controlling various risk factors such as hypertension , diabetes mellitus and obesity ."
106975,There,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106976,is,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106977,also,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106978,evidence,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106979,that,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106980,a,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106981,low,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106982,serum,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106983,albumin,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106984,may,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106985,be,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106986,causally,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106987,linked,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106988,to,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106989,stroke,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106990,risk,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106991,and,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106992,outcome,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106993,and,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106994,that,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106995,a,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106996,significant,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106997,number,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106998,of,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106999,stroke,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107000,patients,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107001,are,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107002,undernourished,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107003,on,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107004,admission,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107005,and,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107006,their,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107007,nutritional,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107008,status,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107009,deteriorates,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107010,further,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107011,whilst,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107012,in,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107013,hospital,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107014,.,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107514,The,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107515,approach,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107516,by,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107517,which,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107518,the,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107519,insulinemia,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107520,was,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107521,kept,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107522,constant,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107523,by,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107524,the,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107525,artificial,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107526,pancreas,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107527,seems,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107528,to,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107529,be,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107530,a,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107531,valuable,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107532,tool,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107533,for,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107534,studying,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107535,glycemic,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107536,responses,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107537,to,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107538,different,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107539,meals,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107540,in,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107541,IDDM,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107542,patients,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107543,who,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107544,otherwise,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107545,show,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107546,great,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107547,variations,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107548,in,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107549,circulating,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107550,insulin,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107551,and,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107552,glucose,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107553,levels,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107554,when,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107555,treated,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107556,by,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107557,subcutaneously,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107558,administered,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107559,insulin,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107560,.,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107607,Although,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107608,OTA,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107609,has,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107610,been,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107611,shown,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107612,to,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107613,cause,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107614,kidney,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107615,disease,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107616,",",O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107617,including,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107618,kidney,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107619,cancer,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107620,",",O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107621,in,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107622,multiple,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107623,animal,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107624,species,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107625,",",O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107626,the,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107627,impact,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107628,of,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107629,dietary,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107630,OTA,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107631,on,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107632,human,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107633,health,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107634,from,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107635,a,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107636,global,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107637,perspective,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107638,has,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107639,been,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107640,less,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107641,clear,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107642,.,O,3741.0,"Although OTA has been shown to cause kidney disease , including kidney cancer , in multiple animal species , the impact of dietary OTA on human health from a global perspective has been less clear ."
107844,Age-,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107845,",",O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107846,gender-,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107847,",",O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107848,education-,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107849,and,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107850,total,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107851,energy,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107852,intake,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107853,-,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107854,adjusted,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107855,odds,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107856,ratios,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107857,(,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107858,OR,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107859,),O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107860,were,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107861,computed,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107862,.,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
108922,This,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108923,study,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108924,supports,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108925,food,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108926,-,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108927,based,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108928,dietary,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108929,guidelines,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108930,recommending,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108931,to,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108932,consume,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108933,a,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108934,variety,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108935,of,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108936,vegetables,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108937,from,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108938,all,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108939,subgroups,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108940,.,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
109021,It,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109022,was,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109023,found,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109024,that,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109025,cranberries,B-http://purl.bioontology.org/ontology/SNOMEDCT/227421003,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109026,positively,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109027,affect,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109028,atherosclerotic,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109029,cholesterol,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109030,profiles,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109031,and,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109032,that,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109033,they,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109034,reduced,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109035,several,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109036,cardiometabolic,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109037,risk,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109038,factors,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109039,.,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109556,We,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109557,computed,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109558,the,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109559,odds,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109560,ratios,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109561,(,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109562,ORs,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109563,),O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109564,of,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109565,thyroid,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109566,cancer,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109567,and,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109568,the,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109569,corresponding,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109570,95,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109571,%,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109572,confidence,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109573,intervals,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109574,(,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109575,CIs,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109576,),O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109577,according,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109578,to,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109579,the,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109580,median,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109581,of,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109582,control,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109583,group,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109584,daily,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109585,intake,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109586,of,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109587,each,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109588,food,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109589,group,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109590,",",O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109591,using,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109592,multiple,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109593,logistic,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109594,regression,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109595,models,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109596,adjusted,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109597,for,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109598,major,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109599,confounding,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109600,factors,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109601,.,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109895,These,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109896,results,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109897,warrant,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109898,further,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109899,investigations,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109900,and,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109901,",",O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109902,if,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109903,confirmed,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109904,",",O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109905,they,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109906,might,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109907,have,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109908,important,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109909,public,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109910,health,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109911,implications,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109912,for,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109913,the,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109914,reduction,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109915,of,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109916,thyroid,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109917,cancer,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109918,through,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109919,the,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109920,improvement,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109921,of,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109922,dietary,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109923,habits,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109924,.,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
110182,Anthocyanins,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110183,have,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110184,demonstrated,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110185,antioxidant,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110186,potential,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110187,in,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110188,both,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110189,in,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110190,vitro,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110191,and,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110192,in,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110193,vivo,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110194,studies,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110195,",",O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110196,and,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110197,the,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110198,consumption,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110199,of,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110200,foods,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110201,high,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110202,in,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110203,anthocyanins,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110204,has,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110205,been,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110206,linked,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110207,to,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110208,lower,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110209,risks,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110210,of,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110211,chronic,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110212,diseases,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110213,.,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110230,This,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110231,paper,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110232,will,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110233,review,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110234,the,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110235,characteristics,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110236,of,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110237,cereal,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110238,anthocyanins,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110239,",",O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110240,and,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110241,assess,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110242,their,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110243,prevalence,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110244,in,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110245,various,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110246,commercially,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110247,relevant,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110248,crops,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110249,including,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110250,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110251,",",O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110252,barley,B-http://purl.bioontology.org/ontology/SNOMEDCT/735124003,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110253,",",O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110254,maize,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110255,",",O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110256,and,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110257,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110258,.,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110862,Systematic,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110863,examination,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110864,of,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110865,the,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110866,effects,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110867,of,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110868,dietary,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110869,patterns,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110870,that,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110871,include,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110872,regular,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110873,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110874,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110875,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110876,",",O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110877,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110878,and,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110879,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110880,on,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110881,human,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110882,health,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110883,is,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110884,warranted,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110885,.,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
111088,Countries,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111089,with,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111090,discordant,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111091,rates,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111092,of,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111093,colon,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111094,and,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111095,breast,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111096,cancer,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111097,reveal,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111098,a,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111099,similar,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111100,discordance,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111101,between,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111102,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111103,and,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111104,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111105,product,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111106,consumption,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111107,of,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111108,dairy,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111109,cattle,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111110,.,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111111,The,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111112,recent,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111113,isolation,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111114,of,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111115,a,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111116,larger,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111117,number,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111118,of,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111119,novel,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111120,presumably,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111121,viral,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111122,DNAs,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111123,from,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111124,serum,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111125,",",O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111126,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111127,and,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111128,dairy,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111129,products,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111130,of,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111131,healthy,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111132,dairy,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111133,cows,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111134,",",O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111135,at,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111136,least,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111137,part,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111138,of,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111139,them,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111140,infectious,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111141,for,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111142,human,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111143,cells,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111144,",",O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111145,deserves,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111146,further,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111147,investigation,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111148,.,O,3872.0,"The recent isolation of a larger number of novel presumably viral DNAs from serum , meat and dairy products of healthy dairy cows , at least part of them infectious for human cells , deserves further investigation ."
111645,These,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111646,data,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111647,indicate,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111648,that,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111649,greater,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111650,intake,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111651,of,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111652,vegetables,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111653,and,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111654,fruits,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111655,is,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111656,associated,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111657,with,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111658,a,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111659,decreased,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111660,risk,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111661,of,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111662,breast,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111663,cancer,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111664,among,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111665,Chinese,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111666,women,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111667,residing,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111668,in,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111669,Guangdong,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111670,.,O,3894.0,These data indicate that greater intake of vegetables and fruits is associated with a decreased risk of breast cancer among Chinese women residing in Guangdong .
111901,Grape,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,3908.0,Grape or apple juices increased RUNX-2 and decreased RANK - L immunoexpression after cadmium intoxication .
111902,or,I-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,3908.0,Grape or apple juices increased RUNX-2 and decreased RANK - L immunoexpression after cadmium intoxication .
111903,apple,I-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,3908.0,Grape or apple juices increased RUNX-2 and decreased RANK - L immunoexpression after cadmium intoxication .
111904,juices,I-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,3908.0,Grape or apple juices increased RUNX-2 and decreased RANK - L immunoexpression after cadmium intoxication .
111905,increased,O,3908.0,Grape or apple juices increased RUNX-2 and decreased RANK - L immunoexpression after cadmium intoxication .
111906,RUNX-2,O,3908.0,Grape or apple juices increased RUNX-2 and decreased RANK - L immunoexpression after cadmium intoxication .
111907,and,O,3908.0,Grape or apple juices increased RUNX-2 and decreased RANK - L immunoexpression after cadmium intoxication .
111908,decreased,O,3908.0,Grape or apple juices increased RUNX-2 and decreased RANK - L immunoexpression after cadmium intoxication .
111909,RANK,O,3908.0,Grape or apple juices increased RUNX-2 and decreased RANK - L immunoexpression after cadmium intoxication .
111910,-,O,3908.0,Grape or apple juices increased RUNX-2 and decreased RANK - L immunoexpression after cadmium intoxication .
111911,L,O,3908.0,Grape or apple juices increased RUNX-2 and decreased RANK - L immunoexpression after cadmium intoxication .
111912,immunoexpression,O,3908.0,Grape or apple juices increased RUNX-2 and decreased RANK - L immunoexpression after cadmium intoxication .
111913,after,O,3908.0,Grape or apple juices increased RUNX-2 and decreased RANK - L immunoexpression after cadmium intoxication .
111914,cadmium,O,3908.0,Grape or apple juices increased RUNX-2 and decreased RANK - L immunoexpression after cadmium intoxication .
111915,intoxication,O,3908.0,Grape or apple juices increased RUNX-2 and decreased RANK - L immunoexpression after cadmium intoxication .
111916,.,O,3908.0,Grape or apple juices increased RUNX-2 and decreased RANK - L immunoexpression after cadmium intoxication .
112056,In,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112057,contrast,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112058,",",O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112059,isoflavone,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112060,supplementation,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112061,had,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112062,little,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112063,effect,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112064,on,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112065,serum,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112066,lipid,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112067,levels,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112068,or,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112069,gene,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112070,expression,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112071,and,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112072,exerted,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112073,no,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112074,synergistic,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112075,effects,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112076,with,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112077,soy,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112078,protein,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112079,or,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112080,tofu,B-http://purl.bioontology.org/ontology/SNOMEDCT/227365007,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112081,.,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112135,Groups,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112136,of,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112137,18,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112138,-,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112139,21,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112140,male,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112141,weanling,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112142,C3H,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112143,mice,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112144,were,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112145,given,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112146,",",O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112147,as,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112148,drinking,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112149,fluid,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112150,",",O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112151,tap,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112152,-,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112153,water,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112154,",",O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112155,12,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112156,%,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112157,ethanol,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112158,solution,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112159,",",O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112160,one,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112161,of,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112162,two,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112163,commercial,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112164,white,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112165,wines,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112166,",",O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112167,or,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112168,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112169,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112170,",",O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112171,ad,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112172,lib,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112173,.,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112178,Ethyl,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112179,carbamate,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112180,was,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112181,added,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112182,to,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112183,each,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112184,of,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112185,the,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112186,drinking,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112187,liquids,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112188,at,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112189,levels,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112190,adjusted,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112191,to,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112192,provide,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112193,average,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112194,daily,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112195,ethyl,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112196,carbamate,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112197,intakes,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112198,of,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112199,0,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112200,",",O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112201,10,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112202,or,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112203,20,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112204,mg,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112205,/,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112206,kg,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112207,body,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112208,weight,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112209,.,O,3918.0,"Ethyl carbamate was added to each of the drinking liquids at levels adjusted to provide average daily ethyl carbamate intakes of 0 , 10 or 20 mg / kg body weight ."
112689,These,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112690,findings,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112691,could,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112692,support,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112693,future,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112694,interventions,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112695,and,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112696,policies,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112697,for,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112698,optimal,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112699,food,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112700,intake,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112701,in,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112702,Brazil,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112703,.,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112761,An,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112762,interviewer,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112763,-,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112764,administered,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112765,questionnaire,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112766,was,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112767,used,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112768,to,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112769,ascertain,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112770,major,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112771,life,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112772,events,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112773,and,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112774,obtain,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112775,estimates,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112776,of,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112777,consumption,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112778,(,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112779,ever,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112780,-,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112781,never,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112782,),O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112783,and,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112784,frequency,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112785,of,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112786,consumption,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112787,throughout,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112788,life,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112789,.,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
113044,There,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113045,is,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113046,growing,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113047,evidence,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113048,that,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113049,intakes,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113050,of,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113051,high,B-http://purl.bioontology.org/ontology/SNOMEDCT/412064009;http://purl.bioontology.org/ontology/SNOMEDCT/412357001;http://purl.bioontology.org/ontology/SNOMEDCT/229862008,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113052,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/412064009;http://purl.bioontology.org/ontology/SNOMEDCT/412357001;http://purl.bioontology.org/ontology/SNOMEDCT/229862008,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113053,fructose,I-http://purl.bioontology.org/ontology/SNOMEDCT/412064009;http://purl.bioontology.org/ontology/SNOMEDCT/412357001;http://purl.bioontology.org/ontology/SNOMEDCT/229862008,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113054,corn,I-http://purl.bioontology.org/ontology/SNOMEDCT/412064009;http://purl.bioontology.org/ontology/SNOMEDCT/412357001;http://purl.bioontology.org/ontology/SNOMEDCT/229862008,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113055,syrup,I-http://purl.bioontology.org/ontology/SNOMEDCT/412064009;http://purl.bioontology.org/ontology/SNOMEDCT/412357001;http://purl.bioontology.org/ontology/SNOMEDCT/229862008,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113056,(,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113057,HFCS,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113058,),O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113059,",",O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113060,HFCS,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113061,-,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113062,sweetened,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113063,soda,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113064,",",O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113065,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/226465004,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113066,drinks,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/226465004,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113067,and,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113068,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/226491003;http://purl.bioontology.org/ontology/SNOMEDCT/735215001;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113069,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226491003;http://purl.bioontology.org/ontology/SNOMEDCT/735215001;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113070,-,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113071,a,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113072,high,B-http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113073,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113074,fructose,I-http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113075,100,I-http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113076,%,I-http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113077,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113078,-,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113079,are,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113080,associated,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113081,with,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113082,asthma,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113083,",",O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113084,possibly,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113085,because,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113086,of,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113087,the,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113088,high,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113089,fructose,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113090,:,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113091,glucose,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113092,ratios,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113093,and,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113094,underlying,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113095,fructose,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113096,malabsorption,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113097,",",O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113098,which,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113099,may,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113100,contribute,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113101,to,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113102,enteral,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113103,formation,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113104,of,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113105,pro,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113106,-,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113107,inflammatory,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113108,advanced,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113109,glycation,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113110,end,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113111,products,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113112,",",O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113113,which,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113114,bind,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113115,receptors,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113116,that,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113117,are,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113118,mediators,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113119,of,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113120,asthma,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113121,.,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113148,Diet,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113149,soda,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113150,and,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113151,orange,B-http://purl.bioontology.org/ontology/SNOMEDCT/226496008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113152,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226496008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113153,-,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113154,a,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113155,100,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113156,%,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113157,juice,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113158,with,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113159,a,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113160,1:1,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113161,fructose,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113162,:,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113163,glucose,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113164,ratio,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113165,-,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113166,were,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113167,included,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113168,for,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113169,comparison,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113170,.,O,3944.0,Diet soda and orange juice - a 100 % juice with a 1:1 fructose : glucose ratio - were included for comparison .
113285,There,O,3947.0,There were no associations with diet soda / orange juice .
113286,were,O,3947.0,There were no associations with diet soda / orange juice .
113287,no,O,3947.0,There were no associations with diet soda / orange juice .
113288,associations,O,3947.0,There were no associations with diet soda / orange juice .
113289,with,O,3947.0,There were no associations with diet soda / orange juice .
113290,diet,O,3947.0,There were no associations with diet soda / orange juice .
113291,soda,O,3947.0,There were no associations with diet soda / orange juice .
113292,/,O,3947.0,There were no associations with diet soda / orange juice .
113293,orange,B-http://purl.bioontology.org/ontology/SNOMEDCT/226496008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3947.0,There were no associations with diet soda / orange juice .
113294,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226496008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3947.0,There were no associations with diet soda / orange juice .
113295,.,O,3947.0,There were no associations with diet soda / orange juice .
113313,Recommendations,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113314,to,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113315,reduce,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113316,consumption,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113317,may,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113318,be,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113319,inadequate,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113320,to,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113321,address,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113322,asthma,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113323,risk,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113324,",",O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113325,as,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113326,associations,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113327,are,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113328,evident,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113329,even,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113330,with,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113331,moderate,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113332,intake,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113333,of,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113334,these,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113335,beverages,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113336,",",O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113337,including,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113338,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/226491003;http://purl.bioontology.org/ontology/SNOMEDCT/735215001;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113339,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226491003;http://purl.bioontology.org/ontology/SNOMEDCT/735215001;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113340,-,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113341,a,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113342,100,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113343,%,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113344,juice,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113345,.,O,3949.0,"Recommendations to reduce consumption may be inadequate to address asthma risk , as associations are evident even with moderate intake of these beverages , including apple juice - a 100 % juice ."
113693,Even,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113694,when,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113695,circulating,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113696,PTHrP,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113697,levels,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113698,are,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113699,extremely,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113700,low,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113701,or,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113702,below,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113703,the,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113704,detection,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113705,limit,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113706,",",O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113707,milk,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113708,PTHrP,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113709,levels,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113710,are,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113711,remarkably,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113712,high,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113713,.,O,3961.0,"Even when circulating PTHrP levels are extremely low or below the detection limit , milk PTHrP levels are remarkably high ."
113764,Here,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113765,",",O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113766,we,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113767,investigated,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113768,the,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113769,effect,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113770,of,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113771,various,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113772,pretreatment,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113773,procedures,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113774,and,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113775,diluent,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113776,constitutions,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113777,and,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113778,the,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113779,consequent,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113780,PTHrP,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113781,concentrations,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113782,in,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113783,commercial,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113784,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113785,and,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113786,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113787,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113788,in,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113789,Japan,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
113790,.,O,3964.0,"Here , we investigated the effect of various pretreatment procedures and diluent constitutions and the consequent PTHrP concentrations in commercial milk and milk products in Japan ."
114017,In,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114018,some,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114019,countries,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114020,(,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114021,eg,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114022,",",O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114023,United,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114024,States,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114025,",",O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114026,Canada,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114027,),O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114028,",",O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114029,the,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114030,gluten,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114031,-,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114032,free,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114033,diet,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114034,is,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114035,completely,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114036,devoid,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114037,of,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114038,gluten,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114039,and,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114040,is,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114041,based,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114042,on,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114043,foods,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114044,such,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114045,as,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114046,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114047,and,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114048,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/412357001,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114049,that,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114050,are,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114051,naturally,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114052,gluten,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114053,free,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114054,.,O,3972.0,"In some countries ( eg , United States , Canada ) , the gluten - free diet is completely devoid of gluten and is based on foods such as rice and corn that are naturally gluten free ."
114661,There,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114662,were,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114663,1109,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114664,(,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114665,5·2,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114666,%,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114667,),O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114668,first,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114669,sepsis,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114670,events,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114671,.,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
115844,The,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115845,association,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115846,was,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115847,stronger,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115848,for,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115849,the,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115850,"69,181",O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115851,women,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115852,whose,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115853,margarine,B-http://purl.bioontology.org/ontology/SNOMEDCT/226890008,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115854,consumption,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115855,over,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115856,the,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115857,previous,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115858,10,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115859,years,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115860,had,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115861,been,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115862,stable,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115863,(,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115864,1.67,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115865,[,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115866,1.05,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115867,-,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115868,2.66,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115869,],O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115870,",",O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115871,p,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115872,for,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115873,trend,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115874,=,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115875,0.002,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115876,),O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115877,.,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
116167,But,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116168,is,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116169,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116170,an,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116171,alternative,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116172,to,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116173,established,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116174,methods,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116175,of,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116176,disease,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116177,prevention,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116178,or,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116179,treatment,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116180,?,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116181,Scientists,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116182,from,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116183,around,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116184,the,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116185,world,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116186,have,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116187,identified,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116188,a,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116189,number,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116190,of,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116191,bioactive,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116192,substances,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116193,in,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116194,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116195,that,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116196,are,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116197,water,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116198,soluble,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116199,(,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116200,e.g.,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116201,",",O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116202,S,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116203,-,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116204,allyl,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116205,methylcysteine,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116206,),O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116207,",",O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116208,and,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116209,fat,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116210,soluble,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116211,(,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116212,e.g.,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116213,",",O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116214,diallyldisulfide,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116215,),O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116216,.,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116570,Therefore,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116571,because,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116572,hyperlipidemia,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116573,is,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116574,a,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116575,major,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116576,etiopathological,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116577,factor,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116578,for,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116579,atherosclerosis,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116580,",",O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116581,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116582,may,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116583,play,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116584,an,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116585,important,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116586,role,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116587,in,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116588,the,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116589,prevention,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116590,of,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116591,atherosclerosis,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116592,.,O,4065.0,"Therefore because hyperlipidemia is a major etiopathological factor for atherosclerosis , garlic may play an important role in the prevention of atherosclerosis ."
116619,The,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116620,development,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116621,of,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116622,this,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116623,disease,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116624,is,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116625,influenced,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116626,by,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116627,genetic,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116628,and,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116629,environmental,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116630,factors,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116631,.,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
117106,Safety,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117107,concerns,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117108,are,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117109,limited,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117110,to,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117111,the,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117112,infrequent,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117113,occurrence,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117114,of,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117115,nut,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117116,allergy,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117117,in,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117118,children,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117119,.,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117610,The,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117611,characteristic,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117612,phenolic,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117613,compounds,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117614,and,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117615,their,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117616,metabolites,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117617,may,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117618,also,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117619,act,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117620,as,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117621,antibacterial,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117622,agents,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117623,in,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117624,both,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117625,gastrointestinal,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117626,and,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117627,urinary,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117628,tracts,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117629,.,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117812,Increased,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117813,basophil,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117814,sensitivity,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117815,to,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117816,birch,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117817,pollen,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117818,was,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117819,found,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117820,in,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117821,the,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117822,group,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117823,with,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117824,fruit,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117825,allergy,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117826,(,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117827,P,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117828,<,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117829,0.001,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117830,),O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117831,.,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
118090,Cooking,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118091,by,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118092,the,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118093,steaming,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118094,process,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118095,generally,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118096,increased,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118097,the,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118098,bioaccessibility,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118099,of,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118100,Cd,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118101,in,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118102,French,B-http://purl.bioontology.org/ontology/SNOMEDCT/256354006,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118103,bean,I-http://purl.bioontology.org/ontology/SNOMEDCT/256354006,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118104,",",O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118105,carrot,B-http://purl.bioontology.org/ontology/SNOMEDCT/256319004,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118106,",",O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118107,and,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118108,leek,B-http://purl.bioontology.org/ontology/SNOMEDCT/726755004,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118109,.,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118139,The,O,4121.0,The estimation of metal bioaccessibility in vegetables is helpful for human health risk assessment .
118140,estimation,O,4121.0,The estimation of metal bioaccessibility in vegetables is helpful for human health risk assessment .
118141,of,O,4121.0,The estimation of metal bioaccessibility in vegetables is helpful for human health risk assessment .
118142,metal,O,4121.0,The estimation of metal bioaccessibility in vegetables is helpful for human health risk assessment .
118143,bioaccessibility,O,4121.0,The estimation of metal bioaccessibility in vegetables is helpful for human health risk assessment .
118144,in,O,4121.0,The estimation of metal bioaccessibility in vegetables is helpful for human health risk assessment .
118145,vegetables,O,4121.0,The estimation of metal bioaccessibility in vegetables is helpful for human health risk assessment .
118146,is,O,4121.0,The estimation of metal bioaccessibility in vegetables is helpful for human health risk assessment .
118147,helpful,O,4121.0,The estimation of metal bioaccessibility in vegetables is helpful for human health risk assessment .
118148,for,O,4121.0,The estimation of metal bioaccessibility in vegetables is helpful for human health risk assessment .
118149,human,O,4121.0,The estimation of metal bioaccessibility in vegetables is helpful for human health risk assessment .
118150,health,O,4121.0,The estimation of metal bioaccessibility in vegetables is helpful for human health risk assessment .
118151,risk,O,4121.0,The estimation of metal bioaccessibility in vegetables is helpful for human health risk assessment .
118152,assessment,O,4121.0,The estimation of metal bioaccessibility in vegetables is helpful for human health risk assessment .
118153,.,O,4121.0,The estimation of metal bioaccessibility in vegetables is helpful for human health risk assessment .
118536,Adequate,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118537,evidence,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118538,is,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118539,lacking,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118540,on,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118541,the,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118542,association,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118543,between,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118544,shellfish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735029006,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118545,consumption,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118546,and,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118547,the,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118548,risk,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118549,of,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118550,colorectal,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118551,cancer,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118552,",",O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118553,pancreatic,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118554,cancer,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118555,",",O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118556,oral,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118557,cancer,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118558,",",O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118559,endometriosis,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118560,",",O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118561,hip,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118562,fracture,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118563,",",O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118564,cognitive,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118565,function,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118566,",",O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118567,wheeze,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118568,",",O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118569,eczema,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118570,and,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118571,food,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118572,allergy,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118573,.,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118615,Traditional,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118616,analysis,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118617,of,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118618,food,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118619,intake,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118620,usually,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118621,fails,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118622,to,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118623,show,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118624,an,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118625,association,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118626,between,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118627,energy,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118628,and,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118629,nutrient,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118630,intake,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118631,and,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118632,indicators,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118633,of,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118634,obesity,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
118635,.,O,4137.0,Traditional analysis of food intake usually fails to show an association between energy and nutrient intake and indicators of obesity .
119003,Eleven,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119004,intervention,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119005,studies,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119006,that,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119007,involved,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119008,a,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119009,total,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119010,of,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119011,366,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119012,participants,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119013,investigating,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119014,the,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119015,role,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119016,of,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119017,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119018,on,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119019,cognitive,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119020,performance,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119021,in,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119022,children,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119023,and,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119024,young,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119025,adults,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119026,(,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119027,average,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119028,age,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119029,≤,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119030,25,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119031,years,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119032,old,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119033,),O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119034,were,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119035,finally,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119036,selected,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119037,.,O,4150.0,Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults ( average age ≤ 25 years old ) were finally selected .
119319,Variation,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119320,in,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119321,the,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119322,intakes,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119323,of,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119324,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119325,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119326,vegetables,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119327,and,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119328,sugar,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119329,-,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119330,sweetened,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119331,beverages,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119332,(,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119333,SSB,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119334,),O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119335,across,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119336,consumer,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119337,groups,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119338,contributed,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119339,to,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119340,the,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119341,largest,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119342,variance,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119343,in,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119344,DED,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119345,estimates,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119346,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119347,followed,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119348,by,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119349,variation,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119350,in,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119351,the,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119352,intakes,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119353,of,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119354,potatoes,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119355,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119356,fresh,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119357,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119358,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119359,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119360,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119361,chips,B-http://purl.bioontology.org/ontology/SNOMEDCT/227282006,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119362,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119363,ready,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119364,-,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119365,to,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119366,-,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119367,eat,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119368,breakfast,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119369,cereals,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119370,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119371,and,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119372,confectionery,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119373,.,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
120056,To,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120057,evaluate,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120058,the,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120059,possible,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120060,effects,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120061,on,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120062,insulin,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120063,function,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120064,",",O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120065,49,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120066,herb,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120067,",",O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120068,spice,B-http://purl.bioontology.org/ontology/SNOMEDCT/24515005,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120069,",",O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120070,and,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120071,medicinal,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120072,plant,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120073,extracts,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120074,were,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120075,tested,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120076,in,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120077,the,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120078,insulin,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120079,-,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120080,dependent,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120081,utilization,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120082,of,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120083,glucose,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120084,using,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120085,a,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120086,rat,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120087,epididymal,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120088,adipocyte,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120089,assay,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120090,.,O,4183.0,"To evaluate the possible effects on insulin function , 49 herb , spice , and medicinal plant extracts were tested in the insulin - dependent utilization of glucose using a rat epididymal adipocyte assay ."
120165,The,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120166,activity,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120167,of,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120168,sage,B-http://purl.bioontology.org/ontology/SNOMEDCT/227411006,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120169,",",O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120170,mushrooms,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120171,",",O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120172,and,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120173,brewers,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120174,'s,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120175,yeast,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120176,was,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120177,not,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120178,removed,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120179,by,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120180,PVP,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120181,.,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120365,In,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120366,recent,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120367,years,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120368,",",O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120369,the,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120370,prevalence,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120371,of,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120372,metabolic,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120373,syndrome,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120374,",",O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120375,which,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120376,threatens,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120377,public,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120378,health,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120379,",",O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120380,is,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120381,increasing,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120382,rapidly,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120383,.,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120687,The,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120688,expenditure,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120689,of,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120690,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120691,showed,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120692,a,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120693,negative,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120694,association,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120695,with,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120696,SMR,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120697,in,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120698,all,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120699,the,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120700,three,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120701,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120702,expenditure,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120703,subgroups,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120704,",",O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120705,but,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120706,that,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120707,of,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120708,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120709,and,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120710,egg,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120711,in,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120712,the,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120713,low,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120714,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120715,expenditure,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120716,subgroup,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120717,only,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120718,.,O,4206.0,"The expenditure of meat showed a negative association with SMR in all the three rice expenditure subgroups , but that of milk and egg in the low rice expenditure subgroup only ."
120796,These,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120797,findings,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120798,were,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120799,in,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120800,accordance,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120801,with,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120802,the,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120803,generally,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120804,held,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120805,view,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120806,in,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120807,Japan,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120808,that,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120809,moderate,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120810,intake,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120811,of,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120812,animal,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120813,protein,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120814,was,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120815,protective,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120816,against,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120817,stroke,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120818,.,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
121660,The,O,4238.0,The potential beneficial effects of plant - based diets on human health have been extensively studied .
121661,potential,O,4238.0,The potential beneficial effects of plant - based diets on human health have been extensively studied .
121662,beneficial,O,4238.0,The potential beneficial effects of plant - based diets on human health have been extensively studied .
121663,effects,O,4238.0,The potential beneficial effects of plant - based diets on human health have been extensively studied .
121664,of,O,4238.0,The potential beneficial effects of plant - based diets on human health have been extensively studied .
121665,plant,O,4238.0,The potential beneficial effects of plant - based diets on human health have been extensively studied .
121666,-,O,4238.0,The potential beneficial effects of plant - based diets on human health have been extensively studied .
121667,based,O,4238.0,The potential beneficial effects of plant - based diets on human health have been extensively studied .
121668,diets,O,4238.0,The potential beneficial effects of plant - based diets on human health have been extensively studied .
121669,on,O,4238.0,The potential beneficial effects of plant - based diets on human health have been extensively studied .
121670,human,O,4238.0,The potential beneficial effects of plant - based diets on human health have been extensively studied .
121671,health,O,4238.0,The potential beneficial effects of plant - based diets on human health have been extensively studied .
121672,have,O,4238.0,The potential beneficial effects of plant - based diets on human health have been extensively studied .
121673,been,O,4238.0,The potential beneficial effects of plant - based diets on human health have been extensively studied .
121674,extensively,O,4238.0,The potential beneficial effects of plant - based diets on human health have been extensively studied .
121675,studied,O,4238.0,The potential beneficial effects of plant - based diets on human health have been extensively studied .
121676,.,O,4238.0,The potential beneficial effects of plant - based diets on human health have been extensively studied .
121702,The,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121703,aim,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121704,of,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121705,this,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121706,review,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121707,was,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121708,to,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121709,compile,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121710,evidence,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121711,on,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121712,the,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121713,effects,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121714,of,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121715,extracted,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121716,protein,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121717,from,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121718,a,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121719,wide,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121720,range,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121721,of,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121722,traditional,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121723,and,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121724,novel,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121725,plant,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121726,sources,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121727,on,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121728,glycemic,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121729,responses,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121730,",",O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121731,appetite,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121732,",",O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121733,body,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121734,weight,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121735,",",O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121736,metabolic,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121737,",",O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121738,cardiovascular,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121739,and,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121740,muscle,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121741,health,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121742,.,O,4240.0,"The aim of this review was to compile evidence on the effects of extracted protein from a wide range of traditional and novel plant sources on glycemic responses , appetite , body weight , metabolic , cardiovascular and muscle health ."
121910,Twenty,O,4246.0,Twenty - six studies met the inclusion criteria .
121911,-,O,4246.0,Twenty - six studies met the inclusion criteria .
121912,six,O,4246.0,Twenty - six studies met the inclusion criteria .
121913,studies,O,4246.0,Twenty - six studies met the inclusion criteria .
121914,met,O,4246.0,Twenty - six studies met the inclusion criteria .
121915,the,O,4246.0,Twenty - six studies met the inclusion criteria .
121916,inclusion,O,4246.0,Twenty - six studies met the inclusion criteria .
121917,criteria,O,4246.0,Twenty - six studies met the inclusion criteria .
121918,.,O,4246.0,Twenty - six studies met the inclusion criteria .
122121,PE,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122122,significantly,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122123,increased,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122124,plasma,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122125,antioxidant,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122126,capacity,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122127,by,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122128,9,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122129,%,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122130,in,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122131,Group,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122132,E,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122133,+,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122134,PE,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122135,and,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122136,18,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122137,%,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122138,in,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122139,Group,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122140,W,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122141,+,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122142,PE,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122143,compared,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122144,with,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122145,their,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122146,respective,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122147,controls,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122148,.,O,4255.0,PE significantly increased plasma antioxidant capacity by 9 % in Group E + PE and 18 % in Group W + PE compared with their respective controls .
122186,Aortic,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122187,fatty,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122188,streak,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122189,area,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122190,(,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122191,AFSA,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122192,),O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122193,was,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122194,significantly,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122195,reduced,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122196,in,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122197,the,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122198,groups,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122199,receiving,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122200,PE,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122201,in,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122202,ethanol,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122203,(,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122204,-32,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122205,%,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122206,),O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122207,or,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122208,PE,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122209,in,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122210,water,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122211,(,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122212,-29,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122213,%,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122214,),O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122215,in,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122216,comparison,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122217,with,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122218,their,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122219,respective,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122220,controls,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122221,.,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122529,Results,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122530,from,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122531,this,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122532,study,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122533,suggest,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122534,that,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122535,types,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122536,of,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122537,fluids,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122538,consumed,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122539,may,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122540,play,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122541,a,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122542,role,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122543,in,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122544,the,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122545,development,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122546,of,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122547,bladder,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122548,cancer,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122549,.,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122843,We,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122844,studied,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122845,6686,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122846,enrollees,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122847,aged,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122848,65,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122849,+,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122850,(,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122851,55,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122852,%,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122853,women,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122854,),O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122855,in,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122856,the,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122857,ongoing,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122858,French,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122859,population,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122860,-,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122861,based,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122862,NutriNet,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122863,-,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122864,Santé,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122865,e,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122866,-,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122867,cohort,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122868,.,O,4279.0,We studied 6686 enrollees aged 65 + ( 55 % women ) in the ongoing French population - based NutriNet - Santé e - cohort .
122878,The,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122879,sex,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122880,-,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122881,specific,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122882,correlates,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122883,of,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122884,factor,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122885,analysis,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122886,derived,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122887,DP,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122888,were,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122889,identified,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122890,with,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122891,multivariable,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122892,linear,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122893,regression,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
122894,.,O,4281.0,The sex - specific correlates of factor analysis derived DP were identified with multivariable linear regression .
124382,We,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124383,have,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124384,recently,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124385,reported,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124386,that,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124387,patients,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124388,with,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124389,fibromyalgia,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124390,(,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124391,FM,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124392,),O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124393,may,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124394,be,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124395,at,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124396,increased,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124397,risk,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124398,for,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124399,cardiovascular,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124400,disease,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124401,.,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124449,Patients,O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124450,were,O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124451,randomized,O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124452,into,O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124453,two,O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124454,groups,O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124455,:,O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124456,15,O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124457,women,O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124458,ingested,O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124459,extra,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124460,virgin,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124461,olive,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124462,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124463,(,O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124464,EVOO,O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124465,),O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124466,and,O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124467,15,O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124468,refined,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124469,olive,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124470,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124471,(,O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124472,ROO,O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124473,),O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124474,.,O,4341.0,Patients were randomized into two groups : 15 women ingested extra virgin olive oil ( EVOO ) and 15 refined olive oil ( ROO ) .
124579,Dietary,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124580,histories,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124581,concerned,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124582,the,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124583,frequency,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124584,of,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124585,consumption,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124586,per,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124587,week,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124588,of,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124589,alcohol,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124590,",",O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124591,beverages,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124592,that,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124593,contain,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124594,methylxanthine,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124595,",",O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124596,and,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124597,14,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124598,select,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124599,food,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124600,items,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124601,or,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124602,groups,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124603,of,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124604,foods,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124605,(,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124606,including,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124607,major,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124608,sources,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124609,of,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124610,proteins,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124611,",",O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124612,fat,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124613,",",O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124614,fibers,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124615,",",O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124616,and,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124617,vitamin,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124618,A,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124619,in,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124620,the,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124621,Italian,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124622,diet,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124623,),O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124624,.,O,4345.0,"Dietary histories concerned the frequency of consumption per week of alcohol , beverages that contain methylxanthine , and 14 select food items or groups of foods ( including major sources of proteins , fat , fibers , and vitamin A in the Italian diet ) ."
124736,The,O,4350.0,The liver plays an outsized role in oncology .
124737,liver,O,4350.0,The liver plays an outsized role in oncology .
124738,plays,O,4350.0,The liver plays an outsized role in oncology .
124739,an,O,4350.0,The liver plays an outsized role in oncology .
124740,outsized,O,4350.0,The liver plays an outsized role in oncology .
124741,role,O,4350.0,The liver plays an outsized role in oncology .
124742,in,O,4350.0,The liver plays an outsized role in oncology .
124743,oncology,O,4350.0,The liver plays an outsized role in oncology .
124744,.,O,4350.0,The liver plays an outsized role in oncology .
124810,The,O,4353.0,The liver is also the most common site of distant metastasis from solid tumors .
124811,liver,O,4353.0,The liver is also the most common site of distant metastasis from solid tumors .
124812,is,O,4353.0,The liver is also the most common site of distant metastasis from solid tumors .
124813,also,O,4353.0,The liver is also the most common site of distant metastasis from solid tumors .
124814,the,O,4353.0,The liver is also the most common site of distant metastasis from solid tumors .
124815,most,O,4353.0,The liver is also the most common site of distant metastasis from solid tumors .
124816,common,O,4353.0,The liver is also the most common site of distant metastasis from solid tumors .
124817,site,O,4353.0,The liver is also the most common site of distant metastasis from solid tumors .
124818,of,O,4353.0,The liver is also the most common site of distant metastasis from solid tumors .
124819,distant,O,4353.0,The liver is also the most common site of distant metastasis from solid tumors .
124820,metastasis,O,4353.0,The liver is also the most common site of distant metastasis from solid tumors .
124821,from,O,4353.0,The liver is also the most common site of distant metastasis from solid tumors .
124822,solid,O,4353.0,The liver is also the most common site of distant metastasis from solid tumors .
124823,tumors,O,4353.0,The liver is also the most common site of distant metastasis from solid tumors .
124824,.,O,4353.0,The liver is also the most common site of distant metastasis from solid tumors .
125041,Red,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125042,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125043,has,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125044,been,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125045,suggested,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125046,to,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125047,be,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125048,adversely,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125049,associated,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125050,with,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125051,risk,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125052,of,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125053,myocardial,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125054,infarction,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125055,(,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125056,MI,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125057,),O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125058,",",O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125059,whereas,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125060,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125061,consumption,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125062,has,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125063,been,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125064,found,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125065,to,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125066,be,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125067,protective,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125068,.,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125139,Adjusted,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125140,Cox,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125141,proportional,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125142,hazard,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125143,models,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125144,were,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125145,used,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125146,to,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125147,calculate,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125148,hazard,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125149,ratios,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125150,(,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125151,HR,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125152,),O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125153,and,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125154,95,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125155,%,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125156,CI,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125157,for,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125158,MI,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125159,associated,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125160,with,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125161,specified,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125162,food,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125163,substitutions,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125164,of,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125165,150,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125166,g,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125167,/,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125168,week,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125169,.,O,4366.0,Adjusted Cox proportional hazard models were used to calculate hazard ratios ( HR ) and 95 % CI for MI associated with specified food substitutions of 150 g / week .
125213,Replacing,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125214,fatty,B-http://purl.bioontology.org/ontology/SNOMEDCT/227110001;http://purl.bioontology.org/ontology/SNOMEDCT/735971005,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125215,fish,I-http://purl.bioontology.org/ontology/SNOMEDCT/227110001;http://purl.bioontology.org/ontology/SNOMEDCT/735971005,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125216,with,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125217,vegetables,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125218,was,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125219,associated,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125220,with,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125221,a,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125222,higher,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125223,risk,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125224,of,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125225,MI,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125226,(,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125227,HR,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125228,1·23,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125229,;,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125230,95,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125231,%,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125232,CI,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125233,1·05,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125234,",",O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125235,1·45,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125236,),O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125237,",",O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125238,whereas,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125239,an,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125240,inverse,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125241,",",O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125242,statistically,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125243,non,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125244,-,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125245,significant,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125246,association,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125247,was,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125248,found,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125249,for,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125250,lean,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125251,fish,I-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125252,(,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125253,HR,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125254,0·93,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125255,;,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125256,95,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125257,%,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125258,CI,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125259,0·83,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125260,",",O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125261,1·05,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125262,),O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125263,.,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125422,Pigmented,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125423,sorghum,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125424,grain,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125425,is,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125426,a,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125427,rich,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125428,source,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125429,of,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125430,antioxidants,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125431,like,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125432,polyphenols,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125433,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125434,mainly,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125435,tannins,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125436,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125437,which,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125438,have,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125439,multiple,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125440,benefits,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125441,on,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125442,human,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125443,health,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125444,such,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125445,as,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125446,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125447,antiproliferative,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125448,properties,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125449,associated,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125450,with,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125451,the,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125452,prevention,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125453,of,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125454,certain,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125455,cancers,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125456,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125457,antioxidant,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125458,activities,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125459,related,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125460,to,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125461,the,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125462,prevention,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125463,of,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125464,associated,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125465,diseases,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125466,to,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125467,oxidative,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125468,stress,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125469,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125470,antimicrobial,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125471,and,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125472,anti,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125473,-,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125474,inflammatory,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125475,effects,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125476,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125477,it,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125478,also,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125479,improves,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125480,glucose,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125481,metabolism,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125482,.,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125788,Within,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125789,the,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125790,group,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125791,of,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125792,fruits,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125793,",",O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125794,the,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125795,strongest,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125796,inverse,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125797,association,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125798,was,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125799,observed,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125800,for,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125801,banana,B-http://purl.bioontology.org/ontology/SNOMEDCT/256307007,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125802,(,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125803,p,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125804,=,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125805,0.07,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125806,by,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125807,Wald,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125808,test,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125809,),O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125810,.,O,4386.0,"Within the group of fruits , the strongest inverse association was observed for banana ( p = 0.07 by Wald test ) ."
125916,Our,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125917,results,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125918,suggested,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125919,that,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125920,high,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125921,consumption,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125922,of,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125923,fruits,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125924,and,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125925,vegetables,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125926,might,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125927,be,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125928,associated,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125929,with,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125930,reduced,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125931,risk,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125932,of,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125933,RCC,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
125934,.,O,4391.0,Our results suggested that high consumption of fruits and vegetables might be associated with reduced risk of RCC .
126577,In,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126578,contrast,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126579,",",O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126580,individuals,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126581,in,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126582,the,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126583,highest,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126584,quartile,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126585,of,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126586,increased,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126587,consumption,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126588,of,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126589,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126590,(,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126591,OR,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126592,=,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126593,0.6,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126594,;,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126595,CI,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126596,=,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126597,0.3,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126598,-,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126599,1.1,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126600,),O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126601,and,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126602,vegetables,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126603,(,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126604,OR,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126605,=,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126606,0.5,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126607,;,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126608,CI,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126609,=,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126610,0.3,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126611,-,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126612,1.1,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126613,),O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126614,had,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126615,a,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126616,lower,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126617,risk,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126618,compared,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126619,with,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126620,those,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126621,with,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126622,minimal,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126623,increase,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126624,in,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126625,consumption,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126626,.,O,4409.0,"In contrast , individuals in the highest quartile of increased consumption of fish ( OR = 0.6 ; CI = 0.3 - 1.1 ) and vegetables ( OR = 0.5 ; CI = 0.3 - 1.1 ) had a lower risk compared with those with minimal increase in consumption ."
126673,Intake,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126674,in,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126675,the,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126676,morning,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126677,is,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126678,associated,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126679,with,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126680,a,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126681,reduction,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126682,in,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126683,the,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126684,total,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126685,intake,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126686,for,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126687,the,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126688,day,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126689,",",O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126690,while,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126691,intake,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126692,at,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126693,night,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126694,is,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126695,associated,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126696,with,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126697,greater,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126698,overall,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126699,daily,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126700,intake,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126701,.,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126913,Dietary,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126914,energy,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126915,density,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126916,appeared,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126917,to,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126918,mediate,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126919,the,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126920,associations,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126921,between,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126922,particular,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126923,foods,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126924,and,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126925,beverages,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126926,and,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126927,overall,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126928,energy,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126929,intake,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126930,.,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126968,The,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126969,increasing,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126970,prevalence,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126971,of,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126972,childhood,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126973,obesity,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126974,is,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126975,a,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126976,serious,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126977,public,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126978,health,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126979,problem,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126980,associated,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126981,with,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126982,co,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126983,-,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126984,morbidities,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126985,in,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126986,adulthood,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126987,",",O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126988,as,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126989,well,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126990,as,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126991,childhood,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126992,.,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
127160,According,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127161,to,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127162,multiple,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127163,linear,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127164,regression,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127165,analysis,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127166,",",O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127167,there,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127168,were,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127169,no,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127170,significant,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127171,associations,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127172,between,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127173,total,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127174,sugar,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127175,intake,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127176,and,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127177,adiposity,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127178,and,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127179,cMetS.,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127180,However,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127181,",",O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127182,higher,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127183,intake,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127184,of,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127185,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127186,sugar,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127187,at,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127188,baseline,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127189,was,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127190,significantly,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127191,associated,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127192,with,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127193,lower,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127194,body,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127195,mass,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127196,index,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127197,(,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127198,BMI,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127199,),O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127200,z,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127201,-,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127202,scores,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127203,and,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127204,body,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127205,fat,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127206,percentages,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127207,at,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127208,baseline,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127209,(,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127210,β,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127211,=,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127212,-0.10,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127213,",",O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127214,p,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127215,=,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127216,0.02,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127217,and,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127218,β,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127219,=,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127220,-0.78,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127221,",",O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127222,p,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127223,<,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127224,0.01,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127225,",",O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127226,respectively,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127227,),O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127228,.,O,4425.0,"According to multiple linear regression analysis , there were no significant associations between total sugar intake and adiposity and cMetS. However , higher intake of fruit sugar at baseline was significantly associated with lower body mass index ( BMI ) z - scores and body fat percentages at baseline ( β = -0.10 , p = 0.02 and β = -0.78 , p < 0.01 , respectively ) ."
127436,Samples,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127437,from,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127438,each,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127439,step,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127440,of,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127441,bread,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127442,preparation,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127443,were,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127444,analyzed,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127445,for,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127446,folic,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127447,acid,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127448,concentration,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127449,.,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127638,Many,O,4444.0,"Many NHPs exert hypoglycemic effects , among other effects relevant to diabetes management ."
127639,NHPs,O,4444.0,"Many NHPs exert hypoglycemic effects , among other effects relevant to diabetes management ."
127640,exert,O,4444.0,"Many NHPs exert hypoglycemic effects , among other effects relevant to diabetes management ."
127641,hypoglycemic,O,4444.0,"Many NHPs exert hypoglycemic effects , among other effects relevant to diabetes management ."
127642,effects,O,4444.0,"Many NHPs exert hypoglycemic effects , among other effects relevant to diabetes management ."
127643,",",O,4444.0,"Many NHPs exert hypoglycemic effects , among other effects relevant to diabetes management ."
127644,among,O,4444.0,"Many NHPs exert hypoglycemic effects , among other effects relevant to diabetes management ."
127645,other,O,4444.0,"Many NHPs exert hypoglycemic effects , among other effects relevant to diabetes management ."
127646,effects,O,4444.0,"Many NHPs exert hypoglycemic effects , among other effects relevant to diabetes management ."
127647,relevant,O,4444.0,"Many NHPs exert hypoglycemic effects , among other effects relevant to diabetes management ."
127648,to,O,4444.0,"Many NHPs exert hypoglycemic effects , among other effects relevant to diabetes management ."
127649,diabetes,O,4444.0,"Many NHPs exert hypoglycemic effects , among other effects relevant to diabetes management ."
127650,management,O,4444.0,"Many NHPs exert hypoglycemic effects , among other effects relevant to diabetes management ."
127651,.,O,4444.0,"Many NHPs exert hypoglycemic effects , among other effects relevant to diabetes management ."
127852,Treatments,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127853,(,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127854,2,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127855,x,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127856,2,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127857,factorial,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127858,arrangement,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127859,),O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127860,given,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127861,orally,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127862,once,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127863,daily,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127864,for,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127865,the,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127866,first,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127867,3,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127868,d,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127869,postpartum,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127870,were,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127871,water,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127872,(,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127873,control,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127874,),O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127875,",",O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127876,500,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127877,ml,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127878,of,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127879,PG,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127880,",",O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127881,454,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127882,g,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127883,of,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127884,fat,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127885,",",O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127886,or,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127887,500,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127888,ml,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127889,of,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127890,PG,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127891,plus,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127892,454,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127893,g,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127894,of,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127895,fat,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127896,.,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127960,Administration,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127961,of,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127962,either,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127963,PG,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127964,or,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127965,fat,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127966,increased,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127967,plasma,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127968,glucose,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127969,and,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127970,liver,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127971,glycogen,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127972,concentrations,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127973,compared,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127974,to,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127975,the,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127976,control,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127977,or,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127978,PG,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127979,plus,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127980,fat,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127981,treatments,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127982,.,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
128816,Conversely,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128817,",",O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128818,the,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128819,fat,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128820,from,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128821,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128822,alone,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128823,is,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128824,a,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128825,pro,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128826,-,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128827,oxidant,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128828,in,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128829,this,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128830,model,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128831,.,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
129094,The,O,4491.0,The fats in these foods are not associated with increased risk for heart disease .
129095,fats,O,4491.0,The fats in these foods are not associated with increased risk for heart disease .
129096,in,O,4491.0,The fats in these foods are not associated with increased risk for heart disease .
129097,these,O,4491.0,The fats in these foods are not associated with increased risk for heart disease .
129098,foods,O,4491.0,The fats in these foods are not associated with increased risk for heart disease .
129099,are,O,4491.0,The fats in these foods are not associated with increased risk for heart disease .
129100,not,O,4491.0,The fats in these foods are not associated with increased risk for heart disease .
129101,associated,O,4491.0,The fats in these foods are not associated with increased risk for heart disease .
129102,with,O,4491.0,The fats in these foods are not associated with increased risk for heart disease .
129103,increased,O,4491.0,The fats in these foods are not associated with increased risk for heart disease .
129104,risk,O,4491.0,The fats in these foods are not associated with increased risk for heart disease .
129105,for,O,4491.0,The fats in these foods are not associated with increased risk for heart disease .
129106,heart,O,4491.0,The fats in these foods are not associated with increased risk for heart disease .
129107,disease,O,4491.0,The fats in these foods are not associated with increased risk for heart disease .
129108,.,O,4491.0,The fats in these foods are not associated with increased risk for heart disease .
129426,Cancers,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129427,of,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129428,the,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129429,colon,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129430,and,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129431,prostate,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129432,were,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129433,significantly,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129434,more,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129435,likely,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129436,in,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129437,nonvegetarians,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129438,(,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129439,RR,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129440,of,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129441,1.88,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129442,and,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129443,1.54,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129444,",",O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129445,respectively,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129446,),O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129447,",",O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129448,and,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129449,frequent,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129450,beef,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129451,consumers,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129452,also,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129453,had,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129454,higher,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129455,risk,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129456,of,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129457,bladder,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129458,cancer,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129459,.,O,4500.0,"Cancers of the colon and prostate were significantly more likely in nonvegetarians ( RR of 1.88 and 1.54 , respectively ) , and frequent beef consumers also had higher risk of bladder cancer ."
129501,Cross,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129502,-,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129503,sectional,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129504,data,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129505,suggest,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129506,vegetarian,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129507,Seventh,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129508,-,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129509,day,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129510,Adventists,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129511,have,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129512,lower,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129513,risks,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129514,of,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129515,diabetes,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129516,mellitus,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129517,",",O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129518,hypertension,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129519,",",O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129520,and,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129521,arthritis,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129522,than,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129523,nonvegetarians,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129524,.,O,4503.0,"Cross - sectional data suggest vegetarian Seventh - day Adventists have lower risks of diabetes mellitus , hypertension , and arthritis than nonvegetarians ."
129916,Current,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129917,cigarette,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129918,smokers,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129919,at,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129920,time,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129921,of,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129922,examination,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129923,had,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129924,a,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129925,3,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129926,-,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129927,fold,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129928,risk,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129929,for,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129930,upper,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129931,aerodigestive,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129932,tract,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129933,cancer,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129934,compared,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129935,with,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129936,never,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129937,-,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129938,smokers,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129939,.,O,4517.0,Current cigarette smokers at time of examination had a 3 - fold risk for upper aerodigestive tract cancer compared with never - smokers .
129973,Of,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129974,23,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129975,food,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129976,and,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129977,beverage,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129978,categories,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129979,",",O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129980,only,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129981,candy,B-http://purl.bioontology.org/ontology/SNOMEDCT/227607007;http://purl.bioontology.org/ontology/SNOMEDCT/227722009,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129982,/,I-http://purl.bioontology.org/ontology/SNOMEDCT/227607007;http://purl.bioontology.org/ontology/SNOMEDCT/227722009,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129983,jelly,I-http://purl.bioontology.org/ontology/SNOMEDCT/227607007;http://purl.bioontology.org/ontology/SNOMEDCT/227722009,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129984,/,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129985,soda,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129986,pop,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129987,consumption,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129988,had,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129989,a,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129990,statistically,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129991,significant,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129992,inverse,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129993,trend,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129994,.,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
130069,A,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130070,panel,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130071,of,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130072,148,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130073,extracts,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130074,from,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130075,37,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130076,food,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130077,products,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130078,was,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130079,prepared,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130080,using,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130081,organic,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130082,and,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130083,aqueous,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130084,solvents,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130085,and,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130086,both,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130087,neutral,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130088,and,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130089,acidic,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130090,conditions,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130091,.,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130297,Curry,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130298,and,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130299,paprika,B-http://purl.bioontology.org/ontology/SNOMEDCT/227408005,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130300,produced,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130301,reactions,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130302,most,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130303,frequently,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130304,",",O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130305,and,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130306,when,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130307,the,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130308,components,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130309,of,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130310,curry,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130311,were,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130312,tested,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130313,separately,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130314,",",O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130315,coriander,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130316,",",O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130317,caraway,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130318,",",O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130319,cayenne,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130320,and,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130321,mustard,B-http://purl.bioontology.org/ontology/SNOMEDCT/51905005,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130322,were,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130323,responsible,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130324,for,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130325,the,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130326,vast,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130327,majority,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130328,of,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130329,the,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130330,skin,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130331,reactions,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130332,.,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130333,A,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130334,high,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130335,correlation,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130336,between,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130337,positive,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130338,skin,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130339,test,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130340,reactions,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130341,to,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130342,spices,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130343,",",O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130344,especially,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130345,to,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130346,curry,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130347,and,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130348,its,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130349,components,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130350,",",O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130351,and,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130352,tree,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130353,pollens,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130354,",",O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130355,fruits,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130356,and,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130357,vegetables,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130358,was,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130359,demonstrated,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130360,",",O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130361,suggesting,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130362,that,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130363,there,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130364,may,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130365,be,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130366,a,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130367,group,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130368,of,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130369,cross,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130370,allergies,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130371,.,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130372,Clinical,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130373,symptoms,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130374,from,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130375,ingested,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130376,spices,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130377,were,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130378,noticed,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130379,by,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130380,five,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130381,patients,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130382,.,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130420,Peroral,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130421,challenges,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130422,with,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130423,spices,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130424,in,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130425,gelatin,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130426,capsules,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130427,were,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130428,negative,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130429,in,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130430,20,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130431,nonselected,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130432,patients,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130433,.,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130434,Oral,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130435,and,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130436,external,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130437,dosing,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130438,methods,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130439,replicating,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130440,field,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130441,exposure,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130442,were,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130443,developed,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130444,using,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130445,the,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130446,double,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130447,crested,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130448,cormorant,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130449,(,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130450,DCCO,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130451,),O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130452,to,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130453,test,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130454,the,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130455,toxicity,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130456,of,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130457,artificially,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130458,weathered,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130459,Deepwater,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130460,Horizon,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130461,Mississippi,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130462,Canyon,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130463,252,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130464,oil,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130465,.,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130636,Birds,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130637,exposed,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130638,to,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130639,oil,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130640,externally,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130641,consumed,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130642,more,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130643,fish,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130644,than,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130645,control,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130646,birds,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130647,",",O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130648,indicating,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130649,metabolic,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130650,compensation,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130651,for,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130652,thermal,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130653,stress,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130654,.,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130673,In,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130674,recent,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130675,years,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130676,",",O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130677,there,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130678,has,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130679,been,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130680,growing,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130681,interest,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130682,in,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130683,cancer,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130684,prevention,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130685,by,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130686,food,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130687,plants,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130688,and,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130689,their,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130690,products,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130691,.,O,4546.0,"In recent years , there has been growing interest in cancer prevention by food plants and their products ."
130692,Although,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130693,several,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130694,plant,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130695,parts,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130696,have,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130697,potentials,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130698,for,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130699,chemoprevention,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130700,and,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130701,other,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130702,therapeutic,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130703,use,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130704,",",O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130705,their,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130706,molecular,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130707,mechanisms,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130708,of,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130709,action,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130710,are,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130711,not,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130712,always,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130713,well,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130714,understood,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130715,.,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130716,Extensive,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130717,research,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130718,has,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130719,identified,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130720,several,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130721,molecular,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130722,targets,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130723,that,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130724,can,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130725,potentially,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130726,be,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130727,used,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130728,for,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130729,the,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130730,prevention,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130731,and/or,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130732,treatment,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130733,of,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130734,cancer,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130735,.,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
131127,Biochemical,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131128,parameters,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131129,and,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131130,cellular,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131131,and,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131132,circulating,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131133,inflammatory,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131134,biomarkers,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131135,were,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131136,assessed,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131137,at,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131138,baseline,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131139,and,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131140,6,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131141,h,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131142,after,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131143,each,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131144,intervention,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131145,.,O,4558.0,Biochemical parameters and cellular and circulating inflammatory biomarkers were assessed at baseline and 6 h after each intervention .
131554,This,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131555,review,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131556,summarizes,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131557,the,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131558,HDACs,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131559,classification,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131560,",",O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131561,their,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131562,aberrant,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131563,expression,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131564,in,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131565,cancerous,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131566,tissue,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131567,",",O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131568,structures,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131569,",",O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131570,sources,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131571,",",O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131572,and,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131573,the,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131574,anticancer,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131575,mechanisms,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131576,of,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131577,HDACi,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131578,",",O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131579,as,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131580,well,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131581,as,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131582,HDACi,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131583,that,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131584,are,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131585,either,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131586,FDA,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131587,-,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131588,approved,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131589,or,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131590,under,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131591,clinical,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131592,trials,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131593,.,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131727,Breads,O,4578.0,Breads with guar gum had color characteristics similar to French bread .
131728,with,O,4578.0,Breads with guar gum had color characteristics similar to French bread .
131729,guar,O,4578.0,Breads with guar gum had color characteristics similar to French bread .
131730,gum,O,4578.0,Breads with guar gum had color characteristics similar to French bread .
131731,had,O,4578.0,Breads with guar gum had color characteristics similar to French bread .
131732,color,O,4578.0,Breads with guar gum had color characteristics similar to French bread .
131733,characteristics,O,4578.0,Breads with guar gum had color characteristics similar to French bread .
131734,similar,O,4578.0,Breads with guar gum had color characteristics similar to French bread .
131735,to,O,4578.0,Breads with guar gum had color characteristics similar to French bread .
131736,French,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4578.0,Breads with guar gum had color characteristics similar to French bread .
131737,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4578.0,Breads with guar gum had color characteristics similar to French bread .
131738,.,O,4578.0,Breads with guar gum had color characteristics similar to French bread .
131774,Bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/226723006;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131775,prepared,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/226723006;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131776,with,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/226723006;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131777,buckwheat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/226723006;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131778,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/226723006;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131779,had,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131780,improved,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131781,quality,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131782,:,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131783,an,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131784,increased,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131785,specific,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131786,volume,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131787,",",O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131788,a,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131789,softer,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131790,texture,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131791,",",O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131792,color,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131793,characteristics,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131794,",",O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131795,and,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131796,gas,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131797,-,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131798,cell,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131799,size,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131800,distribution,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131801,similar,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131802,to,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131803,French,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131804,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131805,.,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
132165,The,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132166,low,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132167,de,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132168,novo,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132169,diet,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132170,significantly,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132171,increased,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132172,plasma,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132173,Zn,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132174,and,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132175,milk,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132176,Zn,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132177,content,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132178,",",O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132179,whereas,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132180,dietary,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132181,Zn,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132182,level,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132183,did,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132184,not,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132185,in,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132186,itself,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132187,influence,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132188,these,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132189,parameters,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132190,.,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132191,This,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132192,indicates,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132193,that,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132194,the,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132195,transfer,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132196,of,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132197,fat,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132198,from,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132199,diet,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132200,to,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132201,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132202,might,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132203,facilitate,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132204,transfer,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132205,of,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132206,Zn,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132207,from,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132208,diet,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132209,to,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132210,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132211,.,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
